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1 INTRODUCTION 
1.1  Mitochondrial Respiratory Chain 
The metabolic degradation of nutrients, e.g., glucose or fat, enables the formation of 
strong reducing agents like NADH and FADH2 from which the respiratory chain 
transfers electrons through a redox potential span of about 1.1 V to O2. The free 
energy of this electron transfer is used for vectorial proton translocation across the 
inner mitochondrial membrane into the intermembrane space. ATP-synthase uses 
this proton gradient for the synthesis of ATP which serves as universal energy 
supplier in cellular metabolism. The fundamental principle of this energy conversion 
was proposed by Peter Mitchell and is known as the chemiosmotic hypothesis 
(Mitchell, 1961). 
The mitochondrial respiratory chain is an assembly of approximately 20 discrete 
electron carriers of which not all function independently in the membrane. The only 
mobile electron carriers are ubiquinone in the mitochondrial inner membrane and 
cytochrome c in the intermembrane space. When treated with certain detergents in 
low concentrations the mitochondrial respiratory chain can be fractionated into four 
multi-polypeptide complexes named complexes I-IV. Three of these complexes (I, III 
and IV) act as redox-driven proton pumps. There are now detailed crystal structures 
available for three of these complexes (complex  II (Yankovskaya et al., 2003), 
complex III (Hunte et al., 2000; Iwata et al., 1998), complex IV (Iwata et al., 1995; 
Ostermeier  et al., 1997)); only for complex  I there is no high resolution structure 
available. As recently shown in bovine and Saccaromyces cerevisiae mitochondria 
(Schägger and Pfeiffer, 2000) these complexes do not diffuse randomly in the 
mitochondrial membrane; instead they are probably part of supra-molecular 
assemblies (supercomplexes) with defined stoichiometries that can be called 
‘respirasomes’. 
The mitochondrial respiratory chain is not only the major site for production of ATP. 
Recently it was recognised that it plays an important role in apoptosis (Green and 
Reed, 1998; Kroemer and Reed, 2000; Wang et al., 2001) which involves the release 2 
of several proapoptotic regulators including cytochrome c (Du et al., 2000). Defects 
of mitochondrial metabolism are associated with a wide spectrum of disease. 
Significant part of this spectrum is caused by mutations in the mitochondrial DNA 
(mtDNA). 
1.2  Mitochondrial Complex I 
Mitochondrial complex  I is the first component of the respiratory chain coupling 
electron transfer from NADH to ubiquinone to proton translocation across the inner 
mitochondrial membrane. Low resolution electron microscopic 2D and 3D analysis of 
complex I from various sources (Y. lipolytica, Djafarzadeh et al., 2000; N. crassa, 
Guenebaut et al., 1997; E. coli, Guenebaut et al., 1998; Bos taurus heart, Grigorieff, 
1998) have yielded L-shaped structures consisting of a membrane arm and 
peripheral arm extending to the mitochondrial matrix. A so called ‘horse shoe’ 
conformation of E. coli complex I was also described under conditions of zero ionic 
strength (Böttcher et al., 2002). However, this alternate shape could not be 
reproduced by another group under the same conditions working with the same 
organism (Sazanov, 2002). Therefore, the relevance of this extraordinary structure is 
still a matter of debate. 
Enzymes from fungi and mammals are very similar in terms of protein and prosthetic 
group composition, structure and function. Complex  I contains a high number of 
polypeptide subunits of dual genetic origin. In prokaryotes, complex I is formed with a 
minimal set of 14 subunits, while in eukaryotes the number of subunits is increased 
significantly by accessory subunits. Mitochondrial complex  I from mammals is 
composed of 46 subunits (Carroll et al., 2003; Skehel et al., 1998), from plants and 
fungi of at least 35 subunits (Weiss et al., 1991; Djafarzadeh et al., 2000). In 
eukaryotes, seven of the 14 (so called ‘central’) subunits which are also present in 
prokaryotes are nuclear coded and bear all known redox prosthetic groups. The 
remaining seven ND subunits are highly hydrophobic proteins encoded by the 
mitochondrial genome in eukaryotes. The function of the remaining accessory 
subunits is largely unknown.    INTRODUCTION 
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Dissociation of complex I into fragments has been observed with purified complex I. 
In E. coli a subcomplex containing the 75-, 51- and 24-kDa subunit can be generated 
(Leif et al., 1995). When bovine complex I is treated with chaotropes it releases a so 
called ‘flavoprotein’ (FP) (Galante and Hatefi, 1979). FP contains the 51-, 24- and 10-
kDa subunits. This fragment is the electron input domain of the enzyme and transfers 
electrons from NADH to artificial acceptors like hexa-ammine-ruthenium or 
ferricyanide (Gavrikova et al., 1995). Complex I subcomplexes are also generated by 
sucrose gradient centrifugation (Finel et al., 1994) and by ion exchange 
chromatography in the presence of non-denaturating detergents (Finel et al., 1992; 
Sazanov et al., 2000). 
 
Complex I subunit  Subcomplex 
Bovine  Y. lipolytica  E. coli 
CodingP
a
P  Prosthetic 
groups  E. coli  bovine 
75-kDa NUAM  NuoG  nuclear  N1b, N1c, 
N4, N5  DF  Iα 
51-kDa NUBM  NuoF  nuclear  FMN,  N3  DF  Iα 
49-kDa NUCM  NuoDP
b
P  nuclear -  CF Iα 
30-kDa NUGM  NuoCP
b
P  nuclear -  CF Iα 
24-kDa NUHM  NuoE  nuclear  N1a  DF  Iα 
TYKY NUIM  NuoI  nuclear  N6a,  N6b  CF  Iα 
PSST NUKM  NuoB  nuclear  N2  CF  Iα 
ND1 ND1  NuoH  mtDNA  -  MF  Iγ 
ND2 ND2  NuoN  mtDNA  -  MF  Iγ 
ND3 ND3  NuoA  mtDNA  -  MF  Iγ 
ND4 ND4  NuoM  mtDNA  -  MF  Iβ 
ND5 ND5  NuoK  mtDNA  -  MF  Iβ 
ND6 ND6  NuoL mtDNA  -  MF  Iγ 
ND4L ND4L  NuoJ  mtDNA  -  MF  Iγ 
 
Table 1.1 Central subunits of complex I and its subcomplexes 
Abbrevations: DF, dehydrogenase fragment; CF, connecting fragment; MF, 
membrane fragment; FP, flavoprotein 
P
a
PCoding for complex I in eukaryotes 
P
b
PIn TE. coliT both subunits are fused (NuoCD) 
 
 
As shown in Table 1.1, bovine complex I is fragmented into subcomplexes Iα, Iβ and 
Iγ. Subcomplex  Iα contains about 23 mostly hydrophilic subunits, that probably 4 
represent the peripheral arm of complex I, and also bears all the redox centres of the 
enzyme (Finel et al., 1994). Iα shows NADH:ferrycyanide oxidoreductase activity as 
well as NADH:QB1
B oxidoreductase activity. However, the observed NADH:QB1
B 
oxidoreductase activity cannot be inhibited with the typical complex  I inhibitor 
rotenone. Subcomplex  Iβ contains about 13 mainly hydrophobic subunits and is 
derived from the membrane arm of complex I. It has neither known prosthetic groups 
nor biochemical activity. Two mitochondrially coded subunits, ND4 and ND5, are part 
of subcomplex  Iβ. Subcomplex  Iγ contains 5 subunits, from which four are the 
hydrophobic mitochondrially coded subunits, namely ND1, ND2, ND3, ND4L and one 
nuclear coded subunit KFYI. Two more hydrophilic subunits, 42- and 39-kDa, might 
be loosely associated with other proteins in the Iγ fraction. The 39- and 15-kDa 
subunits are found both in the Iα and in the Iγ fragment (Finel et al., 1992). Size-
exclusion chromatography showed that fragment Iα can be altered into the smaller 
subcomplex Iλ (Sazanov et al., 2000). The Iβ subcomplex dissociates further into two 
parts, namely IβL and IβS. IβL contains as major subunits ND4 and ND5, whereas 
IβS contains the rest of the Iβ fraction. 
Complex  I comprises a number of redox active cofactors (Table 1.1). A non-
covalently bound FMN is involved in the oxidation of NADH. Up to nine iron-sulphur 
clusters transfer electrons through the protein to the ubiquinone reducing catalytic 
core. Only six iron-sulphur clusters are visible in EPR spectra of bovine heart 
complex I. On the basis of the terminology introduced by Ohnishi’s group, N1a and 
N1b are binuclear clusters and N2, N3, N4, and N5 are tetranuclear clusters. 
Complex I of certain bacteria contains an additional tetranuclear cluster (designated 
N1c). Clusters N1a and N1b are located in the 24-kDa and 75-kDa subunits, 
respectively. Cluster N3 is located in the 51-kDa subunit. Clusters N4, N5, N1b and 
N1c are present in the 75-kDa subunit. The EPR silent clusters N6a and N6b (2[4Fe-
4S]) are coordinated by the TYKY subunit. Despite all the evidences for a prominent 
function of cluster N2 (see 1.2.2) its assignment to a specific complex I subunit and 
its ligation are a matter of controversial discussion. Albracht and colleagues still 
consider the TYKY subunit as the most likely candidate for harbouring cluster N2 
(Albracht and Hedderich, 2000). New evidence suggests that cluster N2 resides in 
the PSST subunit (Rasmussen et al., 2001; Duarte et al., 2002; Ahlers et al., 2000b) 
at the interface to the 49-kDa subunit (Kashani-Poor et al., 2001b).    INTRODUCTION 
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Although the peripheral arm of complex I bears all known prosthetic groups, FMN 
and [FeS] clusters, this part alone is unable to reduce quinones or quinone 
analogous substrates with the exception of reduction of Q1 by bovine subcomplex Iα. 
Therefore, it was assumed for a long time that the quinone reduction site is localised 
in the membrane arm. A point mutation in the ND1 subunit of Paracocus denitrificans 
that showed a higher KBM
B- value for QB1
B (Zickermann et al., 1998) was considered as a 
hint that this subunit bears the quinone reduction site. So called ‘Fisher-Rich’ quinone 
binding motifs were found in the ND4 and ND5 subunits (Rich and Fisher 1999). 
These two findings supported the idea that the quinone reduction site is in the 
membrane arm. 
The discovery of a mutation in 49-kDa subunit of Rh. capsulatus that leads to 
inhibitor resistance (Darrouzet et al., 1998) and the observation that the PSST 
subunit is labelled covalently with a photoreactive derivative of the quinone 
analogous inhibitor pyridaben (Schuler et al., 1999), led to the conclusion that the 
interface between the 49-kDa and PSST subunits is part of the catalytic core of 
complex  I. Brandt and co-workers have found in inhibitor-competition experiments 
that bovine heart complex I has only one binding domain for numerous structurally 
different inhibitors (Okun et al., 1999). Mutants in the 49-kDa subunit that show either 
complex I inhibitor resistance or lower complex I activity also support the hypothesis 
that catalytic core resides at the interface between the 49-kDa and PSST subunits 
(Dupuis et al., 1998; Kashani-Poor et al., 2001b). 
It is natural to assume that the active site of complex  I should be placed in a 
hydrophobic environment. As a part of the active site the 49-kDa subunit was 
assumed to reside in or very close to the connecting part of complex  I between 
membrane and peripheral arm. Recently, Zickermann et al. (2003) have labelled 49-
kDa subunit of complex I from the yeast Y. lipolytica with monoclonal antibodies and 
2D-structure analysis by electron microscopy revealed that the 49-kDa subunit is 
located at the tip of the peripheral arm, significantly distant from the membrane part 
(Figure 1.1). 
 
  
A
E
B
F
C
D
49.1 49.2
 
 
 
 
 
 
 
 
Figure 1.1 Two-dimensional averages of single particles decorated with 
antibodies
1
A) Average of 60 complex I particles decorated with antibody 49.1 in flip view. B) and 
C) average of 60 complex I particles decorated with antibody 49.2 in flip(B) and flop 
(C) view. D), E) and F) Student’s t test of the averages shown in panels A-C. Light 
areas indicate a statistical difference between labelled and unlabelled particles 
(confidence level >95%). The contour lines of the unlabelled averages (not shown 
here) were superimposed over the Student’s t test images. 
 
6 
                                            
1 From Zickermann et al., J. Biol. Chem., (2003), 278, 29072-29078.    INTRODUCTION 
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1.2.1  Evolutionary Origin of Complex I 
Complex  I is built from three different structural modules namely the NADH 
dehydrogenase module that represents the electron input site located in the 
peripheral arm, the proton pump module that is still largely unknown but is probably 
located in the membrane arm and the quinone reduction module (catalytic core) 
proposed to reside at the interface between the PSST and 49-kDa subunits. The 
proposal that during evolution complex  I was formed from these pre-existing 
structural modules was very useful for structural modelling especially in the case of 
the homology of several subunits of complex  I to hydrogenases (Friedrich and 
Scheide, 2000; Finel, 1998). The different homologies are summarised in Table 1.2. 
The electron input domain of complex I is related to the NAD
+ reducing hydrogenase 
from  Alcaligenes eutrophus (Pilkington et al., 1991). The 24-kDa and 51-kDa 
subunits are homologous to HoxF and the first 200 residues of the 75-kDa subunit 
are homologous to HoxU. HoxF and HoxU together form the NADH oxidoreductase 
part of this hydrogenase. 
Membrane bound type-3 hydrogenases, for example those that are encoded by the 
hyc operon in E. coli or the ech operon in Methanosercina barkeri show not only 
homologies to the 49-kDa and PSST but also to the 30-kDa, TYKY and ND1 
subunits. The complex I subunits ND2, ND4 and ND5 show weak homology to each 
other and also to Na
+/H
+ antiporters of the type encoded by the mrp operon in 
Bacillus  subtilis and the corresponding mnh operon in Staphylococcus  aureus 
(Mathiesen and Hägerhäll, 2002; Steuber, 2001). 
The type-4 hydrogenase in E. coli that is encoded by the hyf operon contains the 
same homologues to complex  I genes already found in type-3 hydrogenase 
(Andrews et al., 1997). Additionally it also contains genes for two more proteins of 
the Na
+/H
+ or K
+/H
+ antiporter family type that are homologous to ND2, ND4 and 
ND5. 
The 49-kDa and PSST subunits are homologous to the large and small subunits of 
water soluble [NiFe] hydrogenases. The homology between the large subunit of 
water soluble [NiFe] hydrogenases and the 49-kDa subunit of complex I is too poor to 
unambiguously align the sequences. However, the corresponding subunit from the 8 
membrane-bound Ech [NiFe] hydrogenase from Methanosarcina barkeri exhibits 
significantly higher homology to the complex  I 49-kDa subunit than to the large 
subunit of its water soluble counterpart (Künkel et al., 1998).  
 
                   120                                     456 
Y.l. 49-kDa HRGTEKLIEYKTYMQALPYFDRLDYVSMMTN   TMDLVFGEVDR 
M.b. EchE  HRGLETFINTKDFNQTTYVCERICGICSAHL   TIDPCVSCTER 
D.f. LS     FRGLEIILKGRDPRDAQHFTQRACGVCTYVH   AFDPCIACGVH 
                     49                      539 
 
Figure 1.2 Partial alignment of sequences of the [NiFe] containing subunit of 
hydrogenases and the 49-kDa subunit of complex I. 
Y.l. 49-kDa = Y. lipolytica complex I, 49-kDa subunit; M.b. EchE = Methanosarcina 
barkeri hydrogenase, EchE subunit; D. f. LS = Desulfovibrio fructosovorans 
hydrogenase, large subunit. In yellow: [NiFe] ligating cysteins replaced by  in red 
highly conserved residues in complex I. 
 
This allowed a reliable alignment of the regions around the [NiFe]-ligating cysteines 
that are arranged in two pairs located near the N-terminus and the C-terminus. 
Interestingly, the inhibitor resistance mutation V407M in the 49-kDa subunit of Rh. 
capsulatus corresponds to one of the cysteine residues that ligate the [NiFe] site in 
water soluble [NiFe] hydrogenases (Darrouzet et al., 1998).  
To test this hypothesis site directed mutagenesis of residues in the 49-kDa subunit of 
complex I from Y. lipolytica was undertaken. Highly conserved residues D143, V460 
and E463 (shown in red in the alignment in Figure 1.2) that correspond to the 
cysteine ligands of the [NiFe] site in [NiFe] hydrogenases were mutated into 
asparagine, alanine and glutamine, respectively. Mutations D143N, V460A and 
E463Q resulted in strong reduction or complete loss of catalytic activity. Mutant 
D458A had a dramatically increased I50 value for DQA and rotenone (Kashani-Poor 
et al., 2001b). These findings strongly suggest that domains around the hydrogen 
active [NiFe] site of hydrogenases have been conserved and play a crucial role in the 
catalytic process of complex I. They also strongly support the hypothesis that the 
quinone reduction site of complex I has evolved from the hydrogen active [NiFe] site    INTRODUCTION 
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of [NiFe] hydrogenases. In our group a structural model based on the known crystal 
structure of the water soluble [NiFe] hydrogenase from D. gigas (Volbeda et al., 
1995) was constructed (Kashani-Poor et al., 2001b). Residues from the large subunit 
from this water soluble [NiFe] hydrogenase were simply replaced with the 
corresponding residues of the 49-kDa subunit (Figure 1.2). From this structural model 
it could be derived that the catalytic core of complex  I resides at the interface 
between the PSST and the 49-kDa subunits. 
 
Homologous subunits in related enzymes 
Complex I 
 
subunit 
NAD
+ 
reducing 
hydrogenase 
A. eutrophus 
Water soluble 
[NiFe] hydro-
genase e.g. D. 
fructosovorans
Membrane 
bound type-3 
hydrogenase 
(FHL-1) 
E. coli (Ech) 
M. brakeri 
Membrane 
bound 
type-4 
hydrogenase 
(FHL-2) 
E. coli 
Antiporter 
e.g. B. 
subtillis 
75-kDa HoxU  -  -  -  - 
51-kDa HoxF  -  -  -  - 
49-kDa -  large  subunit  EchE/HycE  HyfG  - 
30-kDa -  -  EchD/HycE  HyfG  - 
24-kDa HoxF  -  -  -  - 
TYKY -  -  EchF/HycF  HyfH  - 
PSST -  small  subunit  EchC/HycG  HyfI  - 
ND1 -  -  EchB/HycD  HyfC  - 
ND2 -  -  EchA
a/HycC
a HyfB,D,F
a MrpD
a
ND3 -  -  -  -  - 
ND4 -  -  EchA
a/HycC
a HyfB,D,F
a MrpD
a
ND4L -  -  -  HyfE?  - 
ND5 -  -  EchA
a/HycC
a HyfB,D,F
a MrpA
a
ND6 -  -  -  -  - 
 
Table 1.2 Homologies of complex  I subunits to subunits of other bacterial 
enzymes 
aThe ND2, 4 and 5 subunits are weakly homologous to each other, an assignment of 
the individual subunits to other proteins is ambiguous. 1.2.2 Cluster N2 and Its Role in the Mechanism of Proton Translocation 
in Complex I 
One of the main reasons why the catalytic mechanism of complex  I is poorly 
understood lies in the characteristics of its prosthetic groups, the iron-sulphur clusters 
[FeS]. Iron-sulphur clusters cannot be studied by optical spectroscopy but instead 
require the more difficult technique of low temperature EPR for characterisation and 
assessment of their redox state. 
Reaction catalysed by complex I: 
 
NADH + Q + H+ + nH+
in NAD+ + QH2 + nH+
out  
Knowledge of the exact value of n is absolutely necessary to make any assumptions 
about the enzyme catalytic mechanism. For bovine heart mitochondria n = 4 was 
measured (Wikström, 1984). Over the years many proposals have been made 
regarding how mitochondrial complex I might pump protons (Brandt, 1997). There 
are three basic types of mechanism, all present in the oxidative phosphorylation 
system that could serve as a model for complex I: 
-  directly redox linked proton pump (cytochrome c oxidase) 
-  redox linked ligand conduction mechanism (bc1 complex) 
-  conformational energy transfer (ATP synthase) 
It is assumed that FMN (Em,7.5 = -336 mV) together with cluster N3, which is located 
in the same subunit, functions as an electron input device, whereby FMN and its 
semiflavin are the mediators between the two electron donor NADH and the one 
electron transferring iron-sulphur clusters (Sled et al., 1994). The coupling 
mechanism between redox reactions and proton translocation in complex  I is still 
unknown but there are several experimental data which support a key role for cluster 
N2 in quinone reduction and proton translocation. This cluster has the most positive 
redox midpoint potential (Em,7 = -150 mV) which is pH-dependent (–60 mV/pH for 
bovine heart complex  I) (Ingledew and Ohnishi, 1980) and N2 features magnetic 
10    INTRODUCTION 
interactions with semiquinone radicals as shown by EPR spectroscopy (Magnitsky et 
al., 2002). 
 
[ N2 ] 2+--R  
e-
H+
[ N2 ] 1+--R - H +
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e-
[ N2 ] 2+--R - H +
H+
pKox pKred
Em,acids
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Figure 1.3 Proton translocation associated with a Redox-Bohr Group 
Redox- and protonation states of the iron sulphur cluster N2 associated redox-Bohr 
group (R) in complex I. Upon reduction, the basicity of the center is increased and R 
becomes protonated. After reoxidation and deprotonation the initial state is restored 
again. To accomplish a 1:1 stoichiometry in proton/electron transport, the pK values 
have to be at least 2 units apart from each other and the pK of the reduced forms 
should be >8. 
 
These are consistent with the hypothesis that N2 is the immediate electron donor to 
the quinone and that it might be directly involved in a proton pumping mechanism via 
an associated redox-Bohr group (Figure 1.3). Such a group would become 
protonated upon reduction of N2 and deprotonated again when the centre becomes 
reoxidised. Provided that the proton donor and the final proton acceptor are different 
groups, this process would result in a one proton per one electron stoichiometry.  
The recent finding that the 49-kDa subunit and thus the catalytic core comprising 
cluster N2 is clearly separated from the membrane (Zickermann et al., 2003) places 
the site of quinone reduction into the hydrophilic domain. Therefore at this point the 
most likely scenario is that the redox chemistry of quinone reduction around cluster 
N2 induces specific conformational changes. These changes are then transmitted to 
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the hydrophobic subunits in the membrane that have been derived from Na
+/H
+ or 
Na
+/K
+ antiporters and act as ion pumps. 
1.2.3  Complex I and Disease 
Mitochondrial disorders occur in humans with a frequency of around 1:10.000 live 
births (Bourgeron et al., 1995). Most disorders are caused by the malfunction of one 
or more enzyme complexes of the oxidative phosphorylation system (OXPHOS). 
Isolated complex I deficiency is one of the most frequently observed deffects in the 
OXPHOS system. 
Dysfunction of complex I causes 3 different problems: (1) lack of NAD
+ when NADH 
is not reoxidised by complex I, (2) decrease of ATP level due to complex I inability to 
pump protons and (3) production of reactive oxygen species (ROS). 
Mutations in both the mitochondrially and nuclear encoded genes are known to 
cause complex  I deficiencies (Loeffen et al., 2000). Mutations in mitochondrially 
encoded genes lead to a variety of neuromuscular syndromes, including myoclonic 
epilepsy associated with ragged red fibers (MERRF); mitochondrial 
encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS); Chronic 
Progressive External Ophthalmoplegia (CPEO); Kearns-Sayre syndrome (KSS). 
Many cases of Leber's hereditary optic neuropathy (LHON), appear to be associated 
with a defect in complex I. The defect identified in many cases is a single nucleotide 
change in the mitochondrial DNA converting arginine-340 in the ND4 subunit of 
complex I into histidine. Leigh syndrome is a severe progressive neurodegenerative 
disorder that may be caused not only by mutations in mtDNA but also in nuclear 
DNA, as exemplified by mutations in NDUFS7, encoding the homologue of the PSST 
subunit (Triepels et al., 1999) and NDUFS8, encoding the homologue of the TYKY 
subunit (Loeffen et al., 1998). Recently, researchers at the Nijmegen Center for 
Mitochondrial Disorder (Nijmegen, The Netherlands) found mutations in the NDUFS2 
gene, encoding the 49-kDa subunit in four patients (from three families) with 
cardiomyopathy and encephalomyopathy (Loeffen et al., 2001). The three distinct 
mutations are described later in the text (see 1.4.1.2) 
In addition, the compound, 1-methyl-4-phenylpyridium ion (MPP
+), the active 
metabolite of the parkinsonism toxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine    INTRODUCTION 
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(MPTP), acts as an inhibitor of complex  I (Gluck et al., 1994). Association of 
pesticides and environmental toxins are believed to be the most likely cause of 
Parkinson’s disease (PD). It was found that chronic exposure of rats to the commonly 
used complex I inhibitor rotenone also reproduced features of Parkinson’s disease 
(Betarbet et al., 2000). The mechanism of rotenone toxicity in rats is still unknown. 
Recent studies suggest that it is neither due to ATP depletion nor NADH 
accumulation in the mitochondrial matrix but rather due to oxidative damage caused 
by ROS produced most likely by complex I (Sherer et al., 2003). 
1.3  Yarrowia lipolytica a Model Organism 
Compared to the other respiratory enzymes there is not much experimental data 
available about complex  I structural organisation, composition, catalytic core and 
especially about the mechanism of electron transfer from NADH to ubiquinone and its 
coupling to proton translocation. These problems are not only due to the size or 
complexity of this extraordinary enzyme, but also due to the lack of an appropriate 
system for systematic research at the molecular level. The most commonly used 
eukaryotic model system with the most complete set of genetic tools, the yeast 
Saccharomyces cerevisiae, does not bear complex I. Complex I has therefore been 
most extensively characterised in Bos taurus and Neurospora crassa. However, 
genetic manipulation in these organisms is rather difficult and time consuming at the 
moment. Different bacteria such as E. coli and  Rh. capsulatus have very well 
elaborated possibilities for genetic manipulation. However, complex  I from these 
sources is instable and therefore protein handling and characterisation is not trivial. 
Yarrowia lipolytica strains have been found in many dairy products such as cheese 
and yoghurts. It is a strictly aerobic non pathogenic yeast. Its optimum growth 
temperature is about 28°C. Y. lipolytica can use a variety of compounds as a carbon 
source: glucose (2 %), sodium acetate (up to 0.4 %), ethanol (up to 3 %) as well as 
n-, l-alkanes and fatty acids. Most genetic tools such as replicative plasmids and 
strains with stable mating types and different auxotrophies for positive and negative 
selection as well as genome sequence are available. All this makes Y. lipolytica an 
excellent model organism for structural and functional studies of different biochemical 
processes. 1.3.1  Respiratory Chain from the Yeast Yarrowia lipolytica 
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Figure 1.4 Mitochondrial respiratory chain from Yarrowia lipolytica 
Four electron transferring respiratory complexes are labelled as: I (NADH:ubiquinone 
oxidoreductase); II (succinate:ubiquinone oxidoreductase); III (cytochrome c 
reductase); IV (cytochrome c oxidase). Compared to the mammalian respiratory 
chain, Y. lipolytica has an extra external alternative NADH dehydrogenase labelled 
as (NDH-2) and one alternative ubihydroquinone oxidase (Alt-Ox). 
The electron flow is shown with white arrows, whereas proton translocation is shown 
with red arrows. 
FeS: iron-sulphur centre; FMN: flavin mononucleotide; FAD: flavin - adenine 
dinucletide; NAD
+: nicotinamide-adenine dinucleotide; NADH: hydronicotineamide–
adenine dinucleotide; Q: ubiquinone; QH2: ubihydroquinone; b: heme b;  bH: high 
potential heme b;  bL: low potential heme b;  a3: heme a3;  c: cytochrome c;  c1: 
cytochrome c1; CuA and CuB: copper centres. 
 
The respiratory chain of Y. lipolytica is very similar to the mammalian respiratory 
chain. It consists of four multisubunit enzymes (complex  I-IV). Additionally, Y. 
lipolytica has a hydrophilic alternative non proton pumping NADH dehydrogenase 
(NDH-2) (de Vries and Marres, 1987; Rasmusson et al., 1998) which is usually found 
in yeast and plants. NDH-2 consists of one polypeptide which carries one non-
covalently bound flavine adenine dinucleotide (FAD) as a prosthetic group. How this 
water soluble NDH-2 is anchored on the inner membrane and how it interacts with 
14    INTRODUCTION 
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hydrophobic ubiquinone is still unknown (Kerscher, 2000). Y. lipolytica carries only 
one gene copy for NDH-2 (Kerscher et al., 1999). NDH-2 is located in the 
intermembrane space and therefore cannot contribute to the oxidation of NADH from 
the mitochondrial matrix. Therefore complex I is essential for survival (Ahlers et al., 
2000a). To delete complex I subunits and at the same time avoid lethality, NDH-2 
was redirected into the mitochondrial matrix using the mitochondrial import signal 
from the 75-kDa subunit of complex I. This way, NDH-2 was able to compensate for 
complex I defects (Kerscher, 2000) and is called NDH-2i. 
Furthermore Y. lipolytica has one alternative ubihydroquinone oxidase (Kerscher et 
al., 2002), that transfers electrons directly from ubiquinone to oxygen without 
pumping protons. This alternative oxidase is cyanide insensitive and it is induced if 
cytochrome electron transfer via the cytochrome bc1 complex and cytochrome c 
oxidase is inhibited. 
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1.4  Goals of this Study 
1.4.1  Site Directed Mutagenesis in the 49-kDa Subunit of Complex I 
The yeast Yarrowia lipolytica is a well worked out as a genetic model organism. Due 
to easy handling of this organism and stable complex I (Djafarzadeh et al., 2000) it is 
one of the best and fastest systems to study structure and function of complex I. The 
composition of complex I from Y. lipolytica is very similar to that of complex I from 
Neurospora crassa. 32 hydrophilic and 7 hydrophobic subunits of complex  I have 
been detected by isoelectric focusing and 2D PAGE (Abdrakhmanova, unpublished 
data). NDH-2i is able to compensate complex  I disfunction caused by assembly 
defects or any other defect such as specific mutations. The C-terminal His-Tag on 
the 30-kDa subunit allows for the purification of complex  I via Ni-NTA affinity 
chromatography in milligram amounts. This system also allows characterisation of 
site-directed mutations in complex I. The complex I mutants were characterised with 
BN-PAGE for assembly, specific complex  I dNADH:DBQ activity normalised to 
NADH:HAR activity as a measure for the amount of complex I in membranes. Iron-
sulphur cluster were investigated using EPR spectroscopy that was carried out by Dr. 
Klaus Zwicker. Proton pumping was investigated by reconstitution of complex I into 
proteoliposomes measured with ACMA dye fluorescence. 
1.4.1.1  Mutations Selected on the Basis of the Hydrogenase Structural Model 
Based on sequence analysis it had been proposed that the [NiFe] hydrogenase 
structural fold was conserved during evolution and that the [NiFe] site evolved to form 
a significant part of the active site of complex I. It was found that mutants D458A, 
V460M, D143E and D143C, which affect residues that correspond to three cysteines 
that ligate the [NiFe] active centre in [NiFe] hydrogenase, not only lower activity and 
inhibitor sensitivity but also influence the properties of cluster N2 (Kashani-Poor et 
al., 2001b). Therefore residue S146 that is not conserved in complex  I and 
corresponds to the fourth cysteine in [NiFe] hydrogenases was mutated and mutants 
were investigated. It was also found that mutations of the additional specific residues 
in the 49-kDa subunit that are either conserved among complex  I from different 
species or among [NiFe] hydrogenases, or both have a strong influence on cluster    INTRODUCTION 
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N2 which resides in the PSST subunit. These findings brought to attention that one 
ligand of cluster N2 could be located in the neighbouring 49-kDa subunit. As it is 
known that nitrogen from the imidazole ring of histidine is ligand of the Rieske iron-
sulphur cluster in the bcB1
B-complex it seemed possible that also one of the ligands of 
complex I cluster N2 could contain a nitrogen-atom. Therefore conserved arginines 
and histidines that could serve as ligand to N2 were mutated. In the structures of 
water soluble [NiFe] hydrogenases it can be seen that the residues corresponding to 
histidine 226 and arginine 141 (Y. lipolytica numbering, see Figure 4.1) in the Y. 
lipolytica 49-kDa subunit are very close to the proximal iron-sulphur cluster. 
According to the hydrogenase model histidine 226 and arginine 141 both are in a 
distance within 7 Å from cluster N2. Therefore it was necessary to carry out a more 
detailed analysis of these residues. Also other residues such as histidine 91, histidine 
95 and arginine 466 were mutated and investigated although these residues 
according to the hydrogenase model are not as close to cluster N2. 
1.4.1.2  Reconstruction of Human Pathogenic Mutations 
Loeffen et al. (2001) identified mutations in the NDUFS2 (49-kDa) gene in 3 families 
with isolated complex I deficiency: 
•  G-to-A transition at nucleotide 683, resulting in an arginine-to-glutamine 
substitution at codon 228 (human R228Q corresponds to R231Q in Y. 
lipolytica). This arginine is conserved among complex  I from different 
species (see Figure 4.1A). 
•  C-to-A transition at nucleotide 686, resulting in a proline-to-glutamine 
substitution at codon 229 (human P229Q corresponds to P232Q in Y. 
lipolytica). This proline is not strictly conserved among complex I from 
different species; in E. coli it is replaced by isoleucine (see Figure 4.1A). 
•  T-to-C transition at nucleotide 1237, resulting in a serine-to-proline 
substitution at codon 413 (human S413P corresponds to S416P in Y. 
lipolytica). This serine is not strictly conserved among complex I from 
different species; in Rh. capsulatus it is replaced by alanine (see Figure 
4.1A). 18 
One of the goals was to investigate these mutations that were lethal at very young 
age. Mutants R231Q, P232Q and S416P and additional site-directed mutations at 
these positions (Y. lipolytica nomenclature) were generated in the yeast Y. lipolytica 
and complex I properties were studied. 
1.4.2  Mitochondrial Expression of eYFP 
GFP (Green Fluorescent Protein) is found in coelenterates such as the pacific 
jellyfish  Aequoria victoria (Morin and Hastings, 1971). It transduces, by energy 
transfer, the blue chemiluminiscence of another protein, aequorin, into green 
fluorescent light. GFP is a small protein comprised of 238 amino acids and can be 
fused to virtually any protein of interest. DNA constructs encoding such fusions can 
then be introduced into living cells to express the GFP fluorescent tag on the chosen 
protein. GFP is an extremely attractive tool mainly because the protein functions 
without the need for any additional co-factors. This allows expression of GFP in an 
array of living organisms and subcellular departments such as mitochondria, resulting 
in autocatalytic maturation and a fluorescent signal.  
Several GFP chromophore mutations have been described (Cormack et al., 1996). 
eYFP (enhanced Yellow Fluorescent Protein) is one of the variants of GFP and has 
more than 30 times higher fluorescence than wtGFP (Ormo et al., 1996). The eYFP 
gene contains four amino acid substitutions (S65G, V68L, S72A and T203Y). The 
fluorescence excitation maximum of eYFP is 513 nm and the emission spectrum has 
a peak at 527 nm. 
In the present work, eYFP was used to label the mitochondria of Y. lipolytica and 
visualise to the mitochondrial network. Mutant R228Q in human cells caused 
fragmentation of the mitochondrial network. In cooperation with NCMD we intend to 
study whether this mutation has the same effect in Y. lipolytica.     MATERIALS & METHODS 
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2 MATERIALS  AND  METHODS 
2.1 Materials 
2.1.1 Chemicals 
Ethanol (J.T. Baker, Deventer-Netherlands); bovine serum albumin (BSA) (Biolabs, 
New England); n-Dodecyl-β-D-maltoside (Biomol Feinchemikalien GmbH, Hamburg-
Germany); DEAE Bio-Gel A Agarose (Biorad Laboratories GmbH, München-
Germany); Chelating Sepharose (Pharmacia Biotech AB, Uppsala-Sweden); Agar; 
bactoP
TM
P yeast extract, Trypton, selected peptone 140 (Gibco BRL Life Technologies, 
Paisley-United Kingdom); YNB (Difco Laboratories, Sparks, MD, USA); boric acid 
phenol developer, fixer and fixing buffer for X-ray films and X-ray films X-OMAT AR 
(BioMax  MR (Kodak) Rochester-New York); acetone, ammonium peroxosulfate, 
chloroform acetic acid, Folin-Ciocalteus-Phenol reagent, isoamyl alcohol, 
isopropanol, MgSOB4
B, HCl, trichlorine acetic acid (Merck, Darmstadt-Germany); 
ammonium sulphate, EDTA, glas perls (0.25 – 0.5 mm), KCl, KOH, KHB2
BPOB4
B, sodium 
acetate, sodium citrate, NaCl, NaOH, NiSOB4
B, NaHB2
BPOB4
B, saccharose, X-Gal (Carl 
Roth GmbH & Co, Karlsruhe-Germany); ATP, nucleotides, Ni-NTA Fast Flow 
Sepharose (Pharmacia); acrylamide, bisacrylamide, Coomassie-Blue G-250, urea, 
polyethylene glycol (PEG) 4000, dodecylsulphate Na-salt (SDS), tricine, agarose, 
amino caproic acid, amino acids, ampicilline, DMSO, ethidium bromide, glucose, 
glycerine (Pharmacia); hexaammine ruthenuim(III) chloride (HAR), hepes, KCN, 
lithium acetate, mercapto ethanol, mops, d-NADH, NADH, NaNB3
B, nystatine, PMSF, 
TEMED, tris, asolectin, oligonucleotides (Sigma Chemie GmbH, Deisenhofen-
Germany), Bio-Beads SM-2 (Bio-Rad), asolectin (Fluka); oligonucleotides (ARK 
Scientific GmbH Biosystems, Darmstadt-Germany) or MWG-Biotech Ebersberg-
Germany). 
2.1.2 Inhibitors 
2-decyl-4-quinazolinyl amine (DQA) was a generous gift from Aventis CropScience, 
Biochemical Research, Frankfurt am Main, Germany; rotenone was purchased from 
Sigma Chemie GmbH, Deisenhofen, Germany.    
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2.1.3  Media and Solutions 
UMedia for Escherichia coli: 
LB-media: 1 % NaCl, 0.5 % Yeast Extract, 1 % Bactotryptone, pH 7.5 (1.5 % agar for 
plates) 
SOC-media: 0.5 % Yeast Extract, 2 % Bactotryptone, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgClB2
B, 10 mM MgSOB4
B, 20 mM glucose 
UMedia for Yarrowia lipolytica: 
Sporulation medium (CSM): 0.7 % Yeast Nitrogen Base w/o (NHB4
B)B2
BSOB4
B and amino 
acids, 0.5 % (NHB4
B)B2
BSOB4
B, 50 mM sodium citrate 
YPD-medium: 2 % Bacto™Pepton, 1 % Yeast Extract, 2 % glucose 
Permanent culture medium: YPD-media + 40 % glycerine 
Minimal synthetic medium (S): 1.7 % Yeast Nitrogen Base w/o (NHB4
B)B2
BSOB4
B and amino 
acids, 5 % (NHB4
B)B2
BSOB4
B, pH 5.0 were prepared as a 10 × stock solution and sterile 
filtrated. Carbon source (0.4 % acetate or 2 % glucose) were prepared as 2 × stock 
solution, autoclaved and added to 10 × S-media. Depending of the type of selection 
one or several of the following components were added: 130 µM histidine, 200 µM 
lysine, 460 µM leucine, 180 µM uracil. 
UBuffers and solutions: 
10 × TAE-buffer: 400 mM tris / acetate, 10 mM EDTA, pH 8.3 
TE: 10 mM Tris / HCl, 1 mM EDTA, pH 8.0 
20 × SSC-buffer: 3 M NaCl. 0.3 M sodium citrate, pH 7.0 
One step buffer (freshly prepared): 45 % PEG4000, 0.1 M lithium acetate pH 6.0, 100 
mM dithiothreitol, 250 µg/ml salmon sperm DNA as carrier 
IPG Buffer (Sigma) 
Rehydratation Buffer: 8 M Urea, 1.5 % Triton X-100, 10 mg/ml DTE 0.5 % IPG Buffer 
and a trace of bromphenol blue 
SDS equilibration Buffer: containing 50 mM Tris-HCl pH 8.8, 6M Urea, 30 % glycerol, 
4 % SDS, 10 mg/ml DTE and a trace of bromphenol blue     MATERIALS & METHODS 
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2.1.4   Strains 
Escherichia coli competent cells 
 
 
 
 
Table 2.1 Escherichia coli strains 
Yarrowia lipolytica 
 
 
 
 
 
 
 
 
 
Table 2.2 Yarrowia lipolytica strains 
strain genotype 
E129  MatA lys11-13 ura3-302 leu2-270 xpr2-
322 
E150  MatB his-1 ura3-302 leu2-270 xpr2-322 
NK2.1  nucm::URA3  MatA  ndh2i  lys11-23  ura3-
302 leu2-270 xpr2-322 
GB12  30Htg2 MatB  ndh2i  his-1  ura3-302  leu2-
270 xpr2-322 
∆nugm GH1 
nugm::URA3 MatA  ndh2i ura3-302 his-1  
xpr2-322 
KL6  nukm::LEU2 MatB ndh2i leu2-270 lys11-
23  xpr2-322  ura3-302 
PIPO  30 Htg pop-in-pop-out MatA,  lys-1,  ura3-
302, leu2-270 
strain genotype 
XL1-Blue 
recA1 endA1yrA96 thi-1 hsdR17 supE44 
relA1 lac [F’proAB laclP
q
PZ∆M15 Tn10 (TetP
r
P)] 
XL10-Gold 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F’proAB lacIP
q
PZ∆M15 Tn10 (TetP
r
P)] 
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2.1.5 Plasmids 
 
Table 2.3 Plasmids 
name property  source 
pCR2.1  see product’s description  Invitrogen, Groningen, 
The Netherlands 
pBluescript SK(±)  see product’s description  Stratagene, 
Heidelberg, Germany 
pSK-/NUAM 
pBluescript SK(±) with genomic 
DNA coding for 75 Da subunit 
from complex I 
Dr. Stefan Kerscher, 
Frankfurt/Main, 
Germany 
pINA240 
Yarrowia lipolytica 
“shuttle”-vector containing 2,3 
kb fragment with LEU2 gene 
Prof. Gaillardin, Paris, 
France 
pUB4 
Yarrowia lipolytica 
“shuttle”-vector containing 1 kb 
fragment with Hyg BP
R
P gene 
Dr. Stefan Kerscher, 
Frankfurt/Main, 
Germany 
pUB26 
modified pUB4 
base changed in ARS68 
(T737A) 
Dr. Stefan Kerscher, 
Frankfurt/Main, 
Germany 
pINA240/30-
Htag2 
pUB26 with 2.1 kb Sal I fragment of 
30 kDa subunit with modified C-
terminus (6xA + 6xH) from complex I 
Dr. Stefan Kerscher, 
Frankfurt/Main, 
Germany 
pEYFP  see product’s description 
BD Biosciences, 
Clontech, Heidelberg, 
Germany     MATERIALS & METHODS 
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2.1.6 Instruments 
Centrifuges: 
Heraeus Biofuge A (Osterode, Germany) 
Heraeus Labofuge 400 (Osterode, Germany) 
Heraeus Minifuge GL (Osterode, Germany) 
Heraeus Cryofuge 8500i (Osterode, Germany) 
Cool centrifuge J2-21, Beckman Instruments GmbH (München, Germany) 
Ultracentrifuge L7-65 and L8-70M, Beckman Instruments GmbH (München, 
Germany) 
 
Rotors: 
Cooled centrifuge: JA-10, JA-20, JS13.1 Beckman Instruments GmbH 
(München, Germany) 
Ultracentrifuge: Ti 45, Ti 50.38, Ti 70.1, Beckman Instruments GmbH 
(München, Germany) 
 
Photometer: 
UV 300 Shimadzu (Düsseldorf, Germany) 
U-3210 Hitachi (Düsseldorf, Germany) 
MultiSpec-1501, Shimadzu (Düsseldorf, Germany) 
SPECTRAmax PLUSP
384
P, Molecular Devices GmbH (Ismaning, Germany) 
 
Fluorometer: 
HoeferP
®
PDyNA QuantP
®
P200, Pharmacia Biotech (San Francisco,USA) 
RF-5001 Shimadzu, (Düsseldorf, Germany) 
 
Thermo cycler: 
DNA Thermal Cycler 480, Perkin Elmer (Weiterstadt, Germany) 
GeneAmpP
®
P PCR System 2400, Perkin Elmer (Weiterstadt, Germany) 
cycloneP
®
P gradient, Peqlab, Biotechnologie GmbH (Erlangen, Germany) 
 
Electroporation:    
24 
E. coli Pulser Bio-Rad (Hercules, USA) 
DNA Sequencer: 
ABI PRISM
TM 310 Genetic Analyzer, Perkin-Elmer (Weiterstadt, Germany) 
 
Sonifier: 
B 15 Sonifier / Cell Disrupter, Branson (Danbury, UK) 
 
EPR-Spectrometer: 
ESP 300 E, Bruker (Rheinstetten, Germany) with continuous flow cryostat 
ESR 900, 
Tubney Woods Abingdon (Oxon, UK) and liquid helium cooler, Messer- 
Griesheim (Griesheim, Germany) 
 
EPR-tubes: 
Quartz glass Nr.: 707-SQ-250M (length: 250 mm, diameter: 4 mm), Spintec  
(Remshalden, Germany) 
 
Other instruments: 
10 l Fermenter, Biostat E; Braun (Melsungen, Germany) 
Bead-Beater glass pearls mill, Biospec (Bartlesville, USA) 
Cell-Desntegrator-C, Bernd Euler (Frankfurt/Main, Germany) 
BioSys 2000 Workstation
®, Beckman Instruments  
GmbH (München, Germany) 
BioLogic HR Workstation, Bio-Rad Laboratories GmbH (München, Germany) 
with TSKgel G 4000 SW column (21.5 mm × 600 mm), TosoHaas GmbH 
(Stuttgart, Germany) 
Photo camera MP4 land camera, Polaroid 
GelSystem MINI, Biostep (Jahnsdorf, Germany) 
Hybridisations oven HB-1D, Techne (Wertheim, Germany) 
Laser Scanning Microscope (LSM) 510 META (Carl Zeiss, Jena, Germany) 
Microscope, Leitz (Wetzlar, Germany) 
Ultrafree - 20 Centrifugal Filter Unit
® with Biomax
™ - 30 High Flux Polysulfone  
Membrane, Millipore GmbH (Eschborn, Germany)     MATERIALS & METHODS 
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UV-Transiluminator TF 20M, 312 nm, Herolab 
IPGphor Amersham Pharmacia Biotech (Freiburg, Germany) 
 
2.1.7 Software 
DNA and Protein Analysis software: 
Mac Vector 3.5, IBI 
HIBIO DNASISP
™
P for WindowsP
®
P Version 2, Hitachi Software Engineering Co., 
Ltd. 
Sequence Navigator, Applied Biosystems 
Husar, DKFZ, Heidelberg, Germany 
Enzfitter Version 2.0.16.0, Biosoft, Cambridge (UK) 
Swiss-PdbViewer v3.7b2, Glaxo Wellcome Experimental Research 
(http://www.expasy.ch/spdbv/mainpage.html) 
RasWin molecular Grafics, Windows Version 2.7.1, Copyright R. Sayle 1992-
1999. 
SOFTmax PRO, Molecular Devices GmbH (Ismaning, Germany) 
Other software: 
Zeiss LSM Image Browser Version 3,2,0,70 Carl Zeiss GmbH (Jena, 
Germany) 
Microsoft Office Package 
2.2  Methods of Molecular Biology / Gene Technology 
2.2.1  Yarrowia lipolytica ∆nucm CL1 Strain 
Y. lipolytica haploid strain ∆nucm CL1 (nucm::URA3, MatA, 30Htg2, ndh2i, lys11-23, 
ura3-302,  leu2-270,  xpr2-322) was made by mating strain NK2.1 (nucm::URA3, 
MatA, ndh2i, lys11-23, ura3-302, leu2-270, xpr2-322) (Kashani-Poor et al., 2001a) 
with GB12 (30Htg2 MatB, ndh2i, his-1, ura3-302, leu2-270, xpr2-322), followed by 
sporulation of the resulting diploid and selection of a haploid strain carrying the 
appropriate markers. To exclude the possibility of aneuploidity the absence of the 
wild type NUCM gene was checked by Southern Blotting.    
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2.2.2  DNA Gel Electrophoresis 
DNA was separated according to standard procedures (Sambrook et al., 1989) in the 
presence of 0.5 µg/ml of ethiduim bromide. Depending on the DNA fragment length 
agarose concentration from 0.6 – 2.0 % in 1×TEA buffer were used. If the DNA 
fragments were extracted from the gel TEA buffer with extra additive was used (UV-
safe TAE, MWG-Biotech, Ebersberg). Used DNA molecular weight standards: 1 kb 
Ladder, 100 bp Ladder plus (MBI Fermentas, St. Leon-Rot). 
2.2.3  Fill-in Reaction of 5`-Overhang 
DNA blunt-ends were made with large fragment of E. coli DNA-polymerase I 
(Klenow-polymerase, New England Biolabs GmbH, Schwalbach/Taunus) described 
by (Sambrook et al., 1989). 
2.2.4 DNA-Vector  Dephosphorylation 
To avoid self-ligation of empty vectors the DNA ends were dephosphorylated with 
SAP (Shrimp Alkaline Phosphatase, Boeringer Mannheim, Mannheim). 
2.2.5  Phosphorylation of PCR-Products 
To enable the ligation of PCR products it was necessary that both fragment ends 
were phosphorylated. The phosphorylation was made by T4 polynucleotide kinase 
(New England Biolabs) as described by (2000). Alternatively to the phosphorylation 
of DNA fragments, primers could be phosphorylated before PCR. 
2.2.6  DNA Extraction from Agarose Gels 
DNA extractions from agarose gels were made with “Easy Pure Kit” (Biozym 
Diagnostic GmbH, Hess. Oldendorf) or with QIAprep® Gel Extraction Kit (Qiagen). 
2.2.7 Ligation 
T4 DNA-ligase and provided buffer (Gibco BRL Life Technologies) were used to 
ligate DNA fragments. Ligation was usually carried out over night at 14°C. 
2.2.8  Making of Electro-Competent Escherichia coli Cells 
Electro competent E. coli cells were made according the procedure from Current 
Protocols (2000). Transformation efficiency was up to 2×10P
9
P colonies/µg DNA.     MATERIALS & METHODS 
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2.2.9 Transformation  into  Escherichia coli (electro-competent cells) 
The transformation of plasmids (with Amp
R gene) into E. coli electro competent cells 
took place in E. coli Pulser (Biorad) as described in Current protocols (2000). 
Transformants were successively grown over night on LB solid medium in the 
presence of ampicillin (50 µg/ml). 
2.2.10  Preparation of Plasmid-DNA from Escherichia coli 
Plasmid-DNA was prepared according to (Zhou et al., 1990) from small amount of 
cultures (1.5-3 ml). Plasmid DNA for sequencing was prepared using the QIAprep
® 
Spin Miniprep Kit (Qiagen). 
2.2.11 DNA  Sequencing 
Double-strand DNA was used as template for sequencing. The sequencing reaction 
was made with “ABI Prism dye terminator cycle sequencing kit” (Perkin Elmer, 
Weiterstadt). Sequencing was performed in an ABI Prism Automated Sequencer type 
ABI 310. 
2.2.12  Polymerase Chain Reaction (PCR) 
10 ng of plasmid-DNA resp. 100 ng genomic DNA, 5 µl of both oligonucleotides 
(5 µM), 5 µl of provided 10X reaction buffer were combined in a total reaction volume 
of 50 µl. To avoid dimerisation of oligonucleotides as well as non-specific binding of 
oliogonucleotides to matrix DNA manual “hot-start” was used. Used polymerases 
were: Taq DNA polymerase, Taq2000
TM DNA polymerase, Pfu DNA polymerase and 
PfuTurbo
TM DNA polymerase from Stratagene (Heidelberg) as well as Taq DNA 
polymerase from Sigma Chemie GmbH (Deisenhofen). 
2.2.13  Generation of Point Mutations 
The shuttle-vectors pINA240 or pUB4 with 2.87 kb insert coding for the NUCM gene 
was used as template for site directed mutagenesis. Point mutation was introduced 
by PCR with the “QuikChange
TM site-directed mutagenesis kit” (Stratagene, 
Heidelberg).    
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2.2.14 Southern  Blot 
Digested DNA (genomic DNA: 500 ng; plasmid DNA: 50 ng) was separated using 
agarose gel (1 %) electrophoresis. The DNA was transferred over night on Hybond 
NP
+
P-membrane (Amersham, Braunschweig). To covalently crosslink DNA to the 
membrane UV-light radiation from Stratalinker (Stratagene, Heidelberg) was used. 
2.2.15  P
32
PP DNA Labelling 
DNA fragments were labelled with [α-P
32
PP] dCTP (25 µCi for 25 ng DNA) using the 
“Random primer labelling – Prime-ItP
®
PII” Kit (Stratagene, Heidelberg). Efficiency check 
of radioactive labelling was done by pipetting 3 µl of 1:100 diluted reaction mixtures 
onto two filter sheets (Whatman DE 81 ion exchange paper, Whatman International 
Ltd., Maidstone, England). One of the filters was washed two times for 5 minutes with 
2 × SSC buffer and subsequently washed for 5 minutes in cold ethanol. To estimate 
incorporation of the radioactive label, count rates of both filters were controlled after 
drying using a Geiger counter. 
2.2.16  Hybridisation of Radio Active Labelled DNA Probes 
Hybridisation took place in a glass tube in a hybridisation oven (HB-1D, Techne). A 
pre-hybridisation was made for 15 minutes at 68°C and the main hybridisation for 60 
min at 68°C with “QuikHybP
®
P” hybridisation solution (Stratagene, Heidelberg). For the 
main hybridisation, P
32
PP-labelled DNA fragment was used in the presence of 100 µl 
(10 mg/ml) salmon sperm DNA. Subsequently, blots were washed four times (2 × 15 
min with 2 × SSC, 0.1 % SDS; 2 × 15 min with 0.1 × SSC, 0.1 % SDS) to remove 
non-specifically bound radioactive probe. Blots were exposed to Kodak X-Omat AR 
films with an amplifier-sheet over night at –80°C. 
2.2.17 Transformation  of  Yarrowia lipolytica 
Yarrowia lipolytica cells were transformed according to the method of (Chen et al., 
1997). A single colony was taken from a fresh plate or cells from 0.5 ml of an over 
night culture in complete medium was spun down and dispersed by vortexing for 
1 min in 100 µl of freshly prepared one step buffer (45 % PEG4000, 0.1 M lithium 
acetate pH 6.0, 100 mM dithiothreitol, 250 µg/ml salmon sperm DNA as carrier). 
Subsequently the mixture was incubated for 1 h at 39°C and was spread on well     MATERIALS & METHODS 
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dried selection plates. Transformants could be observed after 3 days incubation at 
28°C. 
2.2.18 Conjugation,  Sporulation and Random Spore Isolation 
Strains of opposite mating type were separately inoculated into 10 ml of YPD and 
grown overnight. 0.1 ml of these cultures were transferred into fresh 10 ml YPD and 
grown for 18 - 21 h. Cell were centrifuged (6000 g for 3 minutes) and resuspended in 
1 ml YM (about 2 - 10 X 10
8 cells/ml). One ml of each strain of opposite mating type 
was mixed together with 8 ml YM in a flask, shaken at 28°C for 16 - 24 h and plated 
on selective medium to isolate diploid cells. A single colony from the plate was 
inoculated into 10 ml YPD and grown overnight. Cells were centrifuged and 
resuspended in CSM with a concentration around 2 - 5 X 10
7 and sporulated for 4 
days in flasks at 220 rpm and 23°C. After 4 days the culture was stored at 4°C for 1 
day. 5 ml of the culture were centrifuged and cells resuspended in 10 ml YPD and 
shaken for 2 h at 28°C. The pH was adjusted to 4.5-5.0 and 0.25 ml of a 1 mg/ml 
nystatin solution was added. The incubation at 28°C was continued for another 1.5 h. 
Cells were washed twice with water, resuspended in SD and portioned into 6 
aliquots. Aliquots were incubated with 0.5 ml of a 12.5% ethanol solution and 
incubated for a series of different times (0-120 minutes). After each incubation time, 
cells were washed and plated on selective medium. 
2.2.19  Isolation of Total DNA of Yarrowia lipolytica 
Total DNA isolation was according to the “rapid isolation of yeast chromosomal DNA” 
protocol (2000). Plasmid DNA was obtained by transformation of 150 ng of total DNA 
into E. coli competent cells. 
2.3  Methods of Protein Chemistry 
2.3.1 Growth  of  Yarrowia lipolytica 
Yarrowia lipolytica parental strains were grown in YPD medium at 28°C in rotatory 
flasks. A clone of Y. lipolytica from an agarose YPD plate was taken for a pre-culture 
and shaken in a flask between 18 - 24 hours. Subsequently, 200 - 400 ml were put in    
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a 10 l fermenter (Biostat E; Braun, Melsungen). The fermentation lasted for 14 - 18 
hours. The yield was up to 90 g cells / l (wet weight). 
Mutant strains were grown by fermentation in 10 l of YPD medium. Pre-culture 
medium depended on the plasmid used in Y. lipolytica. Minimal media SD+lysine was 
used if pINA240 plasmid was present or YPD media with Hygromycin BP
R 
Pif pUB4 
plasmidP
 
Pwas present. The fermentation was inoculated with 1/10th of fermentation 
volume of pre-culture. Pre-cultures were shaken in flask for 24 hours and 
fermentation also took 24 hours. Even when omitting selective pressure during 
fermentation, no substantial loss of plasmid was observed. 
2.3.2  Preparation of Mitochondrial Membranes 
Mitochondrial membranes were prepared from freshly harvested cells or from cells 
that had been shock frozen in liquid nitrogen and kept at –80°C. To break the cell 
walls 0.5 mm glass beads (Bend Euler Biotechnologie, Frankfurt) were used in a cell 
disintegrator. 300 – 500 g of cells were suspended in the same amount of buffer (600 
mM saccharose, 20 mM Na/MOPS, 1 mM EDTA, pH 7.2). Cell breakage was carried 
out for at least 2 hours in the presence of 2 mM PMSF (protease inhibitor). 
Centrifugation for 25 min. at 2000 × g was used to separate cell debris (pellet) from 
mitochondrial membranes (supernatant). To collect mitochondrial membranes this 
supernatant was ultracentrifuged for 1 hour at 100,000 × g. The homogenised 
membranes were resuspended in the same buffer as above but without EDTA, shock 
frozen and stored at –80°C.  
Membrane quality was checked by recording absorption spectra (530-630 nm) of the 
reduced minus oxidised forms of the heme groups contained in the respiratory chain. 
Mitochondrial membranes were oxidised by addition of dithionite and reduced by 
addition of ferricyanide. Content of heme groups b and aaB3
B was measured at 562 nm 
(oxidised minus reduced form) and at 605 nm, respectively. Their concentration was 
usually around 1-10 µM and the ratio heme b: heme aaB3
B around 3:1. 
2.3.3  Preparation of Mitochondrial Membranes in Small Amounts 
Freshly harvested cells (4 - 8 g) were used at 1:1:1 ratio of cells to buffer (same as in 
2.3.2) to glass beads. The cell breakage was due to vortexing in a falcon tube for     MATERIALS & METHODS 
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10 × 1 min and intermittent cooling in ice for one minute. Centrifugations and further 
steps were the same as in 2.3.2. 
2.3.4 Protein  Quantitation 
Protein determination was conducted after the procedure of (Lowry et al., 1951) 
modified after (Helenius and Simons, 1972). Calibration was carried out with bovine 
serum albumin (BSA), in a dilution series from 0.1 – 2.0 mg/ml. 
2.3.5 Blue-Native  Polyacrylamide Gel Electrophoresis (BN-PAGE) 
Blue-native polyacrylamide gel electrophoresis was used to separate the 
components of the mitochondrial respiratory chain in membranes of Y. lipolytica 
(Schägger, 2003). 500 µg of total protein was solubilised with 1 g/g dodecyl 
maltoside and 500 mM amino caproic acid and the resulting solubilised mitochondrial 
membranes were placed on 4 / 4 → 13% gradient gels. 
2.3.6  SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Tricine SDS-PAGE was used to check the composition and purity of complex  I 
preparations (Schägger and von Jagow, 1994;Schägger and von Jagow, 1987) 
2.3.7 Isoelectric  Focusing 
For IEF-separation as first dimension was used the IPGphor (Amersham Pharmacia 
Biotech) and 13 cm immobilised pH gradient (IPG) strips (pH 3-10). The samples of 
Complex I (400 µg/ml) was rehydrated in the solution containing 8 M Urea, 1.5% 
Triton X-100, 10 mg/ml DTE, 0.5% IPG Buffer and a trace of bromphenol blue for 12 
h at 20 °C. Focusing was carried out by 50µA per IPG strip using the following steps: 
pH 3-10 gel, 500Vh (max 500V), 1000 Vh (max 1000 V) and 30000 Vh (max 8000V). 
After focusing strips were equilibrated using buffer containing 50mM Tris-HCl pH 8.8, 
6M Urea, 30% glycerol, 4 % SDS, 10 mg/ml DTE and a trace of bromphenol blue. 
The second dimension gel consisted of Tricin-SDS 16% polyacrylamide gel. 
2.3.8 Western  Blot 
To investigate protein expression, the semidry immunoblotting procedure was 
followed using a polyvinylidendifluorid membrane (Immobilon P
TM
PP, Millipore). The    
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primary antibody Anti His-Tag or Anti-GFP and a secondary Anti-Rabbit antibody 
(mouse). 
2.3.9  Measurement of NADH:HAR Activity 
Detergent- and inhibitor-insensitive NADH:HAR [HAR: hexa-ammine-ruthenium(III) 
chloride] activity was measured using a Shimadzu MultiSpec-1501 or a Molecular 
Devices SPECTRAmax PLUSP
384
P spectrophotometer by following NADH-oxidation at 
340 - 400 nm (ε=6.22 mMP
-1
PcmP
-1
P). Assays were performed in the presence of 200 µM 
NADH and 2 mM HAR, 2 mM NaNB3
B in 20 mM NaP
+
P/Hepes, pH 8.0 at 30°C (Sled et al., 
1993). This activity depends only on the FMN and probably Fe-S cluster N3 
(Gavrikova et al., 1995). The reaction was started by the addition of 50 µg (total 
protein) of unsealed mitochondrial membranes. 
2.3.10  Measurement of catalytic activity, KBM
B, IB50
B 
To assay complex  I activity dNADH was used as electron donor, whereas the 
ubiquinone analogue DBQ was used as electron acceptor. dNADH:DBQ activity at 60 
µM DBQ and 100 µM dNADH was measured using a Shimadzu MultiSpec-1501 or a 
Molecular Devices SPECTRAmax PLUSP
384
P spectrophotometer by following dNADH-
oxidation at 340 - 400 nm (ε=6.22 mMP
-1
PcmP
-1
P) at 30°C in 20 mM Na-MOPS pH 7.2 
buffer containing 50 mM NaCl and 2 mM KCN. The reaction was started by adding 
mitochondrial membranes equivalent to 30 to 50 µg of protein/ml. Michaelis-Menten 
and IB50
B parameters were determined using microtiter plates in a Molecular Devices 
SPECTRAmax PLUSP
384
P spectrophotometer. The obtained data were fitted using 
“Enzfitter” (Version 2.0.16.0 Biosoft 1999, Cambridge). 
2.3.11  pH Dependence of dNADH:DBQ Activity 
The pH dependence was measured using a Molecular Devices SPECTRAmax 
PLUSP
384
P spectrophotometer by following dNADH-oxidation at 340 - 400 nm (ε=6.22 
mMP
-1
PcmP
-1
P) in a buffer containing 30 mM of each MES, MOPS, sodium acetate, tris, 
glycine, 50 mM NaCl and 2 mM KCN at pH 5-10. The reaction was started with 
mitochondrial membranes equivalent to 50 µg of protein/ml. 
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Data were fitted according to the following equation (Brandt and Okun, 1997),  
 
(Eq. 1) 
 
where  Rate  is the observed catalytic rate in the presence of saturating substrate 
concentrations (100 µM dNADH, 60 µM DBQ), [HP
+
P] is the concentration of protons, 
KBA
B and KBB
B are the dissociation constants of the two protonable groups A and B, and 
C is the optimal catalytic rate that would be observed if group A was deprotonated 
and group B was protonated in all enzyme molecules. 
2.3.12  Purification of Complex I 
Complex I was purified from isolated mitochondrial membranes that were solubilised 
with n-dodecyl-β-D-maltoside as described (Kashani-Poor et al., 2001a). Purification 
was via NiP
2+
P-affinity with a modest reduction of the imidazole concentration from 60 
mM to 55 mM in the equilibration and washing buffer followed by gel filtration on a 
TSK4000 column. Protein content was determined according to a modified Lowry 
protocol (Lowry et al., 1951). Blue native polyacrylamide gel electrophoresis was 
performed as described (Schägger, 2003). 
2.3.13  Reactivation of purified complex I 
To reactivate purified complex  I it is necessary to add lipids. In its natural 
environment, complex I is embedded in a lipid bilayer and most of these lipids are 
lost during protein purification. To reactivate complex  I dNADH:DBQ activity, 
asolectin was added (total soy bean extract with 20 % lecithin) in a 1:1 (w/w) protein-
to-lipid ratio. The asolectin solution was 10 mg/ml solubilised with 1.6 % OG in 1 mM 
KPBi 
Band 25 mM KB2
BSOB4
B pH 7.2. 
2.3.14  Reconstitution of complex I 
Reconstitution was performed by the method described in (Dröse, in preparation) 
using sodium-cholate as detergent. The final concentration of lipids was 10 mg/ml in 
buffer containing 20 mM KP
+
P-MOPS, 50 mM KCl, pH 7.2, solubilised with sodium-
cholate at a 1:2 (w/w) ratio lipid-to-detergent. 200 µg of purified complex I in 1 ml 
] [
1
1
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1
1
+
+
+
×
+
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H
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A   
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buffer was usually added at a protein-to-lipid ratio of 1:50 (w/w). Detergents were 
removed by adding a 20 fold amount of BioBeads SM2 (pre-treated according to 
Holloway 1973), following the guidelines detailed by Rigaud and co-workers (Rigaud 
et al., 1995). 
2.3.15  Fluorometric measurements of H
+ transport via ACMA dye 
Fluorimetric measurements were carried out at a Shimadzu RF-5001 fluorometer. 
Different quantities of proteoliposomes were diluted under stirring in 2 ml buffer 20 
mM K
+-MOPS pH 7.2 containing 50 mM KCl. Proton translocation was measured 
with ACMA that was added to a final concentration of 0.5 µM. The fluorometer 
settings (integration time 1s) were: excitation wavelength 430 nm; emission 
wavelength 475 nm; band pass 5 nm in both cases. H
+-translocation was started by 
the addition of 60 µM DBQ and subsequently 100 µM NADH. Inhibitors and 
ionophores were added at following final concentration: 5 µM valinomycin; 12.5 µM 
nigericin; 1 µM FCCP; 1 µM DQA. 
2.3.16 EPR-Spectra 
Low temperature EPR spectra were obtained on a Bruker ESP 300E spectrometer 
equipped with a liquid helium continuous flow cryostat, ESR 900 from Oxford 
Instruments. Samples were mixed with NADH in the EPR tube and frozen in liquid 
nitrogen after 30 seconds reaction time. Spectra were recorded at 12 K or at 40 K 
with the following instrument settings: microwave frequency 9.475 GHz, microwave 
power 1 mW, modulation amplitude 0.64 mT. Under these conditions spectra show 
contributions from clusters N1, N2, N3 and N4. Spectra were recorded and analysed 
by Dr. Klaus Zwicker. 
2.3.17 Redox  titrations 
For redox titrations mitochondrial membranes (~200 mg protein) were sedimented by 
centrifugation for 1 h at 48,000 X g. The pellet was suspended in 30 ml of buffer 
containing 30 mM each of sodium-acetate, Mes, Mops, Tris, glycine, pH 7.0, 100 mM 
NaCl and 1 mM EDTA and centrifuged as before. After one additional washing step 
the resulting pellet was suspended in 4–5 ml of the above buffer yielding a final 
protein concentration of 25–30 mg/ml. The following redox mediators were added to 
a final concentration of 30 µM each: tetramethyl-phenylenediamine, phenazine-    MATERIALS & METHODS 
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methosulfate, methylene blue, menadione, resorufin, indigotrisulfonate, 1,2-
naphthoquinone, 2-hydroxy-1,4-naphthoquinone, phenosafranine, benzyl viologen, 
and methyl viologen. Redox titrations were performed anaerobically as described in 
(Dutton, 1978). The membrane suspension was poised at appropriate potential 
values by small additions of freshly prepared 50 mM dithionite. Aliquots were 
anaerobically transferred into an EPR tube, frozen rapidly in cold 
isopentane/methylcyclohexane (5:1), and stored in liquid nitrogen. Cluster N2 
reduction rates in the frozen samples were then determined by recording EPR 
spectra at 12 K from samples poised at redox potentials between +100 and -500 mV. 
After subtraction of the oxidised spectrum recorded at redox poise between +30 and -
30 mV, to eliminate signal contributions from components with higher redox potential, 
the intensity of the N2 EPR signal was calculated by scaling it to a simulated N2 
spectrum. The resulting N2 reduction rates were fitted to the Nernst equation using 
PSI Plot (Poly Software International, Salt Lake City, UT, USA). 
2.4  Confocal Laser Scanning Microscopy (CLSM) 
Yarrowia lipolytica strain described in 2.2.1 with a 30kDa-eGFP/pUB26 plasmid was 
grown overnight in YPD media with Hygromycin B
R at 28°C in a flask. Cells were 
washed with a TE buffer and subsequently fixed in 1 % agarose. CLSM was 
performed on LSM 510 META (Carl Zeiss, Jena, Germany).    
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3 RESULTS 
3.1  TYarrowia lipolytica Strains 
3.1.1 Strain  ∆nucm  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Strategy for generation of strain  ∆nucm with His-Tag on 30-kDa 
subunit 
Strains NK2.1 and GB12 were mated and sporulated. The desired spore should 
contain the TNUGMT allele with C-terminal His-Tag from strain GB12 and the 
Tnucm::URAT3 allele from strain NK2.1. PCR products from primer pairs (URAds, 49us) 
and (30c3, 30nc1) and Southern Blots were used for checking. (see Figure 3.2 and 
Figure 3.3). 
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49us   RESULTS 
To obtain a strain that allows to purify complex I from 49-kDa mutants via His-Tag 
affinity chromatography two haploid Y. lipolytica strains, NK2.1 (nucm::URA3, MatA, 
ndh2i,  lys11-23,  ura3-302,  leu2-270,  xpr2-322) (Kashani-Poor et al., 2001b) and 
GB12 (30Htg2 MatB,  ndh2i,  his-1,  ura3-302,  leu2-270,  xpr2-322) were mated, 
followed by sporulation and selection of haploid strains carrying the appropriate 
genetic markers (see Figure 3.1). Strain GB12 carries a His-Tag on the C-terminus of 
the 30-kDa subunit and strain NK2.1 has a genomic deletion of the NUCM gene 
(nucm::URA3). Both strains have a copy of ndh2i integrated randomly into their 
genomes and it was not determined which of these ndh2i allele was incorporated in 
the final strain.  
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- 
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Figure 3.2 A) PCR proof for deletion of the NUCM gene. B) PCR checking for 
His-Tag
1
A) PCR product generated with primer pair URAds and 49us. As a negative control a 
DNA (-) from strain GB12 and as positive control (+) genomic DNA from strain NK2.1 
was used a template for PCR. 
B) PCR product generated with primer pair 30c3 and 30nc1. The negative control (-) 
shows a 252bp PCR product generated from strain NK2.1 genomic DNA. The 
positive control (+) shows a 264 bp PCR product generated from strain GB12 
genomic DNA. 
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1 Data from his
- spores not shown.    
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Figure 3.3 Southern Blot proof for deletion of NUCM gene 
Genomic DNA from spores was extracted and digested with BamHI. The Southern 
Blot Probe used is the Nhe I fragment from the NUCM locus of strain GB12 as shown 
in Figure 3.1. The spores that contain the NUCM allele have a BamHI site in the ORF 
of the NUCM gene and therefore 2 bands should be visible and the spores that have 
the nucm::URA3 allele are missing this BamHI site and show only one band. 
 
Two different phenotypes were observed after sporulation, strains that were lys
- or 
his
- with either MatA or MatB. To check for the presence of the NUGM His-Tag allele 
a PCR using primer pair 30c3 and 30nc1 was performed (see Figure 3.2 Gel B). To 
exclude the possibility of aneuploidity the absence of the wild type NUCM gene was 
checked by Southern Blotting (see Figure 3.3. The probe is the Nhe I fragment from 
the NUCM locus of strain GB12, as shown in Figure 3.1) and also a PCR check using 
primer pair URAds and 49us was done (see Figure 3.2 Gel A). 
CL-Strains (lys
-): nucm::URA3, 30Htg2, ndh2i, lys11-23, ura3-302, leu2-270, xpr2-322 
CH-Strains (his
-): nucm::URA3, 30Htg , ndh2i, his-1, ura3-302, leu2-270, xpr2-322 
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Strain CL1 was used for all preparations of Y. lipolytica mitochondrial membranes 
and complex I. CL1 is named “∆nucm” in the following. 
3.1.2  Complementation of strain ∆nucm with plasmids bearing wild type 
or mutant versions of the NUCM gene 
To have higher yields and faster growth of Y. lipolytica it was necessary to switch 
from pINA240/NUCM to pUB4/NUCM. The latter plasmid enables cells to grow on 
YPD complete medium with HygBP
R
P as selection marker instead of SD minimal 
medium with LEU2 as selection marker. Firstly, the BamHI site in the NUCM gene in 
pINA240/NUCM was removed by the introduction of a silent mutation. The GGA 
codon for glycine-298 was changed into the glycine codon GGC. The modified 
NUCM gene was cut from pINA240/NUCM using restriction enzymes BamHI and 
EcoRI. The 3.1 kb BamHI / EcoRI fragment was ligated into pUB4 (7.6 kb) which had 
also been cut with BamHI and EcoRI and its ends were dephosphorylated to prevent 
self ligation. Complex I properties from Y. lipolytica ∆nucm strains when transformed 
with the newly generated plasmid pUB4/NUCM were the same as when transformed 
with plasmid pINA240/NUCM. Plasmid pUB4/NUCM was used as template for site 
directed mutagenesis in the NUCM gene. Complemented strain CL1 with plasmid 
pUB4/NUCM is named ‘parental’ in the following.    
3.2   Mutagenesis of Conserved Histidines and Arginines in the 49-
kDa Subunit 
3.2.1  Mutagenesis of Histidine 226 
His-226 is invariant in all known complex I 49 kDa subunit sequences (Figure 4.1). It 
corresponds to a highly conserved histidine in water soluble [NiFe] hydrogenases 
that forms a hydrogen bond to the proximal iron-sulphur cluster of the small subunit 
(Volbeda et al., 1995). His-226 was mutagenised into alanine and the potential iron-
sulphur cluster ligands glutamine, cysteine and methionine. As judged by BN-PAGE 
(not shown) and NADH:HAR activity, complex  I was fully assembled to normal 
expression levels in all His-226 mutants (Table 3.1) 
 
Complex I  I50
Strain 
content (%)  activity (%) 
KM 
(µM)  DQA (nM)  rotenone(nM) 
Parental 100  100  11 13  600 
H226M 120  80  9  9  300 
H226Q 112  56  9 13  600 
H226C 122  43  5 13  600 
H226A
1 100 20  n.d.  18  770 
 
 
 
 
 
Table 3.1 Activity tests, KM for DBQ and I50 for DQA and rotenone measured on 
mitochondrial membranes of H226 mutants 
Complex I content, activity, and inhibitor sensitivity in mitochondrial membranes of 
site-directed Y. lipolytica mutants in the 49-kDa subunit are compared to the plasmid 
complemented nucm::URA3 deletion strain (parental). Complex I content is given as 
specific NADH:HAR oxidoreductase activity in mitochondrial membranes (100% = 1.0 
µmol min
-1mg
-1), dNADH:DBQ oxidoreductase activity was normalised for complex I 
content (100% = 0.3 µmol min
-1mg
-1). I50, concentration needed for 50 % inhibition of 
the inhibitor-sensitive fraction of the dNADH:DBQ oxidoreductase activity; n.d., not 
determined. 
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Only mutation H226A had a pronounced effect on specific ubiquinone reductase 
activity, reducing it by 80 %. Mutants H226Q and H226C had retained 56 % and 
43 % activity, respectively. Membranes from mutant H226M were only slightly less 
(about 20 %) active than those from the parental strain. Hardly any changes were 
observed in the Michaelis-Menten constant KM. A slight hypersensitivity of mutant 
H226M and a minor resistance of mutant H226A towards the complex I inhibitors 
DQA and rotenone was observed. For mutants H226C and H226Q, the I50 values for 
DQA and rotenone were unchanged (Table 3.1).    
3.2.2 Mutations of Histidine 226 Affect the Properties of Iron-Sulphur 
Cluster N2 
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Figure 3.4 EPR spectra of H226 mutants in the 49-kDa subunit. A) Spectra of 
mitochondrial membranes. B) Spectra of purified complex I. 
A) EPR spectra of H226 mutants from mitochondrial membranes. The EPR spectra 
of mitochondrial membranes were recorded at a temperature of 12 K, a microwave 
frequence of 9.48 GHz, a microwave power of 2 mW, and modulation amplitude of 
0.8 mT. Membranes were reduced with NADH. The line represents the gz signal of 
cluster N2. B) EPR spectra of purified complex I from H226 mutants. EPR spectra of 
complex I reduced with NADH were recorded at a temperature of 12 K, a microwave 
frequency of 9.48 GHz, a microwave power of 2 mW, and a modulation amplitude of 
0.8 mT. Under these conditions spectra show contributions from clusters N1, N2, N3 
and N4 (Djafarzadeh et al., 2000). The dashed lines indicate the position of the gz 
signal of cluster N2. The N2 gz signal in H226M shows a shift to lower field values 
and the signal is reduced. H226Q, H226C and H226A show no shift but a very 
significant reduction of the gz signal, which is comparable to the reduction in 
dNADH:DBQ activity. 
 
In EPR spectra recorded from both mitochondrial membranes and purified complex I, 
marked effects on iron-sulphur cluster N2 but not on the other EPR detectable iron-
42    RESULTS 
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sulphur clusters resulted from all four mutations (Figure 3.4). The quality of the 
spectra obtained with purified complex  I was much higher, because of markedly 
increased protein concentrations and the exclusion of interference from other 
paramagnetic components of the mitochondrial respiratory chain. However, the 
analysis of EPR spectra of mitochondrial membranes was critical to decide whether 
iron-sulphur clusters were lost during the purification procedure and allowed a direct 
comparison with the functional data summarised in Table 3.1. Again, mutation H226A 
had the most drastic effect resulting in complete loss of iron-sulphur cluster N2 
signals. These were not even observed upon reduction of the sample with NADH/ 
dithionite (EBh
B ≅ -450 mV).  
Similar results were obtained for mutants H226C and H226Q, but residual signals 
from cluster N2 corresponding to less than 10 % of wild-type level were observed in 
EPR spectra of purified complex  I and - in the gBxy
B region - of mitochondrial 
membranes. In membrane preparations from mutant H226M, the gBz
B signal of cluster 
N2 was reduced by about two thirds compared to enzyme from the parental strain. 
An approximate N2 EPR spectrum of mutant H226M could be obtained by calculating 
the difference spectrum from a spectrum recorded at 45 K (N1 spectrum) and one 
recorded at 25 K (contributions from N1 and N2) (Figure 3.5). The resulting spectrum 
still had an axial line shape but with significantly shifted gBz
B=2.053 and gBxy
B~1.930 
(N2Bparental
B: gBz
B=2.051, gBxy
B=1.925, as determined from experimental spectra). The 
analysis of the power saturation behaviour at 12 K of the cluster N2 signal intensity 
also revealed a significant change of the half saturation parameter PB1/2
B. In the mutant 
PB1/2
B was decreased to ~1 mW, which means only about one tenth of the value which 
could be determined in the parental sample. The spin concentration of cluster N2 in 
isolated NADH reduced complex  I from H226M was estimated from EPR spectra 
recorded under non-saturating conditions to be ~67 % of the parental N2 intensity. 
These results indicate that H226 is in close proximity of N2 and the exchange of this 
residue had direct effects on EPR spectroscopic properties of the cluster.  
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Figure 3.5 Difference EPR spectra at 25 K and 45K of mutant H226M compared 
to wild type 
At 25 K the cluster N2 is visible whereas at higher temperature at 45 K because of 
much faster relaxation time cluster N2 is not detectable. This fact can be used to 
extract EPR signal that comes only from cluster N2. Red spectrum presents 
simulated spectrum of parental cluster N2. 
 
The redox titrations of mitochondrial membranes from H226M at pH 7.0 revealed a 
highly diminished midpoint potential for cluster N2 of –218 mV (Figure 3.6). The 
dramatic effect of this mutation indicated that H226 is close enough to increase the 
electron affinity of N2 by its positive charge and hence a mutation in this position 
affects the redox properties of the centre.  
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Figure 3.6 Redox behaviour of cluster N2 in parental and mutant H226M strain 
at pH 7.0 
The reduction rate of cluster N2 was monitored by EPR spectroscopy at 12 K. (●) 
parental; (○) H226M. Data points were fitted according to the Nernst equation 
resulting in the indicated Em-values and n-values close to 1 (n = number of 
transferred electrons, mean = 0.9 ± 0.1 for all redox titrations of cluster N2 performed 
during this study). Redox-Titrations were performed by Dr. Klaus Zwicker. 
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The pH-dependence of the cluster N2 redox midpoint potential, detected in complex I 
from bovine heart (Ingledew and Ohnishi, 1980), was an important argument to claim 
a prominent function of this redox group in the coupling of electron transfer and 
proton pumping. Therefore the pH-dependence of the N2 midpoint potential in Y. 
lipolytica mitochondrial membranes was monitored between pH 5.0 to pH 9.0. At pH 
7.0 the N2 midpoint potential of Y. lipolytica complex I was Em,7 = -139 mV (Figure 
3.6), a value very similar to those reported for complex I from other sources (Sled et 
al., 1993). 
In the physiological pH-range the midpoint potential of N2 was clearly pH-dependent 
with a slope of –36 mV/pH-unit (calculated between pH 5.7 and 8.0). This value 
differed significantly from the theoretically expected –60 mV/pH-unit (Dutton, 1978) 
which was found in membrane preparations from bovine heart mitochondria and in 
membrane particles from Paracoccus denitrificans (Sled et al., 1993). 
If we assume an amino acid side chain in close proximity of N2 which functions as 
redox-Bohr group, dependent on the redox state of N2, this group is characterized by 
specific pK values. The calculation of pK values resulted in pKox = 5.7 and pKred = 
7.3. The value for pKred was well defined by the experimental data but there was 
some uncertainty for pKox because there was only one data point (at pH 5.4) 
representing the pH-independent region. In model calculations with fixed pKox values 
from pH 4.0 to pH 6.0 the slope in the pH-dependent region did only slightly change 
and the resulting pKred values changed only half a unit from pH 7.0 (pKox =4.0) to 7.5 
(pKox= 6.0).  
Hence the small difference of the pK values and especially the low pK for the 
reduced species, which means that under physiological conditions only about half the 
concentration of the redox-Bohr group becomes protonated upon reduction, make a 
proton transfer reaction which is coupled to an electron transfer in a one to one 
stoichiometry unlikely. 
Even more striking than the shift of the N2 midpoint potential was the complete loss 
of its pH-dependence as determined in the range of pH 6.0 to 8.0 (Figure 3.7). It can 
be concluded that protonation of H226 at low pH increases the midpoint potential of 
cluster N2. When the pH becomes more basic, H226 becomes deprotonated and Em 
of N2 decreases.     RESULTS 
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Figure 3.7 Redox behaviour of cluster N2 in H226M 
pH-dependence of redox midpoint potentials of cluster N2 in mitochondrial 
membranes prepared from parental (●) and mutant H226M strain (○). The pH-
dependence of EBm
B was completely lost in membranes from the mutant and the 
midpoint potentials were shifted by 50 - 120 mV to the negative when compared to 
the potential of parental membranes at the same pH. Redox-Titrations were 
performed by Dr. Klaus Zwicker. 
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These results confirm our structural model that iron-sulphur cluster N2 is located at 
the interface of the PSST and 49-kDa subunits. H226 of the 49-kDa is in close 
proximity to iron-sulphur cluster N2, close enough to modulate its electron affinity, 
and consequently the redox midpoint potential of this centre. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 pH dependence of specific activity 
The steady-state rates of dNADH:DBQ oxidoreductase activity were measured 
covering pH range from 5.0 to 10.0 using mitochondrial membranes (50 µg/ml total 
protein) at saturating substrate concentrations as described in 2.3.10. The 
parameters used to plot the fitted curve are listed in Table 3.2. ●, parental strain; ○, 
mutant H226M. 
 
Despite these significant changes of N2 properties in the mutant H226M the pH 
dependence of enzymatic activity was essentially the same as for the parental 
membrane preparation (Figure 3.8). Both profiles showed a steep increase between 
pH 5.5 and 7.0, where a broad maximum between pH 7.0 to pH 8.0 was reached, 
followed by decay with half maximal activity between pH 8.5 and 9.0. The 
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characteristic pK values which can be obtained from these pH-dependencies did not 
change in the mutant membranes. 
The maximal dNADH:DBQ activity for wild type and for mutant H226M was almost at 
the same pH range between 7.4 and 7.7 (Figure 3.8). pK values for wild type and for 
mutant H226M did not show any significant shift (Table 3.2). 
 
 
 
 
 
Table 3.2 pK values controlling dNADH:DBQ activity 
pTKT values were determined by fitting pH dependent activities to Equation 1 (see 
2.3.10). 
 
 p KBA
B  pKBB
B  C 
parental  6.3 ± 0.1  8.6 ± 0.1  0.347 ± 0.015 
H226M  6.4 ± 0.1  8.8 ± 0.1  0.236 ± 0.009    
50 
3.2.3  Reactivation and Reconstitution of Mutant H226M  
During the purification of enzymes that are imbedded in the membrane bilayer at first 
enzymes need to be solubilised with detergents. With each subsequent 
chromatographic step more of the phospholipids attached to the enzyme are lost. 
Due to loss of lipids that are absolutely essential for activity, enzymes become 
‘deactivated’. To reactivate enzymes after purification it is necessary to add specific 
(phospho)lipids. Purified complex I was fully reactivated by the addition of asolectin 
(mixture of soybean phospholipids) (Kashani-Poor et al., 2001a; Dröse et al., 2002). 
Purified H226M complex I could be also reactivated to the same degree as the wild 
type enzyme. For purified H226M complex I the NADH:HAR activity was in the same 
range either with or without asolectin (Table 3.3). 
Complex I  of  Y. lipolytica has been successfully imbedded into proteoliposomes 
formed of asolectin and by using sodium-cholate for the solubilisation of lipids and 
Bio Beads for the removal of detergent (Kashani-Poor et al., 2001a; S. Droese et al. 
in prep). 
 
 
 
 
 
Table 3.3 Asolectin reactivation of purified parental and H226M mutant 
complex I 
Asolectin to protein ratio is 1200:1 mol/mol (~1:1 mg/mg). Asolectin was added and 
left on ice for 10-20 min. The results are average from 3 individual measurements, 
SD is given in brackets. 
 
The redox coupled proton translocation of isolated complex I from the parental strain 
and strain H226M was analysed after reconstitution into liposomes. NADH:DBQ 
activities were measured in the presence and in the absence of the protonophore 
FCCP, that dissipates a proton-motive-force generated during the pumping of protons 
w/o asolectin (U/mg)  with asolectin (U/mg) 
  NADH:HAR NADH:DBQ NADH:HAR NADH:DBQ 
parental 49  (±10) 0.2  (±0.1) 50  (±6) 2.8  (±0.3) 
H226M  43 (±6) 0.3  (±0.2) 40  (±2) 3.2  (±0.7)    RESULTS 
into the lumen of the proteoliposomes. The ‘theoretical’ specific activity (U/mg th.) 
assumes that all the protein was incorporated and contributed to the activity. This 
could be regarded as the minimal specific NADH:DBQ activity. And finally, the 
coupling factor of the proteoliposomes was expressed as the ratio of the activities in 
the presence and absence of FCCP. One of the possible ways to observe qualitative 
proton pumping into the lumen of proteoliposomes is quenching of the dye ACMA (9-
amino-6-chloro-2-methoxyacridine). After addition of the substrates the quench of 
ACMA fluorescence indicates proton translocation to the lumen of the 
proteoliposomes. This ACMA dye fluorescence quench was observed in 
reconstituted parental and H226M mutant complex I. 
 
DBQ
FCCP
H226M
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10 s
0.69 U/mg
0.85 U/mg
3.0 U/mg
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Figure 3.9 Determination of coupling factor of proteoliposomes 
Measurements of NADH:DBQ  complex I activity in proteoliposomes. OD340-400 was 
followed. 
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NADH:DBQ activity 
(U/mg th)  NADH:HAR activity (U/mg) 
proteoliposomes  Strain 
- FCCP  + FCCP 
purified 
complex I 
Proteo-
liposomes 
coupling 
factor 
parental  0.85 – 1.8  1.8 – 3.0  39 - 59  11 - 20  2.0 – 3.5 
H226M  0.69 - 0.92  2.3 – 3.0  37 - 49  14 - 23  2.5 – 4.3 
 
Table 3.4 Sodium-cholate mediated reconstitution of complex I 
Proteoliposomes were prepared as described in 2.3.13. The 'theoretical' specific 
activity (U/mg th.) assumes that all the protein was incorporated and contributed to 
the activity. And finally, the coupling factor of the proteoliposomes was expressed as 
the ratio of the activities in the presence and absence of FCCP. 
 
As shown in Figure 3.10, after addition of the ACMA dye fluorescence signal reached 
a maximum and after addition of DBQ fluorescence signal was slightly lowered due to 
absorption of emitted light by DBQ. With the addition of NADH the reaction was 
started and protons were translocated into the proteoliposomes. Due to a change of 
pH in the proteoliposomes, the ACMA dye is protonated and cannot leave the 
proteoliposomes in this protonated state. Upon this accumulation of ACMA dye we 
observe a quenching effect which results in a decrease in fluorescence. The 
fluorescence comes to steady state when equilibrium is reached between protons 
translocated into proteoliposomes and protons leaking out of the not perfectly sealed 
proteoliposomes. This steady state level was sensitive to the complex  I specific 
inhibitor DQA. After addition of DQA the reaction was inhibited and no more protons 
were translocated into proteoliposomes. The fluorescence signal went back to the 
same level as it was before adding NADH. In addition, nigericin was added after 
DQA, which catalyses an electroneutral K
+/H
+ exchange across lipid bilayers. If DQA 
had not completely inhibited the reaction there would be a further rise of fluorescence 
signal, what clearly was not the case. 
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Figure 3.10 ACMA quenching measurements on proteoliposomes for the 
parental strain and mutant H226M 
The reconstitutions followed the 'standard' protocol 2.3.13. All measurements were 
done in the presence of 50 mM KCl and 5 µM valinomycin with the same volume (20 
µl) of proteoliposome solution. 0.5 µM ACMA, 60 µM DBQ and 100 µM NADH were 
added subsequently. Ionophores/inhibitors were added as indicated (1 µM DQA and 
12.5 µM nigericin see Appendix for structure and function of used ionophores). 
 
The same effect was observed if we ‘unsealed’ proteoliposomes instead of inhibiting 
the reaction, this was done with uncouplers such as FCCP (Figure 3.11A). FCCP 
transports protons through membranes and prevents formation of a pH gradient, 
therefore, ACMA quenching does not occur. Another control is if we add inhibitor, in 
this case DQA, to the reaction before it starts, so there is no complex I activity; we 
found that there is no ACMA quenching indicating absence of proton translocation 
into the proteoliposomes (Figure 3.11B). As can be seen in Figure 3.10, proton 
translocation could be observed both in the parental strain and in mutant H226M. 
However these measurements are only qualitative and one can only detect if protons 
are being translocated or not. However, no conclusion about HP
+
P/eP
-
P stoichiometries 
can be derived. 
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Figure 3.11 ACMA quenching measurements on proteoliposomes for the 
parental strain and mutant H226M 
The reconstitutions followed the 'standard' protocol 2.3.13. All measurements were 
done in the presence of 50 mM KCl and 5 µM valinomycin with the same volume (20 
µl) of proteoliposome solution. 0.5 µM ACMA, 60 µM DBQ and 100 µM NADH were 
added subsequently. Ionophores/inhibitors were added as indicated 1 µM DQA and 
12.5 µM nigericin. A) FCCP control; B) control demonstrating that no proton gradient 
was built when complex I was inhibited by DQA. 
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3.2.4 Mutations of Arginine 141 Have Moderate Effects on Activity, but 
Drastically Reduce Iron-Sulphur Cluster N2 Content 
Arg-141 is invariant in all known 49-kDa subunit sequences of complex I and in the 
large subunits of [NiFe] hydrogenases (Figure 4.1). In the hydrogenase structure it is 
found in close vicinity to the proximal iron-sulphur cluster (Volbeda et al., 1995). This 
residue has been changed to alanine, lysine and methionine. In all Arg-141 mutants 
complex  I was assembled (not shown) and complex  I content in mitochondrial 
membranes tended to be even slightly higher than in the parental strain (Table 3.5). 
Complex I  I50
Strain 
content (%)  activity (%) 
KM 
(µM)  DQA (nM) rotenone(nM)
Parental 100  100  11 13  600 
R141A
1 130 17  10  21  570 
R141K 136  45  13  55  1500 
R141M 111  40  11 11  500 
 
Table 3.5 Activity tests, KM for DBQ and I50 for DQA and rotenone measured on 
mitochondrial membranes of R141 mutants 
Complex I content, activity, and inhibitor sensitivity in mitochondrial membranes of 
site-directed Y. lipolytica mutants in the 49-kDa subunit are compared to the plasmid 
complemented nucm::URA3 deletion strain (parental). Complex I content is given as 
specific NADH:HAR oxidoreductase activity in mitochondrial membranes (100% = 1.0 
µmol min
-1mg
-1), dNADH:DBQ oxidoreductase activity was normalised for complex I 
content (100% = 0.3 µmol min
-1mg
-1). I50, concentration needed for 50 % inhibition of 
the inhibitor-sensitive fraction of the dNADH:DBQ oxidoreductase activity. 
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Mitochondrial membranes from mutant R141A exhibited a dNADH:DBQ activity that 
was some 80 % reduced, while the two more conservative exchanges R141K and 
R141M reduced activity only by about 50 %. For 4 different batches of mitochondrial 
membranes from mutant R141K ubiquinone oxidoreductase activity varied quite 
substantially between 30 % and 70 % of wild-type activity; the value given in Table 
3.5 is the average of all measured values. The KM value for DBQ was not changed in 
any of the three mutants, but mutation R141K resulted in a clear 4-5 fold higher I50 for 
 
1 Data from Dr. Kashani-Poor    
DQA and a 2-3 fold higher I50 for rotenone. Of the two other mutations only R141A 
seemed to have a subtle effect on DQA sensitivity. 
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Figure 3.12 EPR spectra of R141 mutants in the 49-kDa subunit. A) 
mitochondrial membranes. B) purified complex I. 
A) EPR spectra of R141 mutants from mitochondrial membranes. The EPR spectra 
of mitochondrial membranes from Y. lipolytica were recorded at a temperature of 
12  K, a microwave frequence of 9.48 GHz, a microwave power of 2 mW, and 
modulation amplitude of 0.8 mT. Membranes were reduced with NADH. The line 
represents the gz signal of cluster N2. B) EPR spectra of purified complex I from 
R141 mutants. EPR spectra of complex I from Y. lipolytica reduced with NADH were 
recorded at a temperature of 12 K, a microwave frequency of 9.48 GHz, a microwave 
power of 2 mW, and a modulation amplitude of 0.8 mT. Under these condtitions 
spectra show contributions from clusters N1, N2, N3 and N4 (Djafarzadeh et al., 
2000). The dashed lines indicate the position of the gz signal of cluster N2. Only in 
the R141K mutant a cluster N2 gz signal was observable and was shifted to lower 
field values. 
 
56    RESULTS 
57 
In stark contrast to these rather normal functional properties, EPR spectroscopy 
revealed drastic effects specifically on iron-sulphur cluster N2 (Figure 3.12): In 
membranes and purified complex  I from mutants R141M and R141A, cluster N2 
signals were undetectable. Again no altered paramagnetic species were detected in 
a spectroscopic search under various conditions (not shown). A small amount of 
cluster N2 in the order of 5 % compared to wild-type level was detectable when 
mutant R141K was analysed; the very weak gz signal seemed to be shifted towards 
lower field values. 
To address the question whether cluster N2 was in fact missing in the mutant 
membranes or whether the cluster had become just undetectable under standard 
EPR conditions, the possibility that the mutations had turned the spin S = ½ of the 
ground state of cluster N2 to S = 3/2 was considered. EPR signals from Fe4S4 
clusters with S = 3/2 ground states should appear in the g = 4.0-5.5 region, but are 
very difficult to observe, particularly in the event of significant cluster heterogeneity 
(Conover et al., 1990; Duderstadt et al., 1999). 
The EPR spectra from parental and mutant isolated complex  I samples were 
recorded over a wide field range at low temperature (4.3 K) and high microwave 
power (63 mW) as shown in Figure 3.13. No indications for novel paramagnetic 
species could be observed. However, the existence of a S = 3/2 spin could not be 
ruled out completely due to low complex I concentrations and baseline problems in 
the relevant field region.    
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Figure 3.13 Wide-range EPR spectra of isolated complex I from parental and 
mutant enzyme preparations 
To detect possible EPR signals originating from S=3/2 spin states two parental 
enzyme preparations, one highly pure (bottom) and another containing a small 
amount of  cytochrome oxidase as a contaminant (top) were compared to mutant 
preparations R141A and R141M (same samples as in Figure 3.12). EPR signals from 
an S=3/2 state which should appear in the low field region between g = 4 and g = 5.5 
could not be identified. The signals at g = 6 in the mutant samples were attributed to 
the high spin heme of cytochrome oxidase. At g = 4.3 signals from adventitious high-
spin Fe(III) were detectable. In the region around g = 2 the gz-signals of cluster N4 
(gz = 2.10), N5 (gz = 2.06) and N1 (gz = 2.02) could be identified. In this field range 
the EPR signals from cluster N2  are power saturated completely. All samples had 
protein concentrations between 5–10 mg/ml and were reduced by NADH. EPR 
conditions: microwave frequency 9.47 GHz, modulation amplitude 1 mT, microwave 
power 63 mW, temperature 4.3 K. 
 
 
58    RESULTS 
3.2.5  Mutations of Histidine 91 and Histidine 95 Result in Complete Loss 
of Catalytic Activity  
Residues His-91 and His-95 are strictly conserved in all complex I 49 kDa subunit 
sequences but not in [NiFe] hydrogenases (Figure 4.1). However, conservation of the 
structural fold between homologous subunits predicts both residues to be close 
enough to iron-sulphur cluster N2 to be candidate ligands. His-91 and His-95 were 
changed into alanine, methionine and arginine. All His-91 and His-95 mutants 
contained normal or, in the case of H91M and H91R, only slightly reduced amounts 
of complex I (Table 3.6) that was assembled normally (Figure 3.14). In mitochondrial 
membranes from all six mutant strains dNADH:DBQ activity was below the detection 
level of 5 %. However, EPR spectra of all iron-sulphur clusters, including cluster N2 
were indistinguishable from those of the parental strain (Figure 3.15). This was also 
true for complex I from mutant H95A that was purified as a representative of this 
group of mutations. 
 
Complex I 
Strain 
content (%) activity (%) 
Parental 100  100 
H91A 117  <5 
H91M 76  <5 
H91R 75  <5 
H95A 132  <5 
H95M 116  <5 
H95R 98  <5 
 
 
 
 
 
 
Table 3.6 Activity tests measured on mitochondrial membranes from H91 and 
H95 mutants 
Complex  I content is given as specific NADH:HAR oxidoreductase activity in 
mitochondrial membranes (100% = 1.0 µmol min
-1mg
-1), dNADH:DBQ 
oxidoreductase activity was normalised for complex I content (100% = 0.3 µmol min
-1 
mg
-1). 
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Figure 3.14 1.6 mm Blue Native Gel (4/4 to 13% gradient) from isolated 
mitochondrial membranes 
Isolated mitochondrial membranes from parental strain and from mutants H91A, 
H91M, H95A and H95M. Roman numbers show individual complexes of the 
respiratory chain. VD is complex V dimer that occurs at lower detergent 
concentrations. All mutants have assembled complex I. 
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Figure 3.15 EPR spectra of H91 and H95 mutants in the 49-kDa subunit. A) 
Spectra of purified complex I from parental strain and mutant H95A. B) Spectra 
of mitochondrial membranes. 
A) EPR spectra of purified complex I from parental strain and mutant H95A. EPR 
spectra of complex I reduced with NADH were recorded at a temperature of 12 K, a 
microwave frequency of 9.48 GHz, a microwave power of 2 mW, and a modulation 
amplitude of 0.8 mT. Under these conditions spectra show contributions from clusters 
N1, N2, N3 and N4 (Djafarzadeh et al., 2000). The dashed lines indicate the position 
of the gz signal of cluster N2. B) EPR spectra of H91 and H95 mutants from 
mitochondrial membranes. The  EPR spectra of mitochondrial membranes were 
recorded at a temperature of 12 K, a microwave frequence of 9.48 GHz, a microwave 
power of 2 mW, and modulation amplitude of 0.8 mT. Membranes were reduced with 
NADH. The line represents the gz signal of cluster N2. 
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3.2.6  Mutations of Arginine 466 Change Functional Properties of 
Complex I 
The C-terminal arginine R466 is also strictly conserved among complex  I from 
various species. In [NiFe] hydrogenases it corresponds to a strictly conserved 
histidine that is ligand to a Mg
2+ site and resides about 9 Å from the [NiFe] site and 
14 Å from the proximal iron-sulphur cluster. R466 was changed into alanine, 
methionine, histidine and glutamate. Assembled complex I was found in membranes 
from all Arg-466 mutants (not shown) but, with the exception of mutant R466H, 
content was significantly reduced by 30-50 %.  
Complex I  I50
Strain 
content (%)  activity (%) 
KM 
(µM) DQA (nM)  rotenone(nM) 
Parental 100  100 11  13  600 
R466A 53  75  11  35  750 
R466M 73  9  -  -  - 
R466H 99  85  25  36  900 
R466E 50  53 9  20  700 
 
Table 3.7 Activity tests, KM for DBQ and I50 for DQA and rotenone measured on 
mitochondrial membranes of R466 mutants 
Complex I content, activity, and inhibitor sensitivity in mitochondrial membranes of 
site-directed Y. lipolytica mutants in the 49-kDa subunit are compared to the plasmid 
complemented nucm::URA3 deletion strain (parental). Complex I content is given as 
specific NADH:HAR oxidoreductase activity in mitochondrial membranes (100% = 1.0 
µmol min
-1mg
-1), dNADH:DBQ oxidoreductase activity was normalised for complex I 
content (100% = 0.3 µmol min
-1mg
-1). I50, concentration needed for 50 % inhibition of 
the inhibitor-sensitive fraction of the dNADH:DBQ oxidoreductase activity 
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As a strictly aerobic organism, Y. lipolytica does not regulate expression levels for 
complex I. Hence diminished content usually indicates structural destabilization of the 
complex. In fact, reduced stability made it difficult to isolate sufficient amounts of 
protein for EPR spectra of purified complex  I from these mutants. Still, specific 
ubiquinone reductase activity was strongly reduced only in membranes from R466M, 
while the other mutants showed around 80  % (R466A/ R466H) or about 50 %    RESULTS 
(R466E) of wild-type activity (see Table 3.7). Steady-state kinetics revealed a 2-3fold 
increase in the KM for DBQ for mutant R466H, while this parameter was unaltered in 
mutants R466A and R466E. These three mutations also exhibited a small, but 
significant hyposensitivity toward DQA. The normally assembled and most active 
mutant in this set, R466H, also gave rise to EPR spectra of mitochondrial 
membranes that were indistinguishable from a parental spectrum (Figure 3.1). With 
spectra from mitochondrial membranes only, a detailed analysis of the spectral 
signature of mutants R466A, R466M and R466E was not possible. However, it 
seemed clear that iron-sulphur cluster N2 was drastically reduced in all of these three 
mutants, but even in membranes from R466A a trace amount of cluster N2 was 
detectable in the gxy region. 
 
parental
R466A
R466M
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gz N2 gxy N2  
 
 
 
 
 
 
 
 
 
Figure 3.16 EPR spectra of mitochondrial membranes from R466 mutants  
Samples were reduced with NADH.The dashed line represents the gz signal of 
cluster N2. Only mutant R466H shows a similar spectrum as the parental strain. 
However, the concentration of complex I was very low in mutants R466A, R466M and 
R466E. 
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3.2.7  Mutagenesis of Serine 146 
Mutations of residues aspartate 143, valine 460 and glutamate 463 in Y. lipoytica that 
correspond to three of four cysteines that ligate the [NiFe] centre in [NiFe] 
hydrogenases had already been investigated (Kashani-Poor et al., 2001b). The 
fourth residue, Ser-146 unlike the other three residues from this series is not strictly 
conserved and has not been studied yet. Inhibitor resistance found in mutants D458A 
in Y. lipolytica (Kashani-Poor et al., 2001b), V407M in Rh. capsulatus (Darrouzet et 
al., 1998) and the corresponding V460M in Y. lipolytica raised the question if Ser-
146, since it resides in the same domain as resistance mutants according to the 
[NiFe] hydrogenase structural model, would have any influence on catalytic 
properties or inhibitor sensitivity. 
Complex I  I50
Strain 
content (%)  activity (%) 
KM 
(µM)  DQA (nM)  rotenone(nM) 
Parental 100  100  11  13  600 
S146A 107  110  10  10 300 
S146C 100  100  12  80 1500 
 
Table 3.8 Activity tests, KM for DBQ and I50 for DQA and rotenone measured on 
mitochondrial membranes of S146 mutants 
Complex I content, activity, and inhibitor sensitivity in mitochondrial membranes of 
site-directed Y. lipolytica mutants in the 49-kDa subunit are compared to the plasmid 
complemented nucm::URA3 deletion strain (parental). Complex I content is given as 
specific NADH:HAR oxidoreductase activity in mitochondrial membranes (100% = 1.0 
µmol min
-1mg
-1), dNADH:DBQ oxidoreductase activity was normalized for complex I 
content (100% = 0.3 µmol min
-1mg
-1). I50, concentration needed for 50 % inhibition of 
the inhibitor-sensitive fraction of the dNADH:DBQ oxidoreductase activity 
 
Ser-146 was mutated into Ala, Cys, Val and Asp. Complex  I content and 
dNADH:DBQ activity were parental in both mutants S146A and S146C. KM values 
were also parental (see Table 3.8). Mutant S146A showed moderate hypersensitivity 
toward rotenone, whereas I50 for DQA was parental. Mutant S146C exhibited an 
about six fold higher I50 value towards DQA and was 2.5fold less sensitive towards 
rotenone (Figure 3.17).    RESULTS 
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Figure 3.17 DQA and rotenone inhibition in mutants S146A and S146C 
The diagram shows DQA (n-decyl-quinazoline amine) (A) and rotenone (B) inhibition 
of dNADH:DBQ oxidoreductase activity in mitochondrial membranes from (■)parental 
strain (plasmid complemented strain), (□) mutant S146A and (•) mutant S146C. 
Mutant S146C showed significant resistance (~ 6fold higher IB50
B) toward DQA and 
minor resistance (2-3fold higher IB50
B) towards rotenone. Mutant S146A showed 
moderate hypersensitivity toward rotenone. IB50
B values are listed in Table 3.8. 
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3.3  Remodelling of Human Pathogenic 49-kDa Mutations in Y. 
lipolytica 
As mentioned in the introduction three human pathogenic mutations in 49-kDa 
subunit of complex I were remodelled in Y. lipolytica, namely R231Q, P232Q and 
S416P. Residues Arg-231 and Pro-232 according to structural model reside very 
close to [NiFe] active centre of [NiFe] hydrogenases. Arg-231, Pro-232 and Ser-416 
are marked grey in Figure 4.1A. 
  Complex I  I50
 
Strain 
content (%)  activity (%) 
KM 
(µM)  DQA (nM)  
Rotenone(nM) 
 Parental 100  100  11 13  600 
R231Q 84  101 16  17 900 
P232Q 38  17  -  -  - 
human 
pathogenic 
mutations 
S416P 90  111 17  17  1100 
R231E 112  74  29  20  850 
P232G 67  56  -  -  -   
S416A 109  86  39  19 1500 
 
Table 3.9 Activity tests, KM for DBQ and I50 for DQA and rotenone measured on 
mitochondrial membranes 
Complex I content, activity, and inhibitor sensitivity in mitochondrial membranes of 
site-directed Y. lipolytica mutants in the 49-kDa subunit are compared to the plasmid 
complemented nucm::URA3 deletion strain (parental). Complex I content is given as 
specific NADH:HAR oxidoreductase activity in mitochondrial membranes (100% = 1.0 
µmol min
-1mg
-1), dNADH:DBQ oxidoreductase activity was normalised for complex I 
content (100% = 0.3 µmol min
-1mg
-1). I50, concentration needed for 50 % inhibition of 
the inhibitor-sensitive fraction of the dNADH:DBQ oxidoreductase activity. 
 
Mutant R231Q had regular complex  I content according to NADH:HAR activity. 
Mutant R231Q was fully assembled as seen in BN-PAGE (Figure 3.18). dNADH:DBQ 
activity was the same as in the parental strain (Table 3.9). No significant differences 
were observed in the KM for DBQ and I50 for DQA and rotenone. Purified complex I 
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from mutant R231Q had wild-type EPR spectra and could be reactivated by the 
addition of asolectin (data not shown). Also, proteoliposomes containing R231Q 
mutant complex I showed no difference in proton translocation to the parental strain 
in ACMA dye measurements (data not shown). In stark contrast mutant P232Q had 
very low NADH:HAR activity, less than 40 % of the wild type and in BN-PAGE (Figure 
3.18) the complex I band was completely absent. dNADH:DBQ activity was very low, 
less than 20 % (Table 3.9) of the parental activity. Mutant S416P had regular 
complex  I content and the enzyme was assembled normally as judged from BN-
PAGE (Figure 3.18). dNADH:DBQ activity was parental (Table 3.9). 
 
V
complex
I
III
VD
parental R231Q P232Q S416P
 
 
 
 
 
 
 
 
Figure 3.18 1.6 mm Blue Native Gel (4/4 to 13% gradient) from isolated 
mitochondrial membranes 
Isolated mitochondrial membranes from parental strain and from mutants R231Q, 
P232Q, S416P. Roman numbers show individual complexes of the respiratory chain. 
VD is complex V dimer that occurs at lower detergent concentrations. Mutant R231Q 
and S416P have assembled complex I whereas mutant P231Q shows no assembled 
complex I.  
 
In summary mutants R231Q and S416P showed no effect on dNADH:DBQ activity  
and complex I assembly; mutant R231Q could also be reactivated after purification 
and exhibited proton pumping. From these results it was unclear why these mutations 
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are pathogenic in humans. One possible explanation was that the mutations made 
complex  I less stable. To explore this possibility, dNADH:DBQ activities were 
checked after incubation for 10 min at different temperatures. As can be derived from 
Figure 3.19 there was no difference in temperatures stability between mutants and 
parental mitochondrial membranes. 
 
 
 
 
 
 
Figure 3.19 Temperature stability of mutants R231Q and S416P 
dNADH:DBQ activities measured after incubation for 10 min at different 
temperatures, normalised to NADH:HAR oxidoreductase activities. (♦) parental; 
(■) R231Q; (•) S416P. 
 
Since mutants R231Q and S416P did not show appreciable differences to the 
parental strain, more drastic mutations were introduced such as R231E and S416A. 
Mutant P232Q had no assembled complex  I, so the more conservative mutation 
P232G was introduced. In mutant R231E there was no effect on dNADH:DBQ activity 
and complex I assembly. The KBM
B value was more than 2 fold higher. IB50
B values for 
DQA and rotenone were just slightly higher. Complex  I from mutant P232G in 
contrast to human pathogenic mutation P232Q was assembled as judged by BN-
PAGE. However, NADH:HAR activity was about one third and the NADH:DBQ 
activity about 50 % lower than in the parental strain. Mutant S416A had regular 
complex I content and dNADH:DBQ activity was only slightly reduced. The KBM
B value 
was more than 3fold higher. IB50
B value for DQA was just slightly higher and for 
rotenone 2fold higher compared to the parental values (see Table 3.9). 
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3.4  Mitochondrially Targeted eYFP in Yarrowia lipolytica 
Some human mutations e.g. R231Q in the 49-kDa subunit have been reported to 
have a negative effect on the complexity of the mitochondrial network. One goal of 
the present work was to explore whether similar effects can also be observed in Y. 
lipolytica. To be able to visualise mitochondria in the yeast Y. lipolytica, eYFP was 
chosen because GFP had already been successfully expressed in mitochondria in 
other related yeasts such as S. cerevisiae. 
3.4.1 Strategy 
To import eYFP into Y. lipolytica mitochondria it is necessary to have a mitochondrial 
targeting signal. Two different approaches, free eYFP and eYFP fused with a 
mitochondrial protein, were tried. 
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Figure 3.20 Strategies for expression of eYFP in Y. lipolytica mitochondria 
For detailed sequence see Appendix. A) 75-kDa subunit pre-sequence is used as a 
targeting signal for import into mitochondria of Y. lipolytica. B) fusion of the complex I 
30-kDa subunit with eYFP. 
 
The first strategy was to import free eYFP into mitochondria by fusing the 
mitochondrial import signal of the 75-kDa subunit with eYFP. The 7.7 kb product of 
the inverse anchor PCR with primers 75NdeInc and 75NdeIc with vector pSK/NUAM 
(9.7 kb) as template was self ligated and amplified in E. coli. The newly generated 
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plasmid (called pLG1) was digested with Nde I and its ends dephophorylated to 
prevent self-ligation. The 0.7 kb product of anchor PCR with primers EYFPc and 
EYFPnc with pEYFP as template was digested with Nde I. The two products were 
ligated and the resulting plasmid was called pYFP. The Sal I fragment of pYFP as 
shown in Figure 3.20A was subcloned into pUB26 and the new plasmid (called 
pUB26y) was transferred into strain PIPO. CLSM experiments revealed no 
fluorescence from this strain. The reason for this was not investigated further. 
The second strategy was to fuse eYFP with a mitochondrial protein. The 30-kDa 
subunit of complex I was chosen because of its small size and also because a His-
Tag had already been successfully attached to its C-terminus (Kashani-Poor et al., 
2001a). In plasmid pINA240/30-Htag2 Nde I site was generated between the C-
terminal end of the 30-kDa subunit gene and the his-tag with inverse anchor PCR 
using primers 30kNdeInc and 30kHtgnc2. The resulting plasmid was restricted with 
Nde  I and the above described 0.7 kb PCR product from the EYFP gene was 
subcloned into this Nde I site. The Sal I fragment (Figure 3.20B) from the resulting 
plasmid containing the 30-kDa subunit gene fused in frame with EYFP was 
subcloned into pUB26. This construct was called pEYFP30. Plasmid pEYFP30 was 
transferred into strains PIPO and ∆nugm GH1. CLSM on these straines revealed 
clear signs of fluorescence (Figure 3.21). 
 
 
 
 
Figure 3.21 Y. lipolytica cells from strain PIPO complemented with plasmid 
pYFP30 A) Phase Contrast Microscopy and B) CLSM 
The cells were harvested from an overnight culture in YPD medium in the presence 
of hygromycin B, washed twice with PBS buffer and fixed in 1 % agarose gel. The 
cells were excited at 475 nm and the emission peak at 508 nm was detected. Only 
the middle slice from a series of 10 optical sections is shown. 
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Figure 3.22 Two dimensional isoelectric focusing A) PIPOTP
1
PT B) ∆nugm GH1 
complemented with pEYFP30 plasmid 
For IEF-separation of Complex  I samples (400 µg/ml) in the first dimension the 
IPGphor system (Amersham Pharmacia Biotech) and 13 cm immobilised pH gradient 
(IPG) strips (pH 3-10) were used. The second dimension was 16 % SDS PAGE. A) 
PIPO, 30-kDa subunit is circled in red. B) complex  I from strain ∆nugm GH1 
complemented with pEYFP30 plasmid. As expected the 30-kDa subunit band does 
not occur and a new band (circled in red) of about 53-kDa that presents the 30-kDa 
subunit fused with eYFP is observed. 
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Complex  I from strain ∆nugm GH1 complemented with plasmid pEYFP30 was 
purified and complex I subunits were separated by IEF (Isoelectric Focusing, pH 3-
10). Subsequently a second dimension 16% SDS gel was carried out. The SDS gels 
are shown in Figure 3.22. The wild-type 30-kDa (in Figure 3.22A) and also the new 
generated subunit (in Figure 3.22B) that presents the 30-kDa subunit fused with 
eYFP (~ 53 kDa) are circled in red. 
In the next step, the normal or the R231Q mutant version of the NUCM gene were 
subcloned as 3.1 kb Nhe I fragments into pEYF30, resulting in constructs pEYFP30-
NUCM-WT and pEYFP30-NUCM-R231Q which were transformed into strain ∆nucm. 
In both the normal (in figures marked as EYFP) and the R321Q mutant (in figures 
marked as EYFP/R231Q) strains there were clear signs of fluorescence (Figure 
3.23). As can be derived from CLSM pictures, Y. lipolytica cells take a spherical to 
ovoid shape and the mitochondria are arranged in groups at the periphery of the 
cells, very close to the cell wall. 
 
 
 
 
 
 
 
 
Figure 3.23 CLSM of the EYFP and the EYFP/R231Q mutant strain  
EYFP (∆nucm strain complemented with plasmid pEYFP30-NUCM), EYFP/R231Q 
(∆nucm strain complemented with mutated (R213Q) plasmid pEYFP30-NUCM). The 
cells were harvested from an overnight culture in YPD medium in the presence of 
hygromycin B, washed twice with PBS buffer and fixed in 1 % agarose gel. The cells 
were excited at 475 nm and the emission peak at 508 nm was detected. Only the 
middle slice from a series of 10 optical sections is shown. 
EYFP                             EYFP/R231Q   RESULTS 
There was no obvious difference between the normal and the R231Q mutant strains 
in CLSM pictures. To check for expression of the eYFP fusion construct a Western 
Blot with Anti-GFP antibody was run (Figure 3.24). In both the normal and the R231Q 
mutant strains not only a band corresponding to fully assembled complex I but also 
subcomplexes of complex I were detected. These subcomplexes might not just be 
breakdown products of complex I but may represent assembly intermediates. They 
might also indicate interferance of the fusion of the 30-kDa subunit with eYFP with 
assembly of complex I. 
 
 
 
 
 
 
 
 
 
Figure 3.24 Western Blot of EYFP and EYFP/R231Q mutant with an anti-GFP
1 
antiserum 
Western Blot of two dimensionl BN-PAGE with mitochondrial membranes detected 
with a polyclonal rabbit anti-GFP primary and a peroxidase conjugated swine anti-
rabbit polyclonal secondary antibody. 
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1 Western Blot was carried out by Dr. Leo Nijtmans in Nijmegen, The Netherlands    
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4 DISCUSSION 
4.1  Ligands of Iron-Sulphur Cluster N2 
In the PSST subunit of complex I from different organism there are four conserved 
cysteines (Y. lipolytica nomenclature: Cys-85, -86, -150 and -180) that could ligate 
iron-sulphur cluster N2. However, according to the homology of the PSST subunits 
and the small subunits of [NiFe] hydrogenases only three conserved cysteines 
correspond to the ligands of the proximal iron-sulphur cluster. In addition two 
cysteines namely Cys-85 and Cys-86 are direct neighbours and it is energetically not 
favoured that both cysteines serve as ligands of cluster N2 although this was recently 
proposed by Friedrich (Flemming et al., 2003). Up to now all attempts to find the 
missing fourth ligand in the PSST subunit have failed (Ahlers et al., 2000b; Garofano 
et al., 2003). According to the hypothesis that subunits PSST and 49-kDa are direct 
neighbours and that cluster N2 resides on the interface between these two subunits, 
one could speculate that the missing fourth ligand resides in the 49-kDa subunit 
(Kashani-Poor et al., 2001b). 
His-228 in the [NiFe] hydrogenase from D. gigas forms a hydrogen bond to the 
proximal iron-sulphur cluster (Volbeda et al., 1995). This His-228 corresponds to a 
highly conserved histidine in complex I (Y.l. His-226 see Figure 4.1). Assuming that 
during evolution the protein fold of the large subunit of [NiFe] hydrogenases has been 
maintained in the 49-kDa subunit of complex I, His-226 would be in a distance less 
than 5 Å from cluster N2. Thus it could also serve as fourth ligand to this cluster 
(Figure 4.2). In mutant H226R complex I was not assembled and in H226A there was 
no EPR visible cluster N2 and at the same time complex I activity was abolished. 
Therefore, one could assume that His-226 plays a prominent role in the catalytic 
process of quinone reduction and maybe in proton pumping. 
Not only His-226 showed such remarkable effects on the catalytic process and on the 
properties of cluster N2 but also residue Arg-141 if mutated into alanine followed a 
very similar pattern. R141A showed also abolished complex I activity and no EPR 
visible cluster N2 (Kashani-Poor et al., 2001b). These results further support the    DISCUSSION 
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hypothesis that cluster N2 resides on the interface between subunits PSST and 49-
kDa. 
Alignment A 
      H91 H95            H120             R141 
Yl-NUCM  NFGPQHPAAHGVLRLILELSGEEIIRSDPHVGLLHRGTEKLIEYKTYMQALPYFDRLDYVS 146 
Nc.NUCM  NFGPQHPAAHGVLRLILELKGEEIVRADPHVGLLHRGTEKLCEYRTYLQALPYFDRLDYVS 111 
Bt-49kDa NFGPQHPAAHGVLRLVMELSGEMVRKCDPHIGLLHRGTEKLIEYKTYLQALPYFDRLDYVS 159 
Rc-NouD  NFGPQHPAAHGVLRMVLELDGEIVERADPHIGLLHRGTEKLMESRTYLQNTPYFDRLDYVA  74 
Ec-NuoCD NLGPNHPSAHGAFRIVLQLDGEEIVDCVPDIGYHHRGAEKMGERQSWHSYIPYTDRIEYLG  73 
 
            H226          S416                 R466 
Yl-NUCM   ARLHAAYVRPGGV 235  VVSDGSERPY 423  DLVFGEVDR 466 
Nc.NUCM   ARLHAAYVRPGGV 200  VVSDGSERPY 318  DLVFGEVDR 431 
Bt-49kDa  ARMHAAYVRPGGV 248  LVSDGSSRPY 436  DIVFGEVDR 479 
Rc-NouD   ARLHANYVFPGGV 162  LVADGTNKPY 350  DVVFGEIDR 394 
Ec-NuoCD  FRMHPAWFRIGGV 161  LTSDGSTMSY 349  DFVMSDVDR 393 
 
 
Alignment B 
           H91 H95              H120       
Yl-NUCM FTINFGPQHPAAHGVLRLILELSGEEIIRSDPHVGLLHRGTEKLIEYKTYMQALPYF 140 
Mb-EchE TVIPFGPQHPVLPEPVSLKLEIDDNVVVGVLPSLGYVHRGLETFINTKDFNQTTYVC  59 
Df-HydB GPIVVDPIT-RIEGHLRIMVEVENGKVKDAWS-SSQLFRGLEIILKGRDPRDAQHFT  68 
 
         R141                  H226                R466 
Yl-NUCM  DRLDYVSMMTNEQ 153  GARLHAAYVRPGGVS 236  AVAIIGTMDLVFGEVDR 466 
Mb-EchE  ERICGICSALHGI  72  GNRVIHSISKVGGVT 156  VPIVVLTIDPCVSCTER 358 
Df-HydB  QRACGVCTYVHAL  81  GKNPHTQFTVVGGCS 238  ILRTVHAFDPCIACGVH 549 
 
 
Figure 4.1 Alignments 
All alignments were done using the program CLUSTAL W. In alignments A and B the 
[Ni] ligating cysteines in the hydrogenase sequences are highlighted in blue, 
histidines in red and arginines in yellow the positions of mutations, human pathogenic 
are marked in grey. A: Sequences of the 49 kDa subunit from Y. lipolytica, N. crassa, 
Bos taurus,  P. denitrificans,  Rh. capsulatus and E. coli. B: 49-kDa subunit of 
complex I from Y. lipolytica aligned with the EchE subunit of the membrane bound 
[NiFe] hydrogenase from M. barkeri and the large subunit of the soluble [NiFe] 
hydrogenase from D. fructosovorans.  The epitope recognised by a monoclonal 
antibody (49.2) against the Y. lipolytica 49-kDa subunit is underlined (Zickermann et 
al., 2003)    
4.1.1 Histidine  226 
[FeS]
His 91
His 95
Very specific and striking effects on cluster N2 were observed when residue His-226 
was exchanged. When it was substituted by a small hydrophobic alanine residue 
cluster N2 could not be detected in EPR spectra. On the other hand, the more 
conservative exchange to methionine (H226M) gave rise to EPR signals that were 
reduced in intensity and shifted towards lower field values. Other mutations in these 
positions resulted in dramatic reduction (H226C, H226Q) of cluster N2 as judged by 
EPR spectroscopy. These results initially seemed to support the already mentioned 
hypothesis that His-226 could serve as 4
th ligand of cluster N2.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Structural model of the 49-kDa subunit based on the [NiFe] 
hydrogenase from D. gigas 
Residues from the 49-kDa subunit are placed into the crystal structure of the [NiFe] 
hydrogenase from D. gigas. The approximate distances between [Fe4S4] cluster ‘N2’ 
and side chain nitrogen from different residues in Å are shown in grey. 
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Given the feasibility to purify complex I in milligram amounts, a more detailed EPR 
analysis was considered as a possibility to investigate the properties of cluster N2. 
Two specific experiments were adequate to explore the ligand field of cluster N2: 
First, it would be interesting to detect direct ligands of cluster N2 with ENDOR 
experiments and second to determine with ESEEM experiments elements that are 
not direct ligands but interact with cluster N2 (e.g. forming hydrogen bonds). If His-
226 would be the ligand of cluster N2 then a specific nitrogen signal should be 
detectable in ENDOR experiments with parental complex I. On the other hand when 
His-226 is exchanged to a methionine residue then the nitrogen signal should 
disapear. In comparison to the ENDOR, the ESEEM experiment would not give 
information about direct ligands but about the enviroment of the cluster. If His-226 is 
not a direct ligand but interacts with cluster N2 then in ESEEM experiments a 
nitrogen modulation should be observed. This nitrogen modulation should not be 
observed in mutant H226M. In both, parental and H226M, a nitrogen derived 
modulation was observed in ESEEM measurements and a nitrogen coordination 
could not be confirmed by ENDOR experiments (Maly, personal communications). 
From this result we can conclude that His-226 is most likely not the fourth missing 
ligand of cluster N2. 
This result was supported by REFINE (Relaxions Filtered Hyperfine) spectroscopy. 
REFINE spectroscopy allows the simultanious characterisation of multiple 
paramagnetic centres within one sample (Maly, et al., 2004 in press). From these 
measurements it was concluded that the observed nitrogen modulations were due to 
cluster N1 and not N2. 
Although, His-226 is not a direct ligand it seems to play a very prominent role in the 
catalytic process. Complex  I is not well understood mechanistically and there are 
more assumptions and hypothesis than solid data that could help to determine how 
this complex enzyme works and how electron transfer is coupled to proton pumping. 
It is believed that cluster N2 due to its highest redox midpoint potential (Em = -139 mV 
for Y. lipolytica Figure 4.3) is the immediate electron donor to ubiquinone (Ingledew 
and Ohnishi, 1980; Sled et al., 1993). All other iron-sulphur clusters are called 
‘isopotential’ clusters because their redox midpoint potentials are in the same range.    
Cluster N1a which also was described to have a pH-dependent midpoint potential, 
recently was shown to change its redox properties upon pH-linked changes in protein 
charge and not due to a specific ionisable residue (Zu et al., 2002). 
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Figure 4.3 Redox midpoint potential (Em) of complex I prosthetic groups in Y. 
lipolytica  
The midpoint potentials of [FeS] cluster N3 and N4 were not determined exactly but 
were estimated to be similar to that of N1. Clusters N1, N3 and N4 are called 
‘isopotential’ clusters since their redox midpoint potentials are in the same range. The 
redox midpoint potential of cluster N2 is pH dependent. The range of the redox 
midpoint potential of cluster N2 is shown in red. 
 
In several mechanistic models, N2 was predicted to function in association with a 
redox-Bohr group (see Figure 1.3). The group becomes protonated upon reduction of 
N2 because of the increased basicity and becomes deprotonated again after the 
cluster is re-oxidised by ubiquinone (Brandt, 1997; Dutton et al., 1998). This would 
allow the translocation of one proton per one electron. The redox titrations of Y. 
lipolytica mitochondrial membranes also revealed that the redox midpoint potential of 
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cluster N2 is higher than that of the other clusters (e.g. Em,7(N2) = -139 mV, Em,7(N1) 
= -260 mV) and that it is pH-dependent. But the slope of the pH dependent part of the 
titration curve did not reflect the expected 60 mV/pH unit. Calculation of the pK-
values of reduced and oxidised species revealed values separated only by 1.6 pH-
units, with a pK of 7.3 for the reduced state. The close proximity of the pK-values 
results in the decreased slope of the Em-pH dependence. The calculated pKox was 
less exactly to define than the pK for the reduced form. This was probably due to 
instability of iron-sulphur clusters below pH ~5.5 which could be deduced from 
significantly diminished signal intensities. For evaluation of the effects of varying pKox 
values on the slope of the pH-dependence and the value of pKred model calculations 
were performed assuming pKox in the range of 4.5-6 and fitting the corresponding 
pKred values. As a result, the pH-dependence was only slightly affected and pKred 
showed only minor changes (7< pKred <8) upon variation of pKox. The still low pK for 
the reduced form of cluster N2 means that under physiological conditions (pH ~7) the 
reduced redox centre is not quantitatively in the protonated state which would be a 
prerequisite for a 1H
+/1e
- stoichiometry. 
Mutation H226M had no striking impact neither on enzymatic activity of membrane 
preparations nor on isolated complex I. However as a consequence of the mutation 
the redox midpoint potential of cluster N2 was dramatically decreased and the pH-
dependence of the redox potential was lost. The Em,7 value of –218 mV for N2 in the 
mutant comes closer to the values which are known for the other ‘isopotential’ 
clusters (Ohnishi, 1998) N1, N3 and N4 having midpoint potentials in the range of –
200 to –270 mV. It is quite obvious that residue His-226 is close enough to influence 
the electron affinity of cluster N2 by its polar side chain. At low pH the histidine 
carries a positive charge thereby increases the electron affinity of cluster N2, which 
means a more positive redox potential. At high pH the histidine is deprotonated and 
as a consequence the potential is decreased 
As pointed out above the proximity of the pK values of the oxidised and reduced 
forms of cluster N2 and the inadequate slope of its redox-Bohr effect rules out 
hypothetical mechanisms that directly link proton translocation to electron transfer. In 
addition, the fact that complex I is active even when the special properties of cluster 
N2, a high and pH-dependent midpoint potential, are lost such as in mutant H226M 
also does not support such hypothetical mechanisms. Interestingly, the pH    
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dependence of the dNADH:DBQ activity of mitochondrial membranes from parental 
and mutant H226M strains showed very similar behaviour. The highest activity was in 
the range around pH 7.5 for the parental strain and mutant H226M as well. 
ACMA dye measurements in proteoliposomes revealed proton pumping in mutant 
H226M even though the pH dependence of midpoint redox potential of cluster N2 
was lost. However, from our measurements we cannot draw any conclusions about 
the H
+/e
- stoichiometry. The only possible explanation for this behaviour: Cluster N2 
is not involved in proton pumping and its associated redox-Bohr group is only one 
element of a more complex proton-pumping machinery. Recently this view was 
supported by the finding that the 49-kDa subunit, and thus cluster N2, is clearly 
separated from the membrane part of complex  I (Figure 1.1) (Zickermann et al., 
2003). These results favour an indirect mechanism of proton pumping in complex I, 
probably accomplished by long range conformational interaction between the 
peripheral part carrying the catalytic core and the membrane part of the enzyme. 
4.1.2 Arginine  141 
The EPR spectra of cluster N2 in Arg-141 mutants show a noteworthy parallel pattern 
to the mutants of residue His-226. In mutant R141A as well as in H226A cluster N2 
was not detectable. Similar to mutant H226M, mutant R141K gave also rise to a 
shifted gz signal from cluster N2. On the contrary the gz signal was even more 
dramatically reduced than in the H226M mutant. The intensity of the gz signal was 
less than 5 % in R141K in contrast to about 65 % in the H226M mutant. Mutant 
R141M showed even more striking results, because there was no observable cluster 
N2 either in membranes or in purified complex I. This remarkable parallel effect from 
mutants of both residues Arg-141 and His-226 could not be observed if we consider 
the activity of complex I. The gz signal intensities from His-226 mutants corresponds 
more or less to complex I activity. In contrast, the gz signal intensities in mutants of 
Arg-141 do not correspond to the complex I activity. This effect is clearly observable 
in mutants R141M and R141K. Mutant R141M did not give rise to any of N2 signal 
whatsoever, but complex I activity was only half reduced. In mutant R141K the DQA 
sensitive activity varied from 30-55 % whereas in mutant R141M it was stable at 
about 40 %. These rates were not due to increased reactivity towards the artificial 
substrate decylubiquinone because inhibitor insensitive rates were not found to be 
increased in mutant membranes neither in dNADH-oxidase nor in dNADH:DBQ    DISCUSSION 
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oxidoreductase activity tests. The most obvious explanation would be that cluster N2 
that is believed to be the immediate electron donor to ubiquinone was still present in 
the mutant enzymes, but could not be detected anymore with standard EPR 
spectroscopy. The mutation could have changed the redox potential of the cluster to 
very negative values that prevented reduction of cluster by NADH or NADH/dithionite. 
However this scenario is most unlikely because in this case the midpoint potential 
would be below -450 mV, corresponding to a shift of at least 300 mV. To date there is 
no known mutation that causes such a shift in the midpoint potential of an iron-
sulphur cluster. On the other hand the mutation could have changed the magnetic 
properties of cluster N2 making it undetectable by standard EPR methods. The 
possibility that the tetranuclear cluster had turned into a Fe3S4 cluster in the mutant 
could be ruled out because samples were analysed in the oxidised and as well as in 
the reduced state. The EPR signals typical for this type of cluster, which is 
paramagnetic in the oxidised state could not be detected. The reduced samples were 
scanned at many different settings (temperature, microwave power and field range) 
and no new paramagnetic species could be detected. The possibility that the spin of 
the ground state of the cluster had been changed into S=3/2 could also be ruled out 
because this would have been observed in the range g = 4.5–6. From this extensive 
EPR spectroscopic analysis of the mutants it can be concluded that iron-sulphur 
cluster N2 was mostly (R141K) or completely (R141M) absent. 
The view that there is activity even when cluster N2 is not detectable in EPR spectra 
questions the prominent role that has been ascribed to this cluster. Is it possible that 
the catalytic core is still functional even in the absence of cluster N2? The exact 
electron transfer pathway in complex I is not known. Electrons are taken from NADH 
and transferred via FMN and numerous iron-sulphur clusters to the ubiquinone. As 
already mentioned it is believed that the last step in this chain is cluster N2. Typically 
the distances between redox-active clusters are around 5 Å (Volbeda et al., 1995; 
Montet et al., 1997). If one cluster is missing in the chain the distance rises to about 
10 Å. According to electron transfer theory the maximal rates of electron transfer can 
be calculated using the “Moser-Dutton-ruler” (see also 8.3 for details) (Page et al., 
1999). In the case of 5 Å the electron transfer rate would be more than 10
11 s
-1. If one 
cluster is missing the electron transfer rate would drop about 3 orders of magnitude 
to around 10
8 s
-1. Comparison of these estimates with the steady-state turnover    
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number of complex I of about 10
2 s
-1 illustrates that removal of iron-sulphur cluster 
N2 not necessarily limits steady state turnover, because electron transfer is still 
predicted to be much faster. Similar results were measured involving very different 
redox centres of E. coli DNA photolyase (Byrdin et al., 2003). Unfortunately on this 
time range no similar methods are available so far to investigate electron transfer 
within complex I. 
Since His-226 is not the 4
th ligand of cluster N2 and since no nitrogen modulation 
was found in the N2 signal in ESEEM and ENDOR experiments one can rule out Arg-
141 as the 4
th ligand of cluster N2. Even though Arg-141 is not the ligand of cluster 
N2 it is in close proximity to it so that it can exert such striking influence on cluster N2 
and also on catalytic activity. These results clearly demonstrate a specific 
significance of Arg-141 for the local environment of cluster N2 and also provide 
strong support to the structural model of the ubiquinone reducing catalytic core of 
complex I (Kashani-Poor et al., 2001b). 
4.1.3  Histidine 91, 95 and Arginine 466 
Mutations of His-91 and His-95 did not provide any information on the ligation or 
properties of iron-sulphur cluster N2. However, these two residues seem to play a 
central functional role. Virtually complete loss of catalytic activity was observed in all 
mutants without affecting iron-sulphur cluster N2 or reducing stability of the complex. 
According to our structural model based on crystal structures of [NiFe] hydrogenase 
both residues reside on the interface between the PSST and 49-kDa subunits. 
Therefore, both residues might be important for proton delivery to the catalytic core. It 
is also possible that these two residues build hydrogen bonds with residues from the 
PSST subunit. 
Mutation of the C-terminal residue Arg-466 also did not provide any information about 
the ligation of cluster N2. This residue seems to have marked effects on stability of 
complex  I. Complex  I content was lowered in strains carrying non conservative 
mutation. In the case of mutant R466M even the activity of complex I was abolished. 
All mutants also showed hypersensitivity towards DQA. All these data indicate that 
Arg-466 plays an important role in complex I. This residue is probably not directly 
included in the catalytic process but may somehow influence the catalytic core. As 
already mentioned the yeast Y. lipolytica does not have regulatory mechanisms for    DISCUSSION 
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protein expression of the complex I subunits in other words lower enzyme content in 
mitochondria is most likely the result of degradation that can be either due to 
instability, misfolding, or assembly problems. Purification of complex I could not be 
achieved for the Arg-466 mutants and therefore EPR spectra of purified enzyme 
could not be collected. Only mitochondrial membranes from R466H gave EPR 
spectra similar to the parental strain and signal from cluster N2 could be detected 
clearly. However, in all Arg-466 mutants traces of gxy signal could be observed. 
Residues His-91 and -95 are very close to the epitope recognised by monoclonal 
antibody (49.2) against the 49-kDa subunit (underlined in Figure 4.1B) (Zickermann 
et al., 2003). These results support previously stated that catalytic core of complex I 
is clearly separated from membrane part of complex  I suggesting an indirect 
mechanism of proton translocation by redox-driven conformational energy transfer 
(Zickermann et al., 2003).    
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4.2 Serine  146 
The hypothesis that the ubiquinone reducing active site of complex I has evolved 
from the [NiFe] active site of [NiFe] hydrogenases has been discussed previously 
(Kashani-Poor et al., 2001b). In complex I, three residues that correspond to three 
cysteines that ligate the [NiFe] centre in [NiFe] hydrogenases have already been 
mutated and investigated. In contrast to these three residues (Asp-143, Val-460 and 
Glu-463) that are conserved among complex  I from different species, serine 146 
which aligns with the remaining cysteine ligand of the hydrogenase [NiFe] site is not 
conserved. Therefore we were interested to see whether this residue has influence 
on complex  I activity since according to our [NiFe] hydrogenase model it resides 
directly in the catalytic core of complex I. While there was no change in complex I 
activity, as expected the mutations had influence on inhibitor sensitivity. This was 
observed especially in mutant S146C. These results also support previous findings 
that specific inhibitors of complex  I exemplified by DQA and rotenone bind in the 
same pocket of complex  I which probably constitutes the ubiquinone binding site 
itself.    DISCUSSION 
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4.3  Remodelling of Human Pathogenic 49-kDa Mutations in Y. 
lipolyticaTP
1
PT 
In the present work three mutations identified in patients affected with 
cardiomyopathy and encephalomyopathy (Loeffen et al., 2001) that are located in the 
gene coding for the 49-kDa subunit of complex I were remodelled in Y. lipolytica. In 
humans all three mutations, R231Q, P232Q and S416P were lethal at very young 
age. Arg-231 is strictly conserved among complex  I from different species and 
according to our [NiFe] hydrogenase structural model it resides in His228 Loop of the 
proposed catalytic core of complex I, for the proposed structural model see (Kerscher 
et al., 2001). Pro-232 is also well conserved, however in E. coli it is replaced by 
isoleucine. This proline also resides in His228 Loop of the proposed catalytic core of 
complex  I. The serine residue is also conserved, however in Rh. capsulatus it is 
replaced by alanine (see Figure 4.1A). Ser-416 is located in Pro475 Loop of the 
proposed catalytic core of complex I. According to Loeffen et al. (2001) mutations 
R228Q and P229Q (corresponding to R231 and P232 in Y. lipolytica) in human the 
49-kDa subunit are proposed to cause replacement of an α-helix by a β-sheet. In Y. 
lipolytica the R231Q and S416P mutants had he same properties as the parental 
strain. However, the P232Q mutant showed no assembly of complex I, probably due 
to changes in secondary structure and improper folding of this subunit. The attempt 
to create other mutations at these positions gave slightly different results. The R231E 
and S416A mutants had higher KBm
B values for DBQ. This result indicates some 
influence of these residues on the catalytic properties of complex I. Even if these 
residues are not directly involved in the catalytic process, they reside in the catalytic 
core of complex I. The properties of the P232G mutant have changed in comparison 
to P232Q. The P232G mutant showed assembled complex I, however the expression 
was one third lower than in the parental strain, which indicates instability of complex I 
and complex I activity was reduced by almost 50 %. At this point we cannot draw any 
conclusions about the reason why in humans these mutations were lethal at very 
young age, it is very likely that the R228 and S413 residues in mammalian complex I 
have structural importance for the 49-kDa subunit. In the case of mutant P232Q the 
                                            
TP
1
PT Y. lipolytica nomenclature used for numbering    
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probable cause was misfolding of the 49-kDa subunit preventing assembly of 
complex I. Another possibility that should be explained in the future could be higher 
production of ROS. 
4.4  Mitochondrially Targeted eYFP in Yarrowia lipolytica 
Mutation R228Q caused the fragmentation of mitochondrial network (personal 
communications) in patients and it would be interesting to see if the same effect 
occurs in Y. lipolytica mitochondria. Since Y. lipolytica mitochondria are much smaller 
than those of mammalian cells, the normally used mitochondrial targeted 
fluorescence indicators such as rhodamin 123, mitotracker red CMRXos or 
mitotracker green FM gave no good resolution. It was hoped that the use of a 
mitochondrially expressed eYFP variant of GFP would produce good enough 
resolution. The eYFP was successfully expressed as a C-terminal fusion with the 30-
kDa subunit of complex  I. It was also interesting to see where in the cells the 
mitochondria reside. The mitochondria in Y. lipolytica cells did not reside close to 
nucleus or dispersed through the cytoplasm but surprisingly are found close to the 
cell wall. Differences in the mitochondrial network between parental and mutant 
strains are currently being investigated, however preliminary results do not point to 
any detectable differences.     SUMMARY & OUTLOOK 
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5 SUMMARY  AND  OUTLOOK 
5.1 Summary 
5.1.1  Ligands of Iron-Sulphur Cluster N2 
In this work the ubiquinone reducing catalytic core of NADH:ubiquinone 
oxidoreductase (complex  I) from Y. lipolytica was studied by a series of point 
mutations replacing conserved histidines or arginines in the 49-kDa subunit. 
Although the missing 4
th ligand of cluster N2 could not be found in the 49-kDa subunit 
of complex I, it was clearly demonstrated that iron-sulphur cluster N2 resides directly 
on the interface between the PSST and 49-kDa subunits. The results presented in 
this work show that residues in the 49-kDa subunit have strong influence on this 
redox centre and also on catalytic activity. The strong influence of Arg-141 and His-
226 residues in 49-kDa subunit on this cluster can be deducted from complete loss of 
N2 signals in EPR spectra such as in case of mutants H226A and R141A. In the case 
of mutant H226M the EPR signal from cluster N2 was shifted and cluster N2 even 
lost the pH dependence of its redox midpoint potential and became more similar to 
the other so called ‘isopotential’ clusters. Specifically in the case of mutants R141M 
and R141K the characteristic signature of cluster N2 became undetectable in EPR 
spectra. However, specific dNADH:DBQ oxidoreductase activity that could be 
inhibited with the specific complex I inhibitors DQA and rotenone was not absolutely 
abolished but rather reduced. These reductions in complex  I activity did not 
correspond to similar reductions in the specific EPR signal of cluster N2 as it was 
observed in the His-226 mutant series. No indications could be found that these 
mutations had modified the magnetic properties of cluster N2, resulting in different 
EPR spectra. From these observations it could be concluded that both mutants 
R141K and R141M virtually or entirely lack iron-sulphur cluster N2. The rates in 
complex I activity could be reconciled with electron transfer theory: After removal of a 
single redox centre in a chain, electron transfer rates are predicted to be still much 
faster than steady-state turnover of complex I. These results from mutants R141K, 
R141M and also the result from mutant H226M that protons are being pumped even 
if the redox midpoint potential of cluster N2 is not pH dependent questions the    
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prominent role in the catalytic mechanism of complex I that has been ascribed to 
cluster N2. 
Histidine 91 and 95 were found to be absolutely essential for activity of complex I 
since in both mutants complex I was fully assembled and artificial NADH:HAR activity 
was parental whereas complex I specific dNADH:DBQ activity was abolished. The 
signal from cluster N2 in EPR spectra was parental for all His-91 and -95 mutants. 
Mutations at the C-terminal arginine 466 affected ubiquinone affinity and inhibitor 
sensitivity but also destabilised complex I. 
All these results provide further support for a high degree of structural conservation 
between the 49-kDa subunit of complex  I and the large subunit of water soluble 
[NiFe] hydrogenases. 
5.2  Remodelling of Human Pathogenic 49-kDa Mutations in Y. 
lipolytica 
Y. lipolytica has been proven a good system for studying complex I properties and 
thus also for studying defects that occur in humans. In this work pathogenic 
mutations in the 49-kDa subunit of complex I were recreated and studied. The P232Q 
mutant showed non-assembly of complex I and this is probably the cause why this 
mutation was lethal in patients. The mutants R231Q and S416P were parental for the 
content, artificial and also specific complex I activity, Km for DBQ and IC50 for DQA. 
From these results we can conclude that these two residues Arg-228 and Ser-413 in 
mammalian cells have specific structural importance for the 49-kDa subunit even if 
they are not directly involved in catalytic process.  
     SUMMARY & OUTLOOK 
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5.3 OUTLOOK 
5.3.1  Sub Mitochondrial Particles 
Since we do not know how the proton pump of complex I functions and since it is also 
still unknown if the well established 4H
+/2e
- stoichiometry is also true for Y. lipolytica 
complex  I it would be essential to make submitochondrial particles and carry out 
proton pumping experiments. It is also very important to clarify the role of cluster N2 
in proton pumping. Further studies on mutant strains would also help to clarify the 
role of cluster N2 in proton pumping. 
Also it would be very interesting to see which residues are active in proton transport 
either delivering scalar protons to the catalytic core or by forming part of a 
conformational proton pump.    
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6 ZUSAMMENFASSUNG 
Die mitochondriale Atmungskette besteht aus vier Multiproteinkomplexen (Komplex I, 
NADH:Ubichinon Oxidoreduktase; Komplex II, Succinat:Ubichinon Oxidoreduktase; 
Komplex III, Ubichinol:Cytochrom c Oxidoreduktase auch bc1 Komplex genannt; 
Komplex IV, Cytochrom c:O2 Oxidoreductase, auch Cytochrom c Oxidase genannt). 
Die Elektronen der Reduktionsäquivalente NADH und FADH2, die hauptsächlich in 
der Glykolyse, der Fettsäureoxidation und dem Citratcyclus gebildet werden, geben 
ihre Elektronen an die Atmungskette ab, wobei molekularer Sauerstoff als terminaler 
Akzeptor dient. Die durch diesen Elektronentransport freiwerdende Energie wird in 
der Form eines Protonengradients gespeichert. Der so aufgebaute elektrochemische 
Gradient wird zur Synthese von ATP genutzt. Die Kopplung des Elektronentransports 
durch die Atmungskettenkomplexe und der ATP Synthese durch die ATP-Synthase 
wird „oxidative Phosphorylierung“ genannt. Dieses Prinzip der Energieumwandlung 
wurde von P. Mitchell als chemiosmotische-Hypothese vorgeschlagen (Mitchell, 
1961). 
Komplex I ist der größte und am wenigsten untersuchte transmembrane 
Proteinkomplex der Atmungskette. Elektonenmikroskopische Untersuchungen am 
Komplex I aus verschiedenen Organismen haben einen L-förmige Struktur für sowohl 
prokaryotischen also auch eukaryotischen Komplex I gezeigt (Y. lipolytica, 
Djafarzadeh et al., 2000; N. crassa, Guenebaut et al., 1997; E. coli, Guenebaut et al., 
1998; Bos taurus Herz, Grigorieff, 1998)). Der Komplex I aus Säugetieren besteht 
aus 46 Untereinheiten (Carroll et al., 2003; Skehel et al., 1998). Der prokaryotische 
Komplex I besteht aus 14, den so genanten „zentralen“, Untereinheiten (in E. coli 13, 
da die 49-kDa und die 30-kDa Untereinheit fusioniert sind). Alle diese 14 
prokaryotischen Untereinheiten sind auch bei Säugetieren vorhanden, 7 von ihnen 
werden von mitochondrialer DNA kodiert. 
In den letzten Jahren wurde Yarrowia lipolytica, eine obligat aerobe Hefe, als 
Modellsystem etabliert. Die Atmungskette der Hefe S. cerevisiae beinhaltet keinen 
Komplex I. Y. lipolytica hat dagegen einen stabilen Komplex I der sich gut reinigen 
lässt und dem Komplex aus N. crassa sehr ähnelt. All dies macht diese Hefe zu    ZUSAMMENFASSUNG 
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einem hervorragenden Modellsystem für strukturelle und funktionelle 
Untersuchungen an Komplex I (Kerscher et al., 2002). 
Aufgrund der Ergebnisse einer zielgerichteten Mutagenese in Y. lipolytica wurde 
vorgeschlagen, dass das katalytische Zentrum des Komplex I während der Evolution 
aus dem aktiven Zentrum der [NiFe] Hydrogenase entstanden ist und sich 
wahrscheinlich an der Grenzfläche zwischen den PSST und 49-kDa Untereinheiten 
befindet (Kashani-Poor et al., 2001b; Garofano et al., 2003). Die 49-kDa Untereinheit 
ist homolog zu der großen und die PSST zu der kleinen Untereinheit der bakteriellen 
wasserlöslichen [NiFe] Hydrogenasen (Böhm et al., 1990; Albracht, 1994). Die 
Kristallstruktur dieser wasserlöslichen [NiFe] Hydrogenasen wurde aufgelöst 
(Volbeda et al., 1995; Montet et al., 1997). Es wurde auch vorgeschlagen, dass das 
proximale Eisen-Schwefel Zentrum aus diesen wasserlöslichen [NiFe] Hydrogenasen 
sich zum Eisen-Schwefel Zentrum N2 entwickelte. In allen bekannten Sequenzen der 
PSST Untereinheit findet man 4 konservierte Cysteinreste, aber nur 3 von diesen 
können als Liganden des Zentrums N2 dienen. Da zwei Cysteine direkt benachbart 
sind, können beide aus energetischen Gründen nicht gleichzeitig Liganden des N2 
Zentrums sein. Laut Flemming et al., (2003) wird diese Ansicht nicht geteilt. 
Nach unserem Strukturmodell befindet sich das Eisen-Schwefel Zentrum N2 an der 
Grenzfläche zwischen der PSST und der 49-kDa Untereinheit und es wäre durchaus 
möglich, dass ein Rest der 49-kDa Untereinheit als 4ter Ligand des Zentrums N2 
dient. Um diese Hypothese zu testen wurden Histidine und Arginine, die in Komplex 
I-Sequenzen aus verschiedenen Organismen oder in Komplex I und [NiFe] 
Hydrogenasen konserviert sind, mutagenisiert. Histidin 226 ist in allen bis jetzt 
bekannten Komplex I Sequenzen konserviert und entspricht einem hoch 
konservierten Histidin aus wasserlöslichen [NiFe] Hydrogenasen. In [NiFe] 
Hydrogenasen bildet dieser Histidinrest eine Wasserstoffbrücke zu dem proximalen 
Eisen-Schwefel Zentrum. His-226 wurde in Alanin und in die potentiellen Eisen-
Schwefel Cluster Liganden Glutamin, Cystein und Methionin ummutiert. Alle 
Mutanten dieses Restes hatten einen assemblierten Komplex I. Die Mutante H226A 
hatte um 80 % reduzierte Komplex I Aktivität. Die Mutanten H226C und H226Q 
hatten noch ca. 50 % Komplex I Aktivität. Die Aktivität der Mutante H226M war nur 
um 20 % reduziert. Zur genaueren Ansicht der proteinchemischen Daten siehe Table 
3.1. EPR Spektren sowohl aus mitochondrialen Membranen als auch aus isoliertem    
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Komplex I zeigten einen Einfluss auf das Signal des Zentrums N2, wobei die Signale 
der anderen Eisen-Schwefeln Zentren unverändert blieben. Das EPR Spektrum der 
Mutante H226A zeigte kein N2 Signal. Die EPR Signale der übrigen Eisen-Schwefeln 
Zentren waren unverändert. EPR Spektren, die unter vielen verschiedenen 
Bedingungen aufgenommen wurden (Temperatur, Mikrowellen-Stärke und 
Feldbereich) ergaben keine Hinweise auf neue paramagnetische Spezies. Die 
Schlussfolgerung aus diesen Experimenten ist, dass Cluster N2 in der Mutante 
H226A nicht nur in seinen Eigenschaften verändert ist, sondern tatsächlich fehlt. 
Ähnliche Ergebnisse wurden auch in den EPR Spektren der Mutanten H226Q und 
H226C beobachtet, wobei die Intensität des N2 Zentrums in diesen Fällen zwar 
deutlich geringer war als im wildtypischen Enzym (Figure 3.4) aber nicht völlig fehlte. 
Interessanterweise war in den Spektren aus Mutante H226M nicht nur das N2 Signal 
geringer, sondern auch noch zu kleineren magnetischen Feldstärken verschoben. 
Arginin 141 ist in allen bis jetzt bekannten Komplex I Sequenzen konserviert und 
entspricht einem hoch konservierten Arginin aus wasserlöslichen [NiFe] 
Hydrogenasen. Im Hydrogenase-Strukturmodell befindet sich dieser Rest sehr nah 
am Zentrum N2. Der Arg-141 Rest wurde in Alanin, Lysin und Methionin ummutiert. 
Alle Arg-141 Mutanten hatten einen assemblierten Komplex I. Die Mutante R141A 
hatte keine hemmbare Komplex I Aktivität, wobei die Mutanten R141K und R141M 
eine um ca. 50% (unterschiedlich für verschiedene Präparationen insbesondere bei 
Mutante R141K) reduzierte Aktivität zeigten. Es wurde ein signifikanter Unterschied 
zwischen EPR Spektren und Aktivitäten beobachtet. Die Komplex I Aktivität war in 
der Mutante R141M vermindert, wobei das EPR Signal für das Zentrum N2 weder in 
mitochondrialen Membranen noch im isolierten Enzym nicht detektiert werden 
konnte. In der Mutante R141K wurde in isoliertem Enzym weniger als 5  % der 
wildtypischen N2 Intensität beobachtet, und außerdem scheint das gz Signal des 
Zentrums N2 verschoben zu sein. Eine wahrscheinliche Interpretation für dieses 
erstaunliche Ergebnis von Elektronentransport trotz fehlendem Eisen-Schwefel 
Cluster N2 könnte man anhand der Elektronentransport-Theorie ableiten. Der 
’Dutton-Moser-Ruler’ gibt die Abhängigkeit zwischen der Reaktionsrate und dem 
Abstand von benachbarten Redox-Zentren an (Page et al., 1999). Normalerweise 
beträgt der Abstand zwischen benachbarten Redox-Zentren, in unserem Fall Eisen-
Schwefel-Cluster, in einem Protein um 5 Å (Volbeda et al., 1995; Montet et al., 1997).    ZUSAMMENFASSUNG 
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Die Reaktionsrate beträgt 10
11 s
-1 bei 5 Å Abstand. Falls eines der Redox-Zentren 
fehlt, würde der Abstand ca. 10 Å betragen und die Rate wäre entsprechend um 2-3 
Größenordnungen geringer (10
8-10
9 s
-1). Im Vergleich zur Wechselzahl von Kompex 
I, die um 10
2 s
-1 beträgt, sollte ein Ausfallen von einem der Redox-Zentren keinen 
gravierenden Effekt auf die Wechselzahl ausüben. 
Histidin 91 und 95 sind hoch konserviert in Komplex I Sequenzen aus verschiedenen 
Organismen aber sind nicht konserviert in [NiFe] Hydrogenasen. Wenn man 
annimmt, dass die Proteinfaltung während der Evolution erhalten blieb, liegn diese 
beiden Histidinreste in der Nähe von Zentrum N2. His-91 und -95 wurden in Alanin, 
Methionin und Arginin ummutiert. Alle Mutanten dieser beiden Histidine 91 und 95 
hatten einen assemblierten Komplex I, aber keine von ihnen zeigte Komplex I 
Aktivität, auch nicht bei einer sehr konservativen Mutation (Histidin zu Arginin). Die 
EPR Spektren von mitochondrialen Membranen der His-91 und His-95 Mutanten und 
auch von isoliertem Enzym der Mutante H95A waren wildtypisch. 
Der C-terminale Argininrest 466 ist hoch konserviert in Komplex I und entspricht in 
wasserlöslichen [NiFe] Hydrogenasen einem hoch konservierten Histidinrest, der 
dem Mg
2+ Zentrum als Ligand dient. Der Argininrest wurde in Alanin, Methionin, 
Histidin und Glutamat ummutiert. Alle Arg-466 Mutanten außer R466H hatten einen 
stark reduzierten Gehalt (30-50 %) an Komplex I. Normalerweise deutet dies auf 
strukturelle Instabilität hin. Dadurch war es auch nicht möglich, Komplex I zu isolieren 
um ein EPR Spektrum aufzunehmen. Die Komplex I Aktivität war im Fall von R466M 
stark reduziert auf 20 % der wildtypischen Aktivität, während die Mutanten R466A 
und R466H eine Aktivität von 80 % und R466E von 50 % hatten (Table 3.7). 
Einer der wichtigsten Ansätze in dieser Arbeit war zu testen, ob einer dieser 
untersuchten Reste als 4ter Ligand des Eisen-Schwefel Zentrums N2 dienen könnte. 
His-91 und His-95 kann man mit sehr großer Sicherheit  als 4ten Ligand 
ausschließen, da nach dem Austausch des Histidinrestes gegen ein Alanin das EPR 
Spektrum wildtypisch blieb. Arg-466 kann man ebenso ausschließen, denn sogar bei 
so einem geringen Gehalt an Komplex I wie in den Mutanten R466A und R466M 
konnte man typische Merkmale des N2 Zentrums in der gxy Region des EPR 
Spektrums erkennen. Spezifische und außergewöhnlich parallele Effekte auf das 
Zentrum N2 ergaben die Mutationen von Arg-141 und His-226 (siehe Figure 3.4 und    
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Figure 3.12). Bei Umtausch in einen Alaninrest, der klein und hydrophob ist, konnte 
kein N2 Signal im EPR nachgewiesen werden. Bei einem konservativen Umtausch 
(R141K und H226M) wurde die Intensität des EPR Signals für das Zentrum N2 
geringer und zu einer niedrigeren Feldregion verschoben. Andere Mutationen zeigten 
drastische Effekte auf das Zentrum N2, in H226C und H226Q wurde das Signal sehr 
stark reduziert und im Fall von R141M verschwand es ganz. Resultierend aus diesen 
Ergebnissen könnte man schließen, dass einer der beiden Resten der 4te Ligand 
des Zentrums N2 wäre. Das ähnliche Verhalten des Zentrums N2 bei Mutationen der 
beiden Reste R141 und H226 deutet jedoch mehr auf eine Änderung in der nahen 
Umgebung des Zentrums N2 und nicht auf einem Ligandenumtausch. Im Vergleich 
zu R466, wo globale Destabilisierung eintritt, wirkt der Umtausch von H226 und R141 
mehr auf lokaler Ebene, insbesondere auf das Zentrum N2. Obwohl der 4te Ligand in 
dieser Arbeit nicht identifiziert werden konnte, spielen die beiden Reste R141 und 
H226 eine wichtige Rolle im katalytischen Prozess. Dies ist besonderes anschaulich 
in der Mutante H226M, wo das Redox-Mittelpunktspotential von N2 um mehr als 70 
mV positiver ist (Figure 3.6). Auch die Abhängigkeit vom pH-Wert war nicht mehr 
vorhanden (Figure 3.7). Aber das Maximum der Enzymaktivität in Abhängigkeit von 
pH Wert war in der Mutante H226M wildtypisch. Das isolierte Enzym aus H226M 
konnte auch in Anwesenheit von Asolectin reaktiviert werden. Die Proteoliposomen 
der Mutante H226M konnten Protonen gleichermaßen wie der Wildtyp pumpen. Aus 
diesen Experimenten konnte man jedoch nur qualitative Schlüsse ziehen. Die 
genauere H
+/e
- Stöchiometrie konnte man dabei nicht feststellen. 
Dem Zentrum N2 wird eine wichtige Rolle zugeschrieben, es soll die Protonenpumpe 
von Komplex I mit der Reduktion von Ubichinon koppeln. Nach den hier präsentierten 
Ergebnissen wird die Rolle des Zentrums N2 in Frage gestellt. Denn die Mutante 
R141M hatte eine stark ausgeprägte, mit Komplex I spezifischen Inhibitoren 
hemmbare Aktivität, jedoch wurde kein N2 Signal in der EPR Spektroskopie 
detektiert. Noch dazu pumpt die Mutante H226M Protonen gleichermaßen wie der 
Wildtyp, wobei keine pH Abhängigkeit des Mittelpunktspotentials zu beobachten war. 
Dabei stellt sich auch die Frage auf welche Weise die Protonenpumpe in Komplex I 
funktioniert: Ist es eine Redox-Pumpe, eine mechanische Pumpe 
(Konformationsänderung) oder sogar eine Kombination aus beiden Typen? 
Außerdem ist die Rolle vom Cluster N2 in der Protontranslokation zu klären. Dafür    ZUSAMMENFASSUNG 
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sind weitere Untersuchungen an dem wildtypischen Komplex I und an den Mutanten 
H226M, R141M und R141K geplant. 
Neben dem großen akademischen Interesse am Mechanismus von Komplex I spielt 
dieses sehr wenig verstandene und komplizierte Enzym wegen seines 
Zusammenhangs mit einer Vielzahl von Krankheiten eine wichtige Rolle in der 
Humanmedizin (Robinson, 1998; Loeffen et al., 2000; Gluck et al., 1994). Außerdem 
wird Komplex I als eine der Hauptquellen der ROS (Reactive Oxygen Species) 
diskutiert (Wallace, 1999; Sherer et al., 2003). In dieser Arbeit wurden drei 
Mutationen (R231Q, P232Q und S416P, Y. lipolytica Nummerierung), die für 
Menschen pathogen sind, in der 49-kDa Untereinheit reproduziert. Die Mutanten 
R231Q und S416P zeigten keinen Einfluss auf die Enzymaktivität oder auf den Km für 
DBQ und vmax für DBQ. In der Mutante P232Q wurde Komplex I nicht assembliert. In 
dieser Mutante ist wahrscheinlich die nicht richtige Proteinfaltung für das 
Krankheitsbild verantwortlich. Aus den Untersuchungen an Mutanten R231Q oder 
S416P kann man abschließend nicht sagen, warum diese Mutationen pathogen sind. 
Drastischere Mutationen an diesen beiden Positionen, R231E und S416A ergaben 
jedoch Effekte auf das katalytische Zentrum, der Km Werte für DBQ waren im Fall 
von R231E mehr als 2fach und in S416A mehr als 3fach höher (Table 3.9). Dies ist 
im Einklang mit dem [NiFe] Hydrogenase Strukturmodell und auch ein Hinweis auf 
räumliche Nähe dieser Reste zum Chinon-Reduktionszentrum. 
Die Untersuchungen an lebenden Zellen haben gezeigt, dass Mitochondrien nicht 
einzelne isolierte Organellen darstellen, sondern in Form eines 
zusammenhängenden Netzwerks organisiert sind. Die Mutation R231Q verursacht 
bei Menschen eine Fragmentierung des mitochondrialen Netzwerk. Um zu 
überprüfen, ob dies auch in der Hefe vorkommt, wurde eYFP (eine Variante von 
GFP, Green Fluorescent Protein) mitochondrial exprimiert. Das Gen für die 30-kDa 
Untereinheit wurde C-terminal mit dem eYFP-Gen fusioniert. Es wurde beobachtet, 
dass die Mitochondrien sich in der Nähe der Zellwand befinden. In vorläufigen 
Untersuchungen der Mutante R231Q wurden keine Unterschiede im Vergleich zum 
Wildtyp beobachtet. Aber dies muss noch genauer in Kooperation mit Prof. Smeitink 
von NCMD (Die Niederlande) untersucht werden.    
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8 APPENDIX 
8.1  Non-Standard EPR Experiments (ESEEM and ENDOR) 
Since it is still unknown which residue is the 4P
th
P ligand of cluster N2 it is possible that 
a nitrogen from the peptide backbone or some nitrogen containing side chain of 
amino acids such as histidine or arginine could serve as ligand. In x-band cw EPR 
spectroscopy such stakes cannot be visualised. If nitrogen ligates one of the iron-
sulphur clusters in complex I it is possible to detect this using more extensive EPR 
studies. The proposed experiments were ESEEM and ENDOR. ESEEM stands for 
Electron  Spin  Echo  Envelope  Modulation, (cw) ENDOR for (continuous  wave) 
Electron Nuclear Double Resonance. 
8.1.1 Strain  KL6×CH3  
For non-standard EPR experiments it was necessary to make a Y. lipolytica strain 
that can be grown on minimal media without adding any external nitrogenous 
compounds except ammonium sulphate. To make this strains KL6 (nukm::LEU2 
MatB ndh2i  leu2-270 lys11-23  xpr2-322  ura3-302) and CH3 (nucm::URA3, 30Htg , 
ndh2i,  his-1,  ura3-302,  leu2-270,  xpr2-322) were mated to yield the diploid strain 
KL6×CH3. There was no need for DNA analysis since only the diploid strain with both 
alleles nucm::ura3 and nukm::leu2 could grow on SD media without uracil, leucine, 
lysine or histidine. 
8.1.2  P
15
PN-labelled Complex I  
The  P
14
PN nucleus has spin I = 1 and the quadrupole coupling with weakly coupled 
nitrogen can have an extensive influence on the hyperfine spectrum. This leads to 
further splitting of the resonance positions in ESEEM and ENDOR spectra. This 
effect generally causes peak dispersion, which on the other hand complicates peak 
detection. This problem can be solved through a global P
15
PN labelling because the P
15
PN 
nucleus has spin I = ½ and does not show any quadrupole coupling and the 
resonance positions can be easier detected. Also, the spectra of P
15
PN labelled 
enzymes directly deliver hyperfine tensors whose values can be entered into the 
simulations of P
14
PN spectra.    REFERENCES 
To make fully 
15N-labelled complex I from Y. lipolytica firstly it was necessary to have 
a protothrophic strain so that the sole nitrogen source would be 
15N-labelled 
ammonium sulphate. Since 
15N-labelled ammonium sulphate is very expensive it was 
necessary to work with the minimally required amount (Figure 8.1). This was 
determined using small scale (250 ml) cultures. 
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Figure 8.1) Y. lipolytica growth depending on ammonium sulphate 
concentrations 
Y.lipolytica was grown in flasks in SD medium in the presence of 50 mM NaPi buffer, 
pH 6. Different curves present different amounts of ammonium sulphate used. 
 
For a large scale culture (10 l) 
15N-ammonium sulphate was added in SD medium at 
a concentration of 2.5 g/l. About 300 g of wet cells were obtained from a 10 l 
fermenter. Mitochondrial membranes had very low complex I content at about 50 % 
according to NADH:HAR activity, whereas dNADH:DBQ activity was parental when 
normalised for complex  I content. Complex  I was purified via His-Tag affinity 
chromatography and EPR experiments were performed in group of the Prof. Prisner, 
Department of Physical and Theoretical Chemistry at the JWG University of 
Frankfurt. 
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Table 8.1 Activity tests measured on mitochondrial membranes from strain 
KL6×H3  
Complex  I content is given as specific NADH:HAR oxidoreductase activity in 
mitochondrial membranes (100% = 1.0 µmol minP
-1
PmgP
-1
P), dNADH:DBQ 
oxidoreductase activity was normalized for complex I content (100% = 0.3 µmol minP
-
1
PmgP
-1
P). 
 
 
Complex I 
Strain 
content (%) activity (%) 
Parental 100  100 
KL6×H3  50 100    REFERENCES 
8.2 Proton  Pumping 
8.2.1 ACMA  dye 
ACMA (9-amino-6-chloro-2-methoxyacridine) 
 
 
 
 
8.2.2  Ionophores used in ACMA Measurements 
8.2.2.1 Valinomycin 
Valinomycin is mobile carrier that catalyses the electrical movement of K
+ across 
phospholipid bilayers. This implies that the potassium distribution across the 
membrane obeys the Nernst equation once equilibrium has been attained.  
 
 
 
 
 
It is a cyclic amide/ester in which the sequence D-hydroxy- isovalerate, L-valine, L-
lactate and D-valine is repeated three times (-A-B-C-D- in the Figure above). The 
ionophore provides a polar interior to accommodate the potassium ion, but presents 
a non-polar lipophilic exterior to the outside. 
 
    
8.2.2.2 Nigericin 
Nigericin is mobile carrier that resembles valinomycin but contains a carboxyl group 
and forms a potassium salt. It therefore catalyses an electroneutral potassium/proton 
exchange across lipid bilayers.  
This implies that the potassium distribution will be related to the pH gradient once 
equilibrium has been attained: 
 
 
 
[K
+ ]in / [H
+ ]in = [K
+ ]out / [H
+ ]out 
 
 
In some cases (e.g. valinomycin) the ionophore - ion complex has a net electrical 
charge, whereas the empty carrier is neutral. Other ionophores (e.g. nigericin) only 
form electrically neutral complexes. Charge makes an enormous difference to the 
behaviour of each carrier, since the charged complexes interact with membrane 
potentials, whereas the neutral complexes are unaffected. We speak of electrical and 
electroneutral carrier mechanisms to draw attention to this difference.  
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8.3   Moser-Dutton Ruler: A Formalism to Calculate Electron 
Tunnelling Rates in Redox Proteins
1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2 Moser-Dutton ruler. Free energy optimised electron transfer rates vs. 
distance in Rp. viridis and Rb. sphaeroides reaction centres
2
 
 
                                            
1taken from http://www.life.uiuc.edu 
2 taken from http://www.uphs.upenn.edu/biocbiop/local_pages/dutton_lab/ettheory.html    
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Research on photochemical reaction centres has been a primary arena for advances 
in our understanding of the relation between structure and rates of electron transfer 
in proteins, because the crystallographically defined structures provided for the first 
time, in the context of an experimental system in which the rates could be accurately 
measured by picosecond spectroscopy, the spatial parameters and details of the 
reaction medium (the protein) necessary for understanding these processes. 
A major advance in these studies came from an extensive set of experiments from 
Dutton's lab (Moser et al., 1995), in which several different reactions of the 
photochemical cycle were measured (and rate constants determined), with a variety 
of molecular engineering tricks to set up a range of values for ∆GP
o
P for the reactions. 
These made it possible to determine whether the reactions behaved as expected 
from Marcus theory, and to derive a general rule (Dutton's Ruler) relating rate of 
reaction to distance apart of redox centres.    REFERENCES 
 
8.4  NUCM Gene 
8.4.1  NUCM Gene encoding 49-kDa subunit, ACC. No. AJ249783 
         Xba  I 
                                TCTAGAATGTGGTTGGTCGTTTCCTTTTTTGGCGT   35 
       TTTTGAAGGGTTAATCTTGCATCTCATTCACAAAATATGGTGGATTCTGAAGGAGAGAGA   95 
       TGTAGGTTCAAATTTGGGGGAAATATAAGCCGAAACCGTAGTAGGGGTGAAGTTGAGGGG  155 
       GAGGTCGTTGGGACGCCATAATATACTGTGTTGTAGGATATTCTGTGCTAAAATCAACAC  215 
       AAATTAATGGAATAGAGTCCTTTAGAAGTAAATATTCGCAAATTGCGTCCAAAAAATACA  275 
       CCCCTACAGAGCCCGCTCACAGTCACCTGAATCAACTCATTAAACGTTGCTAACCAACTT  335 
       TATCCACTACTTGGAATAAAACAAAGCAGTCTTCAAACTCCCCCAAAAGATCACTTATTG  395 
       AAACTATGAAACTTGCATTACAATAACCGTCCCTTTTTATCCCCTTTTGTATCTTTATAT  455 
       CTTCCTGTTAAACCTCTCAAACTCGCAAAACGTGATTCCTTTGAGCTTGGGAAGTTTGGC  515 
n49knc1TGGTCAGACTTCCACACATAAACCTCCACCCAATGAAAGCCGAGCTATTGAAAGAGGGAG  575 
       ATGGTAGAACGATGCAATTGGGCTTTTTCCACGGGACAAGTCGTGAATTATATAGCTACG  635 
       GGCCAATTGTCTTAATCTACTGACTTCTTACCACCACAACCACCCCCACAACCTATATAC  695 
       ACTCCTTCAACCCTAACCCCCGTTTGCGCCAATCAGCGTTCTCGGAATACTCCCATCTGG  755 
       ACTAAACTCTTCACAGCGACCGAACCTCTGTTACACACCAAAAGCACAACCCCTCACACA  815 
     49-1 
       ATGCTGCGATCTGCTGCTGCCCGAGCCGTCAGGGCTGTGCGCCCCCGGCTGTCTGCTCGA  875 
       MetLeuArgSerAlaAlaAlaArgAlaValArgAlaValArgProArgLeuSerAlaArg   20 
 
       TACATGGCCACCACCGCTCTGCCCCAGGACCCCATCCCCTCCGGAGCTCTGGGCCAGAAG  935 
       TyrMetAlaThrThrAlaLeuProGlnAspProIleProSerGlyAlaLeuGlyGlnLys   40 
   n49nc2 
       GTGCCTCACGTCGATGAGAGCCACCAGGACCTGCTGTTCCGAACCTCTCACATGGTGGAG  995 
       ValProHisValAspGluSerHisGlnAspLeuLeuPheArgThrSerHisMetValGlu   60 
 
       GATCTCGAGACCTACGACGAGGACTCCCCTATCAACACGTCGGACGCCAACACCCGAATC  1055 
       AspLeuGluThrTyrAspGluAspSerProIleAsnThrSerAspAlaAsnThrArgIle   80 
  49-4 
       CGAGCCTTCACCATCAACTTTGGTCCCCAGCATCCCGCTGCCCACGGTGTGCTGCGTCTG  1115 
       ArgAlaPheThrIleAsnPheGlyProGlnHisProAlaAlaHisGlyValLeuArgLeu   100 
      A  
       ATTCTGGAGCTGTCTGGAGAGGAAATCATTCGATCGGACCCCCACGTCGGTCTGCTGCAC  1175 
       IleLeuGluLeuSerGlyGluGluIleIleArgSerAspProHisValGlyLeuLeuHis  120 
        49-2   G 
       CGAGGAACCGAGAAGCTCATTGAGTACAAGACTTACATGCAGGCGCTGCCATACTTTGAT  1235 
       ArgGlyThrGluLysLeuIleGluTyrLysThrTyrMetGlnAlaLeuProTyrPheAsp   140 
 
       CGTCTGGATTACGTGTCCATGATGACCAACGAGCAGGTTTTCTCTCTGGCTGTCGAGAAG  1295 
       ArgLeuAspTyrValSerMetMetThrAsnGluGlnValPheSerLeuAlaValGluLys   160 
 
       CTGCTCAACGTGGAGGTGCCCCTGCGAGGCAAGTACATCCGAACCATGTTCGGAGAGATC  1355 
       LeuLeuAsnValGluValProLeuArgGlyLysTyrIleArgThrMetPheGlyGluIle   180 
 
       ACCCGAGTGCTCAACCATCTCATGTCCGTGTGTTCACACGCCATGGATGTCGGTGCTCTG  1415 
       ThrArgValLeuAsnHisLeuMetSerValCysSerHisAlaMetAspValGlyAlaLeu   200 
 
       ACCCCCTTCCTTTGGGGTTTTGAGGAGCGAGAAAAGCTTATGGAGTTCTACGAGCGAGTC  1475 
       ThrProPheLeuTrpGlyPheGluGluArgGluLysLeuMetGluPheTyrGluArgVal   220 
     49i 
       TCTGGAGCCCGTCTGCACGCCGCGTACGTGCGACCTGGAGGAGTCTCCCAGGACCTGCCC  1535 
       SerGlyAlaArgLeuHisAlaAlaTyrValArgProGlyGlyValSerGlnAspLeuPro   240 
 
 
    
112 
       GCCGGCCTGCTGGACGATATTTACATGTGGGCTACACAGTTCGGTGACCGTCTGGACGAA  1595 
       AlaGlyLeuLeuAspAspIleTyrMetTrpAlaThrGlnPheGlyAspArgLeuAspGlu   260 
   49-3 
       ATCGAGGAGCTGCTGACCGATAACCGAATTTGGAAGCTACGAACCGTCAACATTGGAACC  1655 
       IleGluGluLeuLeuThrAspAsnArgIleTrpLysLeuArgThrValAsnIleGlyThr   280 
                 BamHI 
       GTGACCGCCCAGGACGCCTTGAACCTTGGTCTTTCCGGCCCCATGCTGCGAGGATCCGGT  1715 
       ValThrAlaGlnAspAlaLeuAsnLeuGlyLeuSerGlyProMetLeuArgGlySerGly   300 
 
       ATCCCCTTTGACATTCGAAAGAACGCCCCCTACGACGCATACGACAAGGTCGACTTCGAC  1775 
       IleProPheAspIleArgLysAsnAlaProTyrAspAlaTyrAspLysValAspPheAsp   320 
 
       GTCCCCGTCGGCATGAACGGAGATTGTTACGACCGATACCTGATTCGAATGGCCGAGTTC  1835 
       ValProValGlyMetAsnGlyAspCysTyrAspArgTyrLeuIleArgMetAlaGluPhe   340 
 
     T  
       CGACAGTCGCTGCGAATCATCGAGCAGTGCTGCAACGACATGCCTGCCGGCGCCGTTAAG  1895 
       ArgGlnSerLeuArgIleIleGluGlnCysCysAsnAspMetProAlaGlyAlaValLys   360 
         49i1 
       GTGGAGGACTTCAAGATTAACTCGCCTCCTAGAAACCTCATGAAGGAGGATATGGAGGCC  1955 
       ValGluAspPheLysIleAsnSerProProArgAsnLeuMetLysGluAspMetGluAla   380 
 
       CTGATCCACCACTTCCTGCTCTACACAAAGGGATACTCTGTTCCTCCCGGAGAGACCTAC  2015 
       LeuIleHisHisPheLeuLeuTyrThrLysGlyTyrSerValProProGlyGluThrTyr   400 
     49-2.5   G        C  
       ACCGCCATCGAGGCCCCCAAGGGAGAGATGGGTGTCTACGTCGTCTCCGACGGTAGTGAG  2075 
       ThrAlaIleGluAlaProLysGlyGluMetGlyValTyrValValSerAspGlySerGlu   420 
     
       CGACCATACAAGTGCAAGATCCGAGCCCCCGGATTTGCCCATCTCGGAGCCTTTGATCAC  2135 
       ArgProTyrLysCysLysIleArgAlaProGlyPheAlaHisLeuGlyAlaPheAspHis   440 
      n49kc2 
       ATTGCCCGAGGACATTTCCTTCCCGACGCCGTGGCCATTATTGGTACCATGGATCTTGTG  2195 
       IleAlaArgGlyHisPheLeuProAspAlaValAlaIleIleGlyThrMetAspLeuVal   460 
 
       TTTGGAGAGGTTGATCGATAGTCATAGAATACATACTAAGCAGAGTCGCATATGCGTGTG  2255 
       PheGlyGluValAspArg***                                          466 
 
       CTCGTGGAATGTACTGTAGAGGGTTGTACACTGTATGTGAGAGCAGAGTTGCTATAAGGA  2315 
       GAGGTGGTGGATGCGTGACTGTTAGTTGGACTGTGAGTCAGAATGGTCCGTTGAGAGCAA  2375 
       TGTGGGTCATGCTAAATCTCTTAATGCTTTCTCTTCTACTATGGTGATGTTACCTCACAG  2435 
       ATACAACAATCGAGATACGGGTCGCGAGACGAGTAGATGTGAGACTACAAATACTGTACA  2495 
       CTTGTATAACTAATCTACAGGACAGGTGAATGCGAAAGTAAAATGCGATCATCTCTCGGC  2555 
       CGTAGATGGTCATATTAGTCACATATAATCTGATGCCGGTAAATTTCACATGTCAAGCAT  2615 
n49kc3 GTCCATATGGATCTGTCATCAAGCGAGACAGCCACCAAGACTGGAACCAATGCCGCTGGT  2675 
       AGTAATGGACCTTCTGGTACCAGAGCTGTCATCATTTGCTTGAACCACCTCCTTCATATG  2735 
       CTCACAAAATCACATGGCTGTGGTTCATCTCACACCAATCCTTTGAGCATATGTCATTCA  2795 
 SphI  TGTAGCATGCATAAACATGTCATCAAAGAAACATATTGGGGCGATGGGAACTGATAAGGG  2855 
       GGTGGATGAACATCTGATCTATTGGATGAACTCGATATAAATGATCGTTAATTGAACTAC  2915 
       TTGTAGTTATTACAAACACTTTTGCAAGTGCTAGATCATGATTACTTGTGTACACCTACT  2975 
       GATGCGTGATCAATAGGTAAACCATGATCTGGTGAATACCATTACCTGTCCCCTGGTGTA  3035 
       CATAAGCATACTACGGGACAACTTCTGCACAGAGAGAGATC                     3076 
 
 
Used oligonucleotides, silent mutations and some restriction sites are marked with 
grey, darker grey indicates direction of the primer.    REFERENCES 
 
8.4.2  Used oligonuceotides in the NUCM gene 
 
direction  name        sequence  binding site 
49-1 5’-TCACACAATGCTGCGATC-3’ 809-827 
49-4 5’-TCCGAGCCTTCACCATCAAC-3’  1054-1073 
49-2 5’-ACATGCAGGCGCTGCCATAC-3’  1221-1230 
49i2 5’-GCGTACGTGCGACCTGGA-3’  1497-1516 
49-3 5’-AGGAGCTGCTGACCGATAAC-3’  1600-1620 
49-2.5 5’-GAGACCTACACCGCCATCGAG-3’ 2007-2027 
forward 
n49kc2 5’-ACGCCGTGGCCATTATTG-3’ 2160-2175 
n49knc1 5’-ATGTGTGGAAGTCTGACC-3’  534-515 
n49nc2 5’-CCTGGTGGCTCTCATCGACG-3’  963-943  reverse 
49i1 5’-GCCTCCATATCCTCC-3’  1954-1940 
 
Table 8.2 Oligonucleotides for sequencing the NUCM gene 
 
name sequence  binding  site 
49us 5’-GATCACGCATCAGTAGGT-3’  2986-3004 
49ds 5’-TGTATGCATTGCGTCCAC-3’ 
outside of sequenced 
area 
 
Table 8.3 Oligonucleotides for deletion checking via PCR 
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8.5  Mitochondrially expressed eYFP 
8.5.1  Fusion of the 75-kDa presequence with the eYFP gene
1 
    GTCGACGGTCTCTCCCAGGACACTCCTCTTCCTCATGTCCATGTTCATTGCTTCCACAAG       60 
    TGGGAGGCTGGAGAAGAAGAGCCCTCCAAGGAGGAGACCAAGGCTGCTCTTTTGGAGCGG      120 
    GTGTACAAGCAGATCGACGTGCGACTGGACCCCAACGAGGTTGGAATGCATTGGGTTCGA      180 
    AAGGTGTCTCCCAAGAAGGACATGTTTTGCATTTCTTTCGAGCTGCCCAAGGAGGTTGCA      240 
    TGGGCCCCTCAGGTTAACAAGGAGTAAATGTATATATATGTATTATAATGGTAATGACGG      300 
    CGATGAATTTGCAGAAGTACTCAGGACAGTTCTTTCGTGAGTGGGTGATTTTTCTTGATT      360 
    TTTTCGATTTCTTGATTTTTTCGATTTCTTGATTTTTTCGATTTTCTTGATTTTCCCATT      420 
    ATTCGATTTTCCCCATTATTCGATTTTCCCCATTATTCGATTTTTCATTTTTATGCCGAA      480 
    ATACGAGTATTGTACCACTGGCACCATAAATACAAACCATTCATGACTCCCACAGACCTG      540 
    GACCAAAGAACATCGTACTTGTATCTGAACTCACGACTTCATTATTGCTTGTACCCGTCC      600 
    TCATACCTCTCCCTCCGCTCCGTCTCCCTCCACCATTACTAAGCAACAAGGGCCAATTGT      660 
    GTCGGAGCTTTCTGCTGACCAAAACTCTCCCTCTTGCCAACTTCTCCAATCAAAAAGATG      720 
    ATTTTGCAAGATGTCATTGCCAACACTAGCTTTTAGAGTTGGTCTGGAGGGCTACACAAC      780 
    ATCCGGTAGCGATGCATCCATGTCCGAAAATTTGTAGTGGATGGCGGTGATATTATTGCG      840 
    AGAATTTGCCAACCGCAGCTGAATCAGCCAATTGAGGGGTTTTCCGGCTCCACAGCTCTC      900 
    TGCCACGGCGGAGTTCAACCGACCCCCAAATCTCCGTACTGACATGTACTGTAGGCAGAC      960 
    CCAAAAATAAGCTCTCCCAAGGTCGTAACTCCCAGCCAATGGTAGTGGACCAATTGTGGT     1020 
    GCGTCTGTGTGTAGAAGTGGGTGGGTTTAATCCATCTTTTGAGTATTCAATAGAGTGAAC     1080 
    AGACACATTTCTCAGAAGACACGTCTTAGAAAAGGTGAGTGAAATGAGGACATGTGGAGG     1140 
    ACAAATTGGAGAGATATCAGCAGAGATGCAGCAGGATGAACACACAGACAGACACAACAG     1200 
    CAGGAACGACACAGATGGAACGGCAGACAACACATCCAGGGAAGGACACTATCGGCGGAA     1260 
    GGACACACGCAAAAGGACAGCTGAAAGGGATGGATGACAGCCGAGCCCGACCGAAGACGG     1320 
    TGGCAAAACGAGATGCGACACAATACAGCTGAATCGACAGTTCGATTGTGTCTGGAAGAT     1380 
    GGGCCGTACGGAGATCCAAGCAATACACGGGGTTAGCTGTGCCCCTTCAAAGAGCGGCAA     1440 
    TCGTGCACGAAAAACATAGTCGTGCATCCCCGACAACGGTGGATATGTGGCTGCGTCCGT     1500 
    GTCACTTTGCCCGTGTCATCCAGTTCAGTTTTCTGCAAAGAATATCTCACATCGTTACCT     1560 
    CTTATCTCCAAACCATGCCAATCCACCCAGCTACTAACATAGATGCTCTCGAGAAACCTC     1620 
                                              MetLeuSerArgAsnLeu        6 
 
    AGCAAGTTTGCTCGAGCCGGTCTCATCCGGCCAGCAACCACATCCACACACACCCGACTA     1680 
    SerLysPheAlaArgAlaGlyLeuIleArgProAlaThrThrSerThrHisThrArgLeu       26 
 
    TTCAGCGTCTCCGCCCGACGTCTCGCCGAGATTGAACTCACTATCGATGGTCATATGGTG     1740 
    PheSerValSerAlaArgArgLeuAlaGluIleGluLeuThrIleAspGlyHis  M  V        46 
 
    AGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGAC     1800 
     S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E  L  D  G  D        66 
 
    GTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAG     1860 
     V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A  T  Y  G  K        86 
 
    CTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTG     1920 
     L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W  P  T  L  V       106 
 
    ACCACCTTCGCCTACGGCCTGCAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCAC     1980 
     T  T  F  G  Y  G  L  Q  C  F  A  R  Y  P  D  H  M  K  Q  H       126 
 
    GACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG     2040 
     D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T  I  F  F  K       146 
 
                                            
1 3 letter code used for 75-kDa subunit, 1 letter code used for eYPP    REFERENCES 
 
    GACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAAC     2100 
     D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D  T  L  V  N       166 
 
    CGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG     2160 
     R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L  G  H  K  L       186 
 
    GAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATC     2220 
     E  Y  N  Y  N  S  H  N  V  Y  I  M  A  D  K  Q  K  N  G  I       206 
 
    AAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCAC     2280 
     K  V  N  F  K  I  R  H  N  I  E  D  G  S  V  Q  L  A  D  H       226 
 
    TACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTG     2340 
     Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D  N  H  Y  L       246 
 
    AGCTACCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTG     2400 
     S  Y  Q  S  A  L  S  K  D  P  N  E  K  R  D  H  M  V  L  L       266 
 
    GAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGCATATGGCC     2460 
     E  F  V  T  A  A  G  I  T  L  G  M  D  E  L  Y  K HisMetAla      286 
 
    AAGAGCAGCATTGCATTCAACAAAGACAACAAGAAAAACCAGGCTTTTGCCTAATTAAGT     2520 
    LysSerSerIleAlaPheAsnLysAspAsnLysLysAsnGlnAlaPheAla***            303 
 
    AATCAATTAGATGTTATATGAAAACCCGAGTACAGCATGTACTGGTAGAGGAGTAGGGAT     2580 
    GATTCGAGGATAGTGGAGCTATTGTGAAGTGACCGGGTGGGTTAACAAAA GTATTGCTT     2640 
    TGAATTAGTTTGACGATATAGATGTATATGACTACTGTATGTACTTGTAGTTGCGAGCTC     2700 
    AGAACGAATGAGACAGAGCAGCTCAGCCATTTACAGTACAGTATGTGCTTGCTCATGGGC     2760 
    AGTTACAAGTTCCTACTTGTAATACGGAGTCTGGTTTTTCAGTTGACATGGATTATACAA     2820 
    CTTTAAGGCGCTCGAAAAGCGTTGTACCACTTTCTATCCACTAAGATATGTTTGAACCAA     2880 
    CCAGAGCTATCTACTTGTAGCTACACGGCTGACCACCAAACTCTTGGTCAACTAATGTCA     2040 
    CCAGCAACAACTGATGAACTCCAAAGGGTGAACCATAGACTCCACGCTGTGGAAGGATAT     3000 
    GTAAATAAAGACAACCATAAAACAGAACTTCAGACACTTGGCAAGGAAAAAGATTACAGC     3060 
    ACCTAGGATTCTCGTATGGTCTCCCACTACAATACTAACTAGGCTCTCTGGTGCTTGACT     3120 
    ATGGCTGATCGGACGGGAAGCCGTATTTTCACCAGGATATGGCCGTAACCAAGACTCCGA     3180 
    TACGGGGAATCGAACCCCGGTCTCCACGGTTCTCAACATGAGAGCGTGATGTGATAGCCC     3240 
    CTACACTATATCGGAAATGTGCAAGACACGGTGTTTTTGGCGTCACGCATCTGATTCGCC     3300 
    AAATAAGGTTTAATTAAAAAGTTAACGAATATTAAAATAGTTAGAATAAAAATAATTTGT     3360 
    CAAGCGTTTGTATCGGCTCAAGAAAAGAAAAATAAGGGAACCGGGGAGTGTGGAATTTTC     3420 
    AAACTGTTCGGAGAAAAACTATTACGGGTCTATTGCACGAGATTTCTCCCTGTTTTATGG     3480 
    TCGTTTAGTTGCTGAGATGCATTGGGCAAGAATCACAAAATAAAATGACTCGTGAAATGC     3520 
    GCACAATGCGACCTTAATGCACGTTTAGCCAGTAGTGTGCATGATAATCCACATACAAAG     3580 
    TTAAGATCCGATGTTAGCCTACGTGTATTTACTATAGCTGAAATGTCTACCTGTACTCAT     3640 
    TTAGTGCGAAAAAATTTAACCACCTCTAGCGCCCGGTCTTGTCATGTCTTGGCTCATGTA     3700 
    CATGAGATGAGAGTGTATGTGATCTGACGGAAGTGGGCACATACACGCTGATAACATTTC     3760 
    AGGTGCGTTCCTGCGGTTGATATCACAAGCATCTCCGAGCACACGAAAATGAGATGGTAT     3820 
    GCTGAAGTCTCCACCTTTAGTCGAC                                        3845 
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8.5.2 Oligonucelotides used for fusion of the 75-kDa presequence with 
the eYFP gene 
 
name sequence  binding  site
EYFPCc  5’-ATATATCATATGGTAAGCAAGGGCGAGG-3’  612-631
a
EYFPCnc  5’-ATATATCATATGCTTGTACAGCTCGTCCAT-3’  1330-1311
a
75Nde1c  5’-ATATATCATATGGCCAAGAGCAGCATTGC-3’  1734-1708 
75Nde1c  5’-ATATATCATATGACCATCGATAGTGAGTTC-3’  2451-2472 
 
Table 8.4 Oligonucleotides for  introducing Nde I sites into NUAM and eYFP 
genes 
a the numbering of the oligonucleotides sequence binding site refers to the original 
sequence of eYFP gene  
 
name sequence binding  site 
LGseq1 5’-CCAGCAACCACATCCACAC-3’  1650-1669 
LG75kseq2 5’-CCACTATCCTCGAATCAT-3’  2696-2676 
75kseq1 5’-CCGTGTCATCCAGTTCAG-3’  1511-1529 
EYFPseq 5’-CGCACCATCTTCTTCAAGG-3’  2022-2041 
 
Table 8.5 Oligonucleotides for  sequencing the  fusion between the NUAM ad 
eYFP gene 
    REFERENCES 
 
                                           
8.5.3  Fusion of the 30-kDa with the eYFP gene
1 
 
 
     TATGGTCAGATCAGGTGGTAGTGTGGCAACGCTATCTGTGTGTGGTGTAAAGAGAGTTGT       60 
     ATCGCCAAGTTGTCTGTTTAGTGCCGGGTAAGTTCACAATTTGGCGTGTTTTGTGCCTGC      120 
     TGGGAGCTTGCCCAATTCGGCTGACTAAGTTCCACTTGTATGGAGTCTAATGACATGTGA      180 
     GGACAGGACAGAAATGTGCCTAATACGGTGTTTTACTATCAAAATGCCTGTGGGAAAAAA      240 
     CATAAATACTTATCTGACCCCCCTAAATTCCATCTCCGACCAACCCCTACCCCATCACCG      300 
     CTTCATACACCCACTTATTCAATACCTCCCACTTTTTGGTCACGTGCAGGGTTTCTCCCA      360 
     ACGTCTCGCCCAATCAAACTCGCCAAAATTCAATTGTCAAACCCAACTCTTGTCTGGTGC      420 
     AAAAGCCTGTAATACTGGTTACGCAGGAGCCGTCGTGACACACAACACACAACTAACACA      480 
 
     ATGCTCTCTCGATTCGCCAGAATTGGCAGCATGGGCATCCGCCCCGTCGCAGCAGCCCGT      540 
     MetLeuSerArgPheAlaArgIleGlySerMetGlyIleArgProValAlaAlaAlaArg       20 
 
     GCTACCTTTGTGACCTCCGCCCGAGCCGCCCAGGCCGCCCCCTCTTGGGAGAACATCAAG      600 
     AlaThrPheValThrSerAlaArgAlaAlaGlnAlaAlaProSerTrpGluAsnIleLys       40 
 
     GACATCCGACTCGACCCCAAGGTCCATGTTGACGAGGTTTACGAGCCCATCGTCAACCCC      660 
     AspIleArgLeuAspProLysValHisValAspGluValTyrGluProIleValAsnPro       60 
 
     GCAGACCGATACCTCCAGCACGTGTCGGACCTCCACCAGTACGCCAAATACATCATGGCT      720 
     AlaAspArgTyrLeuGlnHisValSerAspLeuHisGlnTyrAlaLysTyrIleMetAla       80 
 
     GCTCTGCCCAAGTACATCCAGGGCTTTTCTGTGTGGAAGGACGAGCTGACTCTGCACGTT      780 
     AlaLeuProLysTyrIleGlnGlyPheSerValTrpLysAspGluLeuThrLeuHisVal      100 
 
     GCACCAAGCGCTGTCATTCCCGTCACTACCTTCCTGCGAGACAACACCTCGACTCAGTAC      840 
     AlaProSerAlaValIleProValThrThrPheLeuArgAspAsnThrSerThrGlnTyr      120 
 
     AAGTCCATCATCGATATTACCGCCGTGGACTACCCCTCTCGAGAAAACCGGTTCGAGGTG      900 
     LysSerIleIleAspIleThrAlaValAspTyrProSerArgGluAsnArgPheGluVal      140 
 
     GTCTACAACTTTCTGTCTGTGCGACACAACTCGCGAATCCGACTTAAGACATACGCTACC      960 
     ValTyrAsnPheLeuSerValArgHisAsnSerArgIleArgLeuLysThrTyrAlaThr      160 
 
     GAGGTGACCCCCGTCCCCAGTATCACCTGCCTGTACGAGGGCGCCAACTGGTTCGAGCGA     1020 
     GluValThrProValProSerIleThrCysLeuTyrGluGlyAlaAsnTrpPheGluArg      180 
 
     GAGGCCTACGATATGTACGGAGTCTTCTTTGAGGGCCACCCCGATCTGCGACGAATCATG     1080 
     GluAlaTyrAspMetTyrGlyValPhePheGluGlyHisProAspLeuArgArgIleMet      200 
 
     ACCGACTACGGTTTTGAGGGCCACCCTCTGCGAAAGGACTTCCCTCTCACCGGATACACT     1140 
     ThrAspTyrGlyPheGluGlyHisProLeuArgLysAspPheProLeuThrGlyTyrThr      220 
 
     GAGGTCCGATGGGACGAGGAGAAGCGACGAGTGGTTTACGAGCCCCTGGAGCTTACCCAG     1200 
     GluValArgTrpAspGluGluLysArgArgValValTyrGluProLeuGluLeuThrGln      240 
 
     GCCTTCCGAAACTTCTCTGCCGGCTCCACCGCTTGGGAGCCTGTTGGACCCGGTCGAGAC     1260 
     AlaPheArgAsnPheSerAlaGlySerThrAlaTrpGluProValGlyProGlyArgAsp      260 
 
     GACCGACCCGACTCTTTCAAGCTCCCCACCCCCAAGCCCGAGGAGAAGGAAGGCGACAAG     1320 
     AspArgProAspSerPheLysLeuProThrProLysProGluGluLysGluGlyAspLys      280 
 
 
 
1 3 letter code used for 30-kDa subunit, 1 letter code used for eYPP, new inroduced amino acid are 
marked in bold    
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     AAGCATATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAG     1380 
     LysHis M  V  S  K  G  E  E  L  F  T  G  V  V  P  I  L  V  E       300 
 
     CTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCC     1440 
      L  D  G  D  V  N  G  H  K  F  S  V  S  G  E  G  E  G  D  A       320 
 
     ACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGG     1500 
      T  Y  G  K  L  T  L  K  F  I  C  T  T  G  K  L  P  V  P  W       340 
 
     CCCACCCTCGTGACCACCTTCGCCTACGGCCTGCAGTGCTTCGCCCGCTACCCCGACCAC     1560 
      P  T  L  V  T  T  F  G  Y  G  L  Q  C  F  A  R  Y  P  D  H       360 
 
     ATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACC     1620 
      M  K  Q  H  D  F  F  K  S  A  M  P  E  G  Y  V  Q  E  R  T       380 
 
     ATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGAC     1680 
      I  F  F  K  D  D  G  N  Y  K  T  R  A  E  V  K  F  E  G  D       400 
 
     ACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTG     1740 
      T  L  V  N  R  I  E  L  K  G  I  D  F  K  E  D  G  N  I  L       420 
 
     GGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAG     1800 
      G  H  K  L  E  Y  N  Y  N  S  H  N  V  Y  I  M  A  D  K  Q       440 
 
     AAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAG     1860 
      K  N  G  I  K  V  N  F  K  I  R  H  N  I  E  D  G  S  V  Q       460 
 
     CTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGAC     1920 
      L  A  D  H  Y  Q  Q  N  T  P  I  G  D  G  P  V  L  L  P  D       480 
 
     AACCACTACCTGAGCTACCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCAC     1980 
      N  H  Y  L  S  Y  Q  S  A  L  S  K  D  P  N  E  K  R  D  H       500 
 
     ATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTAC     2040 
      M  V  L  L  E  F  V  T  A  A  G  I  T  L  G  M  D  E  L  Y       520 
 
     AAGCATATGGCCGCAGCCCATCATCATCATCATCACTAGATGCTGGTTACATGGGAATGT     2100 
      K HisMetAlaAlaAlaHisHisHisHisHisHis***                           532 
 
     AGGGTGAGATTCGGAATGAGTGCTATTGAAAAGTCCAGAGTAGGAAGATGGCTTTTCACG     2160 
     GAAGTACAACCCGTGATGGCATTGGATGGAGTACTTGTAGTTCAATGGTTGATGCATTAG     2220 
     GGTACAACCTGGGTCGATTCAGAAGGACGGCTTTTGCATGCAACATCTTCTTTGGCAGAT     2280 
     CAAAGAGTGGGTTTCATGGGATTCGAGCTCGCAATAAGTAACATGATAAGTAGGTTACTT     2340 
     AGATTTTAAAGTAATATCAACACTCATCTATCTCCTAACCATTGAGAAGTGTCGTGCACT     2400 
     TTCCCATTCTAAGGCAAAAGCAACAGTTACGAGTAGTTACATATCTACAAGTACTTGTAG     2460 
     TGCTTCCAGACTGAGATTACCTACTGTCACCGGCACAGATTGAGAGAGCATAAGTCGACA     2520 
     CATTGTACATACTGTACAAAGAGAATACTCTTAACTGGGGGCTTATATATAACGGTGACT     1860 
     ACTATGCATAGATTTGTATCATGAGATCTCTCGAGCTGTATGTTTGCTTCACTTTTAGAA     2580 
     AAGCGGCTGGCAATCTCTGTCTTCGCACATGCACGTCCTGTTCCAGTCATTCATTGGCTA     2640 
     TGCTTTCCAGCATTTTTCAGACATTTCTTCATTGCTCGTCAAATTTGTCATTAAATATAC     2700 
     AGCTCAGTTGTGCACCTTCTACTAGAAAATGGTGCTCTACTTACTTTCTCAGAGAAGCCA     2760 
 
    REFERENCES 
 
8.5.4  Oligonucelotides used for fusion of the 30-kDa with the eYFP gene 
 
name sequence  binding 
site 
EYFPCc 5’-ATATATCATATGGTAAGCAAGGGCGAGG-3’ 612-631
a
EYFPCnc 5’-ATATATCATATGCTTGTACAGCTCGTCCAT-3’  1330-
1311
a
30kNdeInc  5’-GGCTGCGGCCATATGCTTCTTGTCGCCT 
TCCTTCTCCTC-3’ 
2052-
2013 
30kHtgnc2 5’-GCCGCAGCCCATCATCATCATCATCACTAG-3’  2049-
2079 
 
Table 8.6 Oligonucleotides for introducing Nde I site into NUAM and eYFP 
genes 
a the numbering oligonucleotides sequence binding site refers to the original 
sequence of the eYFP gene  
 
name sequence  binding  site 
30c3 5’-GTTGGACCCGGTCGAGAC-3’  1242-1260 
30nc1 5’-CTGCCAAAGAAGATGTTG-3’  2218-2199 
EYFPseq 5’-CGCACCATCTTCTTCAAGG-3’  2022-2041 
 
Table 8.7 Oligonucleotides for sequencing the fusion between NUGM and eYFP 
genes    
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8.6 Abbreviations 
(mt)DNA  (mitochondrial) Deoxy Ribonucleic Acid 
ACC. No.  Accession Number 
ACMA 9-amino-6-chloro-2-methoxyacridine 
ATP Adenosine  Triphosphate 
BN-PAGE Blue-Native  Polyacryl Amide Gel Electrophoresis 
bp base  pair 
BSA  Bovine Serum Albumin 
CF Connecting  Fragment 
CLSM  Confocal Laser Scanning Microscopy 
CPEO Chronic  Progressive  External Ophthalmoplegia 
DBQ n-Decyl-Benzoquinone 
DF Dehydrogenase  Fragment 
dNADH  deamino Hydronicotineamide Adenine Dinucleotide (reduced form) 
DQA 2-decyl-4-quinazolinyl  amine 
EPR  Electron Paramagnetic Resonance 
eYFP  enhanced Yellow Fluorescent Protein 
FAD  Flavin Adenine Dinucleotide 
FADH2 Flavin Adenine Dinucleotide reduced form 
FCCP Trifluorocarbonylcyanide  Phenylhydrazone 
FeS Iron-Sulphur  Cluster 
FMN Flavin  Mononucleotide 
FP Flavo  Protein 
GFP  Green Fluorescent Protein 
HAR  Hexaammine ruthenuim(III) chloride    REFERENCES 
 
kb kilobase 
KSS Kearns-Sayre  syndrome 
LHON  Leber’s hereditary optic neuropathy 
MELAS 
Mitochondrial Encephalomyopathy, lactic acidosis and stroke like 
episodes 
MERRF  Myclonic Epilepsy with Ragged Red Fibers 
MF Membrane  Fragment 
MPP
+ 1-methyl-4-phenylpyridium ion 
MPTP N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
NAD
+ Nicotinamide Adenine Dinucleotide 
NADH  Hydronicotineamide Adenine Dinucleotide ( NAD
+ reduced form) 
NDH-2(i) external  alternative NADH Dehydrogenase (internal) 
OXPHOS Oxidative  Phosphorylation 
PCR  Polymerase Chain Reaction 
PD Parkinson’s  Diseas 
PMSF Phenylmethylsulfonyl  flouride 
Q Ubiquinone 
Q1 Quinone with 1 isoprenyl side chain 
QH2 Ubihydroquionone (Ubiquinol) 
ROS  Reactive Oxygen Species 
SDS dodecylsulphate  Na-salt 
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